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Age estimation is a vital part of the creation of a biological profile for the purposes of 
identifying unknown individuals. Numerous macroscopic methods of analysing bone have 
been developed for this purpose. In some cases, however, fragmentation of the bone, poor 
preservation, and taphonomic damage will not allow for the implementation of these 
methodologies. For these cases, microscopic analytical methods have become the standard, 
and in the past several decades methodologies using different parts of the skeleton have 
been developed, most notably those using the rib for age estimation. These histological age 
estimation methods rely upon the measurements for cortical area and osteon population 
density (OPD) for an accurate age estimation. While these population specific methods have 
proven accurate and useful for the purposes of age estimation, they do not consider the 
health of the individual whose age they are attempting to estimate. Chronic pathology can 
change the microstructure of osseous tissue, which in turn could influence the accuracy of 
histological age estimation methods. The purpose of this study is twofold. First, to examine 
the microstructure of chronically ill individuals and provide detailed descriptions of 
microstructural changes for visual identification of pathology. Second, to quantitatively 
evaluate pathological samples using both standard measurements used in most age 
estimation calculations, as well as detailed osteon specific histomorphometrics to measure 
the specific changes to Haversian systems in cases of chronic pathology. By considering both 
the qualitative and quantitative characteristics of pathological bone in comparison with 
healthy controls it will be possible to determine what the effects of pathologically affected 
bone on methods of age estimation could be. 
 
Pathological ribs (N=40) were obtained via autopsy from two populations (Albania and 
Crete), and from a modern skeletal collection (Crete). These were then compared with 
healthy ribs (N=40) obtained from autopsy (Crete) and from two modern skeletal collections 
(Crete and Cyprus). The mid-shafts were then prepared using standard protocols for 
histological methods. First, samples were assessed qualitatively. Samples were visually 
evaluated for abnormal microstructural features, and these features were then categorised. 
Samples were then divided and tested, using these pathological feature categories, by 
disease class and by age group. Second, samples were assessed quantitatively. Thin sections 
were first measured using the standard histological metrics of cortical area, OPD, number of 
complete osteons, number of fragmented osteons, and total number of osteons. Thin 
sections were then evaluated using a sampling method for ten osteon specific metrics 
(osteon maximum length, osteon minimum length, osteon circumference, osteon total area, 
osteon area, osteon circularity, canal area, canal maximum diameter, canal minimum 
diameter, and canal circularity). 
 
Assessment for qualitative features was done by identifying abnormal features of the bone 
microstructure and dividing them into three defined categories. Samples were then sorted 
into seven different disease classes and healthy controls, and the presence or absence of 
these pathological features was noted. The samples were then evaluated using a chi 
squared test. Inter and intra-observer errors were carried out for both quantitative sections 
 6 
using the Technical error of measurement (TEM), rTEM and the coefficient of reliability (R). 
Statistical analysis was carried out using RStudio. 
 
Next comparative statistics, including correlations and regressions, were run between the 
complete data set, the pathological set, and the healthy set, specifically testing the 
relationship between actual age and cortical area, and actual age and OPD.  This 
demonstrated that while the complete set did show a significant relationship between age 
and the two standard variables (R2 0.24 for cortical area and age, R2 0.21 for OPD and age), 
this relationship was stronger in the healthy data set (R2 0.32 for cortical area and age, R2 
0.46 for OPD and age), and much weaker within the pathological data set (R2 0.09 for 
cortical area and age, R2 0.01 for OPD and age). Next the measurements for osteon specific 
metrics were evaluated for their relationship to age as a complete data set, then as a set 
including the metric means of each sample, and finally as forty age matched pairs. This was 
done using t-tests, correlations, and regression analysis. Correlation analysis for metric 
means found significant relationships between osteon area, osteon total area, osteon 
minimum length, osteon perimeter, osteon maximum length, and age in the healthy group. 
All these variables had p-values of <0.004. In the pathological group, correlations between 
the metric variables and age were much weaker, with only three variables, osteon 
maximum length, osteon area, and osteon minimum length yielding statistically significant 
relationships, and the p-values for these three relationships were all greater than 0.02, 
significantly weaker than the healthy group. 
 
This research helps define visually identifiable pathological changes to the bone 
microstructure, and proves that there is a significant difference between the microstructure 
of pathological and healthy bone. It goes on to show that, while there is a strong 
relationship between certain microstructural elements and age which would be beneficial 
for creating population specific age estimation techniques, microstructural elements of 
pathological samples have much weaker relationships to age, and that their inclusion in data 
sets used to create population specific formulae would influence the method’s accuracy. 
Further, if a sample is known to be pathological and shows pathological microstructural 
features, any histological age estimation technique would be less effective, and that if 
applied. It is recommended that more research is carried out focusing on specific 





Age estimation is an important part of the process to identify unknown individuals. Many 
techniques have been developed for this purpose using observational methods, however in 
cases where the bone is fragmented or poorly preserved, these methods are not able to be 
used effectively. In these cases, histology, or microscopic analysis of thin sections, can be 
helpful, and several population specific methods have been developed for this purpose. 
While these methods have proven accurate and useful for the purposes of age estimation, 
they generally do not consider the health of the individual whose age they are attempting to 
estimate. Long-term pathology can often impact the microstructure of bone, which in turn 
can influence the accuracy of histological age estimation. The purpose of this study is to first 
examine the microstructure of bone from chronically ill individuals, and second, to attempt 
to quantify these microstructural changes and their potential effect on histological age 
estimation techniques. 
 
For this study, 80 rib samples, 40 from individuals with a history of chronic illness, and 40 
from healthy individuals as controls, were examined. The mid-shafts of the ribs were then 
prepared using standard histological preparation methods. Samples were visually evaluated 
for abnormal microstructural features, and these features were then categorised and 
significance of relationships between pathology and features were assessed. After the 
samples were visually assessed, each thin section was measured using standard histological 
techniques, as well as new more specific metrics of osteons, the building blocks of bone 
microstructure. Once the relevant measurements had been taken, statistical analysis was 
done to assess the relationship between the various microstructural elements and age, and 
whether the health status of the individual affected said relationships.  
 
This research helps to define visually identifiable changes to the bone microstructure 
related to health, and proves that there is a significant difference between the bone 
microstructure of healthy and chronically ill individuals. Further, while there are strong 
relationships between certain microstructural elements and age in healthy individuals, these 
relationships are much weaker in chronically ill individuals. This means that age estimation 
techniques would be better served taking an individual’s health status into account when 
creating population specific methods, and that histological age estimation techniques 
should not be used on identifiably pathological individuals. The results of this research have 
the potential of being used as a stepping stone to create diagnostic standards for 
pathological conditions using bone histomorphometry. It is recommended that there should 
be further research into specific illnesses and their effects, and more population specific 
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Close-up of sample CC83 exterior surface, a healthy 90-year-old female, 100x magnification; 
Bottom – full cross-section of sample CC83. (Pictures of CC83 courtesy of Julieta Garcia-
Donas), pp 131 
Figure 5.12: Left – Close-up of the exterior surface of sample B41 exterior surface, a 53-year-
old male with generalised fatty liver; Right – Close-up of the interior surface of sample CY61 
interior surface, a healthy 51-year-old female, 100x magnification. (image of sample CY61 
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uraemia, 100x magnification; Right – Close-up of the interior surface of sample CY190, a 57-
year-old healthy male, 100x magnification, pp 135  
Figure 5.15: Left - Close-up of the interior surface of sample FC13 (52-year-old male), from an 
individual suffering from hypertension, coronary disease, and pulmonary complications of 
chronic heavy smoking, showing signs of category 2 features. (100x magnification); Right - 
Close-up of the interior surface of sample CY191, (48-year-old male) healthy control. (100x 
magnification) (image of sample CY191 courtesy of Julieta Garcia-Donas) pp 136 
 19 
Figure 5.16: Heat map of Spearman’s correlations using the entire sample, and the converted 
p-values, pp 142 
Figure 5.17: Heat map showing Spearman’s correlations for only pathological samples, and 
converted p-values, pp 143 
Figure 5.18: Heat map showing Spearman’s correlations using only Healthy Samples, and 
converted p-values, pp 144 
Figure 5.19: Scatterplot of Age compared to Cortical Area for the entire sample with the line 
of regression, pp 145 
Figure 5.20: Scatterplot of Age compared to Cortical Area, separated by health status, with 
lines of regression, pp 146 
Figure 5.21: Scatterplot of Age compared to OPD for the entire sample with the line of 
regression, pp 148 
Figure 5.22: Scatterplot of Age compared to OPD, separated by health status, with lines of 
regression, pp 149 
Figure 5.23: Plot of R-squared of Age and Cortical Area regression bootstrapping using All 
Samples, pp 151 
Figure 5.24: Plot of R-squared of Age and Cortical Area regression bootstrapping using only 
pathological samples, pp 151 
Figure 5.25: Plot of R-squared of Age and Cortical Area regression bootstrapping using only 
healthy control samples, pp 153 
Figure 5.26: Plot of R-squared of Age and OPD regression bootstrapping using All Samples, pp 
154 
Figure 5.27: Plot of R-squared of Age and OPD regression bootstrapping using only 
pathological samples, pp 155 
Figure 5.28: Plot of R-squared of Age and OPD regression bootstrapping using only healthy 
control samples, pp 156 
Figure 5.29: Heat map showing p-value correlations between Age and osteon metric means 
for healthy control samples, pp 185 
Figure 5.30: Heat map showing p-value correlations between Age and osteon metric means 
for pathological samples, pp 186 
Figure 5.31: Scatterplot showing the distribution and lines of regression of osteon area metric 
means compared with Age, pp 187 
Figure 5.32: Scatterplot showing the distribution and lines of regression of osteon total area 
metric means compared with Age, pp 189 
Figure 5.33: Scatterplot showing the distribution and lines of regression of osteon minimum 
length metric means compared with Age, pp 190 
 20 
Figure 5.34: Scatterplot showing the distribution and lines of regression of osteon perimeter 
metric means compared with Age, pp 192 
Figure 5.35: Scatterplot showing the distribution and lines of regression of osteon maximum 
length metric means compared with Age, pp 193 
 
All images, unless otherwise specified, belong to the author.  
 21 
Table of Tables 
 
Table 4.1: Sample Age Distribution, pp 82 
Table 4.2: Table showing distribution of pathologies across the entire sample, pp 83 
Table 4.3: Table of standard histological elements and their definitions; as defined by Stout 
and Crowder (Stout & Crowder, 2012), pp 98 
Table 4.4: Table of the osteon specific metrics, pp 99 
Table 5.1: Distribution of feature categories by disease class, pp 124 
Table 5.2: Distribution of pathological features across age groups in the pathological sample, 
pp 125 
Table 5.3: Table showing the distribution of pathological features in the Healthy Control 
group, separated by age group, pp 126 
Table 5.4: Table of chi squared test results comparing categories of pathological features 
between the pathological and healthy control groups, further separated by age group, pp 137 
Table 5.5: Table of chi squared test results comparing categories of pathological features 
with disease classes, pp 138 
Table 5.6: Table of SEE calculations for linear regression comparing cortical area and age, 
and OPD and age, pp 150 
Table 5.7: Table showing results of independent t-test comparing two observers, pp 158 
Table 5.8: Showing p-values results from the t-tests for intra-observer error, pp 159 
Table 5.9: Welch two sample t-test results comparing the complete healthy set with the 
complete pathological set, pp 160 
Table 5.10: Pair 1 independent t-test results, pp 161 
Table 5.11: Pair 2 independent t-test results, pp 162 
Table 5.12: Pair 3 independent t-test results, pp 162 
Table 5.13: Pair 4 independent t-test results, pp 163 
Table 5.14: Pair 5 independent t-test results, pp 163 
Table 5.15: Pair 6 independent t-test results, pp 164 
Table 5.16: Pair 7 independent t-test results, pp 164 
Table 5.17: Pair 8 independent t-test results, pp 165 
Table 5.18: Pair 9 independent t-test results, pp 166 
Table 5.19: Pair 10 independent t-test results, pp 166 
 22 
Table 5.20: Pair 11 independent t-test results, pp 167 
Table 5.21: Pair 12 independent t-test results, pp 167 
Table 5.22: Pair 13 independent t-test results, pp 168 
Table 5.23: Pair 14 independent t-test results, pp 168 
Table 5.24: Pair 15 independent t-test results, pp 169 
Table 5.25: Pair 16 independent t-test results, pp 170 
Table 5.26: Pair 17 independent t-test results, pp 170 
Table 5.27: Pair 18 independent t-test results, pp 171 
Table 5.28: Pair 19 independent t-test results, pp 171 
Table 5.29: Pair 20 independent t-test results, pp 172 
Table 5.30: Pair 21 independent t-test results, pp 172 
Table 5.31: Pair 22 independent t-test results, pp 173 
Table 5.32: Pair 23 independent t-test results, pp 174 
Table 5.33: Pair 24 independent t-test results, pp 174 
Table 5.34: Pair 25 independent t-test results, pp 175 
Table 5.35: Pair 26 independent t-test results, pp 175 
Table 5.36: Pair 27 independent t-test results, pp 176 
Table 5.37: Pair 28 independent t-test results, pp 177 
Table 5.38: Pair 29 independent t-test results, pp 177 
Table 5.39: Pair 30 independent t-test results, pp 178 
Table 5.40: Pair 31 independent t-test results, pp 178 
Table 5.41: Pair 32 independent t-test results, pp 179 
Table 5.42: Pair 33 independent t-test results, pp 180 
Table 5.43: Pair 34 independent t-test results, pp 180 
Table 5.44: Pair 35 independent t-test results, pp 181 
Table 5.45: Pair 36 independent t-test results, pp 181 
Table 5.46: Pair 37 independent t-test results, pp 182 
Table 5.47: Pair 38 independent t-test results, pp 182 
 23 
Table 5.48: Pair 39 independent t-test results, pp 183 






Glossary of Acronyms 
 
ALD – alcoholic liver disease 
 
ALP – alkaline phosphatase 
 
BCa – bias-corrected and accelerated bootstrap interval 
 
BMD – bone mineral density 
 
BMI – body mass index 
 
BMP – bone morphogenic protein 
 
BMU – basic multicellular unit 
 
CAD – coronary artery disease 
 
CArea – canal area 
 
CCirc – canal circularity 
 
CHD – coronary heart disease 
 
CKD – chronic kidney disease 
 
CMaxL – canal maximum length 
 
CMinL – canal minimum length 
 
COPD – chronic obstructive pulmonary disease(s) 
 
CVD – cardiovascular disease(s) 
 
DISH – diffuse idiopathic skeletal hyperostosis 
 
DXA – dual-energy X-ray absorptiometry 
 
GnRH – Gonadotropin-releasing hormone 
 
GFR – glomerular filtration rate 
 
IDDM – insulin-dependent diabetes mellitus 
 
IHD – ischemic heart disease 
 
HTA – Human Tissue Authority 
 26 
 
MI – myocardial infarction 
 
NCD – non-communicable disease(s) 
 
NCP – noncollagenous proteins 
 
NIDDM – non-insulin-dependent diabetes mellitus 
 
OArea – osteon area 
 
OCirc – osteon circularity 
 
OMaxL – osteon maximum length 
 
OMinL – osteon minimum length 
 
OPD – osteon population density 
 
OPeri – osteon perimeter 
 
OPN – osteopontin 
 
OTArea – osteon total area 
 
TEM – technical error of measurement 
 
rTEM – relative technical error of measurement 
 
SEE – standard error of the estimate 
 
SWGANTH – Scientific Working Group for Forensic Anthropology 
 






In God we trust. All others must have data. 
 
- Bernard Fisher 
 
 
It’s easy to make perfect decisions with perfect information. Medicine asks you to make 
perfect decisions with imperfect information. 
 
- Siddhartha Mukherjee 
 
 
For as long as there have been living things, there have been diseases. Whether they were 
the consequences of microorganisms, viruses, or simply the cells of the body turned against 
itself, they have always existed, adapting to new environments, species, and defences. In 
terms of archaeology, infectious disease has dominated much of human history. While other 
diseases existed, they languished in the shadows, rarely wreaking as much havoc as their 
infectious brethren. Thing began to change, however, as modern science began to catch up 
with these microscopic monsters. Vaccines were developed, penicillin discovered, sanitation 
and hygiene improved. Diseases that had plagued humanity for thousands of years, like small 
pox, were eradicated by the coordinated efforts of the global community. After the infectious 
diseases were, in theory, under control, the other diseases that had been lurking in the 
background, have now come to the fore. The killers of today are generally not infections, but 
instead non-communicable diseases that have flourished from our modern lifestyles. 
 
According to the World Health Organization, non-communicable diseases (NCD’s) are 
responsible for 41 million deaths annually, approximately 71% of all deaths. This includes 15 
million people between the ages of 30 and 70, approximately 80% of all premature deaths. 
There are four major players who fall under the category of NCD’s. The highest death toll 
 28 
belongs to cardiovascular diseases, killing 17.9 million people annually. These include 
infarctions, heart attacks and strokes, the number one killer in the world today. Next is cancer, 
responsible for the deaths of 9 million people annually, then respiratory diseases, responsible 
for killing 3.9 million people annually, and lastly diabetes, responsible for 1.9 million deaths 
annually. Each of these diseases has the capacity to make changes inside the body, altering 
metabolism, changing hormone levels, and affecting other bodily systems. Although these 
diseases have always existed, they have blown up to epidemic proportions, thanks in large 
part to the lifestyles, habits, behaviours, and commodities made available by modern living. 
The inhaling or ingesting of harmful substances, like smoking, drinking alcohol, and breathing 
in the toxic fumes of factories and cities, as well as unhealthy diets full of processed, nutrient 
poor foods, and inactivity, have all lead to the prevalence of these diseases. Although many 
of these lifestyle changes originated in the high-income countries of the western world, NCD’s 
now disproportionately affect the populations of middle and low-income countries, with 
deaths in the developing world now making up three quarters of all NCD deaths (World Health 
Organization, 2018). Without meaningful and drastic changes, to our modern lifestyles, the 
death toll from NCD’s will only increase. 
 
What does the advent of the NCD mean for the osteologist? These diseases are chronic 
conditions, developing over the course of months and years. Unlike many infections of the 
past, the time and the systemic effects of these diseases allow them to penetrate the slow 
metabolism of bone. Many of these diseases set in motion a cascade of pathological effects, 
triggering responses in system after system, until it finally reaches the skeletal system. While 
in the past seeing the bone loss associated with osteoporosis was restricted to the elderly or 
the infirm, it is now possible to see its effects in much younger individuals, thanks in large 
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part to the influence of NCD’s. What we know about the human skeleton is being 
fundamentally changed by these diseases. The methodologies developed over the past one 
hundred years on past populations to create a biological profile, could no longer work on 
modern populations. These diseases have the potential to change not only what we see when 
we observe bone macroscopically, but microscopically as well. 
 
At the microscopic level, changes in the metabolic process have the potential to derail the 
bone remodelling process. A change in hormone levels can trigger the destructive cells of 
bone, leaving them to outpace the constructive cells behind them, leading to a loss of bone. 
The presence of a neoplasm can have the opposite effect, stimulating the constructive cells, 
and creating proliferative lesions or rapid deposits of bone on the periosteum. Either effect 
will alter what is seen in cross-section, and potentially affect the methods developed for 
histological bone analysis, in particular age estimation.  
 
Since the 1960’s, when Jowsey (1960) discovered a possible connection between bone 
microstructure and age, biological anthropologists have been using these relationships for 
the creation of biological profiles. Kerley (1965) was the first to use the correlation between 
cortical area and age, and osteon population density (OPD) and age to develop a histological 
age estimation method for thin sections taken from the femur. Ever since, methods have 
continued to be developed and improved by a host of scientists, all attempting to predict the 
age at death of an individual from a small thin section or core of bone. In the 1970’s Thompson 
(1979) improved upon Kerley’s work by using core samples instead of thin cross-sections, 
making the method less destructive and time consuming. In the 1990’s another significant 
improvement was made, with the introduction of the Stout and Paine method (1992) using 
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the rib and clavicle. Using the ribs, bones that are generally less significant in terms of other 
methodologies used to create biological profiles, was therefore a better choice than the long 
bones in terms of destructive techniques. As the next twenty years moved on, more studies 
appeared, improving on the past by accounting for differences in population (Cho & al., 2002), 
sexual dimorphism (Mulhern & Van Gerven, 1997), nutritional status (Paine & Brenton, 2006) 
and paleopathology (Schultz, 2001). Through each new development, these methods all 
relied upon the same fundamental principles first set out by Jowsey and Kerley, making the 
original idea more accurate, and better for forensic use. Each of these histological age 
estimation methods rely upon the microstructural elements of cortical area and OPD, and 
their relationship to age. While it has been acknowledged that individuals over the age of 50 
yield less accurate results (Christensen, et al., 2014), due to the changes intrinsic in the aging 
process, considerations of these types of skeletal changes are rarely considered in the cases 
of younger individuals.  If, however, these chronic metabolic diseases have a chance to affect 
the microstructure of the bone, especially in those individuals normally deemed young 
enough for worthwhile histological age estimation, it could potentially interfere with the 
ability of these techniques to accurately assess age.  
 
While accuracy is appreciated in all forms of science, including biological anthropology in the 
archaeological context, it becomes absolutely vital in the context of forensics. There, the 
accuracy of the biological profile could mean the difference between identifying a victim or 
not. It has a real, and profound effect on the abilities of the justice system. In this day and 
age, with the realities of migration crises, regional conflicts, civil unrest, and increasing natural 
disasters caused by global warming, the forensic anthropologist’s ability to create an accurate 
biological profile for the purposes of identification is only increasing in importance. While no 
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estimation method is perfect, as referenced in the second quotation at the beginning of this 
chapter, forensic scientists, like doctors, are forced to try to make perfect decisions with 
imperfect information. By increasing the knowledge base, and accounting for more variables, 
such as the increase in non-communicable diseases and their potential effects on the 
microstructure of the skeleton, it is possible for forensic anthropologists to and make better, 
more informed decisions, and create better, more informed biological profiles. The key is to 
understand these new variables to the best of our abilities. 
 
This study hopes to delve deeper into the consequences of chronic disease on the skeletal 
system and its microstructure than previous studies have allowed. By making visual analyses 
of thin sections of both pathological and healthy ribs, and categorising the pathological 
features, it may be possible to simplify the identification of these features, making this kind 
of pathological assessment more accessible to other bone histologists. It further endeavours 
to quantify the changes made to the microstructure by the presence of pathology, and to 
assess the influence these changes have on the vital elements of cortical area and OPD. By 
quantifying these changes, they will not only provide support to the visual analyses of this 
and other studies, but also provide a platform for further studies make corrections to existing 
methods and formulae. In addition, these quantifications and analyses will be useful for 
forensic applications, as they will be able to enumerate the amount to which current forensic 





2. Literature Review 
2.1 Bone Histology 
2.1.1 Introduction to Bone Biology 
Before beginning with the purpose of this study, it is first important to understand the 
fundamentals of bone biology. By understanding how bone is composed, its mechanical 
properties, its function in the human body, and how its microstructure is composed, it will be 
easier to understand what is happening when things go wrong in the presence of pathology. 
Once understood, it will be possible to discuss both the response of bone to pathology, and 
also its response to a pathology in other systems. Discussing the rudiments of bone biology 
will also lay the groundwork for understanding the fundamentals of bone histology, and how 
biological anthropologists use these microstructures to understand more about bone as a 
tissue, as well as the individual being studied.  
 
2.1.1.1 Introduction to Osseous Tissue 
Bone or osseous tissue is what makes up bones, the primary elements of the skeletal system 
(Gray, 2010) At its most fundamental level, bone is a multifunctional tissue. It provides 
support and protection for the body, is quintessential in mechanical function, as well as 
hematopoiesis and hormone production (Burr & Akkus, 2013). In essence, the skeletal system 
provides the scaffolding for the entire human body, and along with the muscular system, is 
what allows the body to move. 
 
Bone can be observed on different microanatomical levels. The first level is the bone tissue 
itself. The second level is the microstructure and concerns the osteons and lamellae that make 
up the osseous tissue. The next level is the nanostructure and concerns the combination of 
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collagen and mineral deposits that come together to make the tissue. The final level is the 
molecular level and concerns the actual molecules that make up the crystal lattice of the 
osseous tissue (Burr & Akkus, 2013). While this study is primarily interested in the 
microstructural level, a basic understanding of the other microanatomical levels is necessary 
to understand why bone reacts to pathological stimuli the way it does. 
 
2.1.1.2 Bone Composition 
Bone is a unique tissue, in that it is made up of both organic and inorganic material, in this 
case, it is a mix of carbonated apatite and collagen. When weighed, approximately 65% of 
osseous tissue is made up of mineral materials, and between 20-25% collagen. The remainder 
is made up of water (Burr & Akkus, 2013). The nanostructure of bone is then made up of 
bundles of collagen fibrils, with crystals of hydroxyapatite embedded in the bundles of 
collagen. This structure is then what makes up the collagen matrix (Olszta, et al., 2007). It is 
during the mineralisation process that the mineral crystals are deposited in and around the 
collagen fibrils (Rey, et al., 2009). In addition to these materials, there is a small amount of 
noncollagenous proteins (NCP’s) that help to regulate the construction and maintenance of 
the bone’s nanostructure (Burr & Akkus, 2013). This combination of organic and inorganic 
materials is essential to providing bone with its unique properties; the mineral material 
provides strength and rigidity, while the collagen lends flexibility and elasticity to the material 
(Clarke, 2008). 
 
Mineralisation is the process through which inorganic minerals are deposited within and 
around the collagen matrix. This takes place in two phases, primary and secondary 
mineralisation. During the initial primary phase of mineralisation, the crystals of 
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hydroxyapatite that are deposited within the framework of the collagen make up about 65-
70% of the osseous tissue’s total mineralisation. This occurs within three weeks of the first 
deposition of collagen. The next phase of mineralisation takes longer, with the crystals slowly 
accumulating more mineral deposits, growing to the physiologic limit. This can take anywhere 
from months to years (Burr & Akkus, 2013). This enlargement of the crystals occurs both as 
crystal growth and aggregation of mineral materials (Clarke, 2008). Vitamin D also plays a role 
in stimulating the mineralisation of bone, although indirectly. After being synthesised by the 
liver, the kidney is then triggered to produce serum 1,25-dihydroxyvitamin D. This serum then 
helps to maintain calcium and phosphorus to allow for passive mineralization of 
unmineralised matrix (Clarke, 2008). The arrangements of these collagen fibrils and mineral 
crystals within bone tissue varies slightly, adapting to the type of bone it will become, either 
trabecular or cortical bone (Burr & Akkus, 2013; Clarke, 2008; Augat & Schorlemmer, 2006).   
 
Moving up from the nanostructure of bone, the collagen fibrils and mineral crystals can be 
arranged into one of two forms; woven, or lamellar bone. Another form of bone, plexiform 
bone, does exist, however this form is rarely, if ever, found in humans (Burr & Akkus, 2013). 
Woven bone is quickly deposited and disorganised in nature (Burr & Akkus, 2013). The 
orientation of the collagen fibrils is loose and random, making it less structurally sound than 
lamellar bone (Currey, 2003). Woven bone, as a rapidly deposited scaffolding for lamellar 
bone, can appear at the site of a healing fracture and in proximity to pathology, such as 
hyperparathyroidism or Paget’s disease (Clarke, 2008; Burr & Akkus, 2013). In contrast, 
lamellar bone is deposited slowly, and usually in organised sheets of fibrils and crystals, 
forming Haversian systems in the cortical bone, and trabeculae in the trabecular bone (Burr 
& Akkus, 2013). Due to its organised and slow growing nature, lamellar bone is known to be 
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stronger than woven bone (Clarke, 2008). Of interest to this study is the lamellar bone found 
in the cortical bone, especially as it relates to the formation of secondary Haversian systems. 
 
Bone tissue usually exists in one of two forms: trabecular or cancellous bone, and cortical or 
compact bone. While these two different organisations of osseous tissue fulfil different 
purposes, they are essential to the proper function of the skeletal system. Trabecular bone is 
sometimes referred to as spongy bone, is organised in a honeycomb-like structure, and is 
found on the interior of vertebrae, ribs, the iliac crest, and in the metaphyses of the long 
bones. It provides structural support for the skeletal system, but its spongy, porous nature 
prevents it from adding too much weight. Overall, it makes up only about 25-30% of bone 
tissue by weight (Burr & Akkus, 2013). In contrast, cortical bone is the dense, hard, outer layer 
of most bone. It is what makes up the diaphyses and shafts of the long bones, and provides a 
hard, protective covering for the trabeculae of the vertebra, ribs, iliac crest, and skull. Unlike 
the porous trabecular bone, cortical bone is only has about 3-5% porosity (Burr & Akkus, 
2013). While trabecular bone in general has a higher turnover rate than cortical bone, it lacks 
the secondary osteons used in most histological age estimation methods. For this reason, this 
study will focus on the microstructure of cortical bone, as this is where the secondary osteons 
used in age estimation are found. 
 
2.1.1.3 Haversian Systems 
 
Haversian systems are the formations within the cortical bone that allow for the blood supply 
to reach the osseous tissue. These systems exist primarily in the intracortical area of the bone. 
The cortical bone has three distinct areas to observe in cross-section, the endosteal surface, 
the intracortical bone, and the periosteal surface. These refer the interior surface adjacent to 
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the medullary cavity, the cortical bone between the surfaces home to the osteonal lamellar 
bone, and the exterior protective surface of the bone, respectively (Currey, 2003). Lamellar 
bone exists in two morphological types; circumferential and osteonal lamellar bone. 
Circumferential lamellar bone is a part of the modelling process and occurs during bone 
growth. It can be found most often near the endosteal and periosteal surfaces. These are 
distinctive in that they do not follow the same patterns as osteonal lamellar bone. Osteonal 
lamellar bone is the production of the remodelling process and occurs as a part of bone 
maintenance. It is most often found in the intracortical bone (Reznikov, et al., 2014). 
According to Giraud-Guille, osteonal lamellar bone can be described as a series of nested arcs 
of “twisted plywood” structured collagen fibrils. This arrangement of fibrils creates the 
concentric circular formations seen in cross-section (Giraud-Guille, 1988). These layers are 
made up of fibrils arranged in both organised and disorganised motifs. The organised motif is 
usually around 2-3 µm thick, while the disorganised motifs are thinner, usually only about 
0.25-1 µm thick (Reznikov, et al., 2014). These formations of osteonal lamellar bone then 
create both the primary and secondary osteons observed in cross-section (Reznikov, et al., 
2014).  
 
These formations often appear in cross-section as concentric circles of lamellar bone arranged 
around a central canal that houses a blood vessel. These systems usually form in one of two 
ways, either as primary or secondary cortical bone (Burr & Akkus, 2013). Primary bone is 
formed during the modelling process, and generally is more common in juveniles, as they are 
still generating new bone, rather than remodelling old bone. In this case, the lamellar bone 
does not completely form concentrically around a canal for a blood vessel, as the bone is 
growing too fast to fully envelop the vessels. These are referred to as primary because they 
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tend to form during the first phase of lamellar bone growth, and therefore are a part of the 
bone modelling, rather than remodelling, process. These are known as primary osteons 
(Kerley, 1965). On average, primary osteons are smaller than those found in secondary bone, 
usually between 50-100 µm in diameter (Burr & Akkus, 2013). 
 
Secondary bone forms after primary bone and is a part of the remodelling process, essentially 
the maintenance of the osseous tissue. Like most bodily tissues, it is required for osseous 
tissue to turn over and be replaced. This occurs when previously existing bone is resorbed, 
and new bone tissue is created in its place. This results in the full concentric formation of 
lamellae around the central Haversian canal known as a secondary osteon (Burr & Akkus, 
2013). These concentric formations are then bounded by a reversal or cement line, marking 
the edge of tissue resorption and recreation (Kerley, 1965). In addition to the presence of a 
cement line, and the complete nature of the concentric circle of lamellar bone surrounding 
the Haversian canal, secondary osteons are also larger than primary osteons, on average 
measuring 100-250 µm (Burr & Akkus, 2013). It is these secondary osteon formations that are 
of concern to this study, both as an indication of health, and as a tool for histological age 
estimation. Secondary bone is common in adults, and the number of secondary osteons seen 
in the bone cross-section often increases and becomes more crowded with age (Kerley, 1965). 
 
Secondary osteons, sometimes referred to simply as osteons, are the building blocks of bone 
microstructure, and represent the mature network of Haversian systems and canals that flow 
through the dense cortical bone. The concentric formations of lamellae surrounding the canal 
are what make up the osteon (Burr & Akkus, 2013). While these appear circular when viewed 
in cross-section, in the actual bone they are more like tubes, branching out and connecting 
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with other canals (Maggiano, 2012). Osteons are formed during the remodelling process, 
when osseous tissue replaces itself, which is a function of the bone’s metabolism. Due to the 
angle of the cross-section, osteons can appear in different shapes than the standard 
concentric circles. If the thin section is cut along a branch of the canal, the canal can appear 
elongated. If the thin section is cut not perfectly perpendicular to the canal shaft, the lamellar 
bone can appear elongated on one side, this is referred to as a drifting osteon. As the 
individual ages, as a consequence of remodelling, new osteons form on top of old osteons, 
sometimes obscuring the old canals and cement lines (Maggiano, 2012; Kerley, 1965). It is 
this phenomenon of bone remodelling and replacement of Haversian systems that this the 
subject of this study. 
 
2.1.1.4 Bone Metabolism 
Bone metabolism refers to the growth and maintenance of osseous tissue. As mentioned 
earlier, like any other bodily tissue, bone tissue is dynamic. It grows, gets worn out, and needs 
to be replaced. While this generally happens much slower in bone than in other bodily tissues, 
it still requires a certain amount of turnover. In the case of osseous tissue, the cells turnover 
about every three months. This occurs throughout the person’s life (Gray, 2010; Maggiano, 
2012).  
 
Bone growth and maintenance is usually divided into two categories; modelling and 
remodelling. Modelling refers to the growth of bone tissue, and is usually seen in juveniles, 
and near the endosteal and periosteal surfaces.  It determines the size and the shape of the 
bone (Frost, 1969). In the initial stages of bone growth in embryonic tissue, growth is divided 
into two categories of formation; endochondral and intramembranous. Endochondral bone 
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formation involves bone that is created from a scaffold of avascular hyaline cartilage. 
Intramembranous bone formation involves the formation of bone within a highly-
vascularised membrane (Scheuer & Black, 2004). These sites of ossification usually begin as 
woven bone, often seen in foetal bones. As the child ages, this woven bone then develops 
into lamellar bone. This lamellar bone is characterised as primary bone and is studded with 
primary osteons formed around the early Haversian systems. During the remodelling process, 
this primary bone changes again, this time developing into the more complex secondary bone 
(Scheuer & Black, 2004). 
 
Remodelling refers to the maintenance of osseous tissue. By destroying and replacing the old 
bone cells, the body is able to maintain the homeostasis of the tissue. This is done by the 
coordinated efforts of two types of cells, osteoblasts and osteoclasts. These cells together are 
referred to as a basic multicellular unit (BMU) (Frost, 1966). Together, these BMU’s break 
down the lamellar bone, and rebuild new Haversian systems. When new osteons are built by 
the BMU’s, they rarely create the new Haversian system in the exact same place, leaving 
partial or fragmented osteons behind. Over the course of an individual’s lifetime, their bone 
will shift from mostly primary bone, to creating more and more secondary osteons, until 
finally a cross-section of their bone would be completely covered in complete and fragmented 
osteons, leaving no primary lamellar bone visible. Due to the fact that bone continuously 
remodels throughout an individual’s life, and because it creates visually distinct micro-
features such as osteons, it is possible to use these features to estimate the age of the 
individual at death (Stout & Crowder, 2012; Kerley, 1965; Frost, 2001).  
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In order for either modelling or remodelling to occur, two types of cells must be present. 
These are osteoblasts and osteoclasts. The first of these cells, osteoblasts, are the building 
cells. They are responsible for bone mineral secretion and mineralisation of bone, and are the 
creators of the bony matrix. Osteoblasts originate from mesenchymal progenitors, which also 
produce other types of cells, including muscle cells, chondrocytes, and adipocytes (Bellido, et 
al., 2013).  In the case of bone modelling, osteoblasts act first, laying down new bony matrix, 
and allowing from the growth of bone in foetuses, infants, and juveniles. In in the case of 
remodelling, osteoblasts act as a part of the BMU. They act second, following the destruction 
of the osteoclasts and remaking the bone that was destroyed in the same place, thereby 
maintaining the osseous tissue that was already there (Seeman, 2008). Once their task has 
been completed, the cells either die by apoptosis, remain trapped in the matrix as osteocytes, 
or coat the bone as bone lining cells (Bellido, et al., 2013). 
 
The other half of the BMU is the osteoclasts. These work in tandem with the osteoblasts 
during remodelling, destroying old bone to make way for the new bony matrix created by the 
osteoblasts. Different to osteoblasts, osteoclasts come from hematopoietic progenitors, from 
which macrophages also originate. It is the function of these cells to resorb the existing bony 
matrix, by excreting a variety of enzymes, which in turn break down the bone (Jähn & 
Bonewald, 2012). During the bone resorption process, osteoclasts become polarised and 
create three distinct membrane zones; a sealing zone to seal off the area from bone that is 
not to be resorbed, a secretory zone for secreting of bone resorbing enzymes, and a ruffled 
edge. This ruffled edge, referred to as a Howship’s Lacuna, appears within the sealing zone 
and can be seen in cross-section (Väänänen, et al., 2000). Unlike osteoblasts, which are quite 
plentiful, osteoclasts are rare, with only two or three existing in each µm3 of bone tissue. They 
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are also much larger in size than osteoblasts (Jähn & Bonewald, 2012). The resorption cycle 
of the osteoclasts ends with the cells either dying by apoptosis, or returning to an inactive, 
dormant state (Väänänen, et al., 2000). 
 
There is a third type of cell involved in bone that should be mentioned. These are the 
osteocytes. They are the most populous cells in bone and make up about 90% of the cells 
within the bony matrix. Osteocytes are made up of osteoblasts that have become trapped in 
the lamellar bone. These can be seen in cross-section, as each cell is entrapped within a 
lacuna. They can be connected and communicate within the bone through narrow canaliculi 
between the layers of the bony matrix. These canaliculi also reach from the endosteal surface 
to the periosteal surface. It is thought that these cells act in a mechano-sensory function, 
controlling the modelling and remodelling processes, and helping the bone to adapt to stress 
and environmental factors (Bellido, et al., 2013). In addition, osteocytes appear to be 
instrumental in the regulation of mineral homeostasis, as well as the availability of calcium 
and phosphates (Jähn & Bonewald, 2012).   
 
2.1.1.5 Bone Pathology 
The above explanation of bone metabolism assumes that the process is uninhibited and that 
the systems of the body are healthy. When everything is working as it should, the activities of 
osteoblasts and osteoclasts are perfectly in balance, and remodelling works as it should, 
maintaining the same amount of bone. If, however, this balance is interfered with in the form 
of pathology, either a primary pathology originating in the bone, or a secondary pathology 
originating in another of the bodily systems and affecting the bone, this system can break 
down. In this case, bone generally behaves in one of two ways; either the osteoblasts outpace 
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the osteoclasts and bone is produced faster than it can be destroyed causing an excess, or the 
osteoclasts outpace the osteoblasts and bone is destroyed faster than it can be regenerated 
causing the bone to become diminished and porous (Väänänen, et al., 2000; Ortner, 2003). 
This can happen either in a localised area, often on the periosteum, the exterior surface of 
the bone, causing a lesion, or it can occur throughout the bone, such as in the case of 
osteoporosis (Burr & Akkus, 2013). In either instance, the metabolism of the bone is thrown 
out of balance, causing changes to the foundations of the bony matrix and affecting the 
microstructure of both the cortical and trabecular bone (Schultz, 2012). For the purposes of 
this study, the focus will be on the changes to the microstructure of the cortical bone, as this 
is the area of primary interest for age estimation techniques (Kerley, 1965). 
 
Lesions and Periostitis 
In general, localised reaction of the bone to disease is referred to as a lesion. As mentioned 
above, this can either be a lytic lesion, which is destructive, or a prolific lesion, which is 
constructive. Lytic lesions tend to be the result of slow, chronic, progressive disease, and 
often form on the bone adjacent to the lytic focus, or source of disease. These are most often 
caused by an imbalance in the BMU favouring the destructive osteoclasts. (Ortner, 2003). In 
most of these cases, the lesion will be sharply defined, and the surrounding bone will appear 
generally unaffected. The lytic focus can either be a primary bone disease, or the effects on 
the bone can be related to a disease of the soft tissue adjacent to the bone, for example, 
metastatic neoplasms (Ortner, 2003). 
 
In contrast, prolific lesions, are often caused by an imbalance of the BMU favouring the 
constructive osteoblasts. Generally, this results in bone hypertrophy, which can occur 
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throughout the skeleton, or localised, and can occur in any part of the skeletal system. 
Proliferative lesions are often further broken down categorically depending on the area of 
the bone they predominantly affect. Lesions that occur on the outer surface of the bone are 
classed as periostitis, referring to the inflammation of the periosteum. Osteitis or endostosis 
refer to inflammation of the inner compact bone and Haversian systems, as well as the bone 
surface adjacent to the medullary cavity (Ortner, 2003). Again, periostitis is often the result 
of chronic conditions, some originating in the bone, and others adjacent to the bone. An 
example of disease originating in the bone that might cause dramatic periostitis is 
osteosarcoma. Most often, however, periostitis arises secondary to an infection (Ortner, 
2003). Another kind of proliferative lesion that may occur is hyperostosis, or excessive 
production of the outer layer of bone (periosteum) (Martin, 2010). Hyperostosis often affects 
the bones of the skull, but can also affect other areas in relation to other skeletal diseases 
such as diffuse idiopathic skeletal hyperostosis (DISH) (Ortner, 2003; Ortner, 2003; Lill, 2013). 
 
Osteoporosis 
Bone is a metabolically sensitive tissue, meaning it is susceptible to changes in metabolism 
throughout the body. These metabolic changes can cause an imbalance in the metabolism 
and mineralisation of bone, with the potential to cause several skeletal diseases, including 
osteopenia and osteoporosis (Imel, et al., 2014).  Osteopenia and osteoporosis are common 
disorders related to an unusual loss of bone, osteopenia being the general term for bone loss 
of any kind, and osteoporosis referring to increased porosity of osseous tissue that results in 
lower bone mass (Rosenberg, 1999; Ortner, 2003). They can also be defined by the degree of 
bone loss, with osteopenia being defined as 1.0-2.5 standard deviations below the young 
adult reference mean when measured by dual-energy X-ray absorptiometry (DXA), and 
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osteoporosis as greater than 2.5 standard deviations below the young adult reference mean 
when measured with DXA (Imel, et al., 2014). Osteoporosis can occur either generally, 
affecting the entire skeleton, or it can affect specific bones, due to disuse (Rosenberg, 1999). 
In either case, the diminishing bone mass is important, as it can, and often does, lead to 
fracture (Rosenberg, 1999; Imel, et al., 2014).  
 
The most common forms of osteoporosis are senile, and postmenopausal osteoporosis. This 
is due to the imperfect remodelling sequence that maintains the osseous tissue. The 
maximum skeletal bone mass is achieved in early adulthood, and subsequently a deficit 
begins to accumulate with each cycle of remodelling, eventually adding up to a noticeable 
loss of bone mass (Rosenberg, 1999). While there are many contributing factors to 
osteoporosis and bone mass, often it is linked to physical activity, diet, hormone balances, 
muscle strength or atrophy, as well as vitamin D absorption (Rosenberg, 1999). In addition to 
the reduction in bone mass observed in individuals as they age, females are also more likely 
to lose additional bone mass in the decades after menopause, likely due to the change in 
hormonal balance, specifically an oestrogen deficiency. Females can lose up to 35% of their 
cortical bone, and up to 50% of their trabecular bone in the three or four decades after 
menopause. Age related osteoporosis and postmenopausal osteoporosis results from slightly 
different imbalances; senile osteoporosis results from a decrease in bone formation involving 
osteoblasts, while postmenopausal osteoporosis is marked by an increase in destructive 
osteoclast activity. Ultimately the result in either case is bone loss (Horvai, 2015). Although 
senile and postmenopausal osteoporosis are the most common forms of osteoporosis, 
osteoporosis is a known comorbidity of many conditions, and also may be connected to other 
diseases due to treatments or resultant inactivity. Of particular note are several thyroid 
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conditions (hyperparathyroidism, and hypo-hyperparathyroidism), type 1 diabetes, Addison’s 
Disease, multiple myeloma, various conditions related to insufficient nutrition (malnutrition, 
malabsorption, vitamin C and D deficiencies, hepatic insufficiencies), chemotherapy, 
corticosteroid use, anticonvulsants, alcohol abuse, pulmonary disease, and anaemia, among 
others (Rosenberg, 1999).  
 
While osteoporosis is often systemic, and does affect the entire skeleton, it does not usually 
affect all bones equally. Often the first bones to be affected, and the most severely affected, 
are the vertebrae, with the trabeculae of the vertebral bodies diminishing, and sometimes 
collapsing. This can force the vertebrae into a wedge shape and cause secondary kyphosis of 
the spine (Ortner, 2003). Another area where the trabeculae are often affected, causing 
collapse, is the femoral head and neck, which put the individual at risk for dangerous and 
painful hip fractures (Imel, et al., 2014). Both of these common problems are caused by the 
bone density loss in the trabecular scaffolding inside the bones. While these are the most 
common and often most dramatic consequences of osteoporosis, bone loss does eventually 
reach the cortical bone as well. This is because the remodelling process is slower within the 
denser cortical bone than the spongiform loose structure of the trabeculae (Ortner, 2003). 
One of the consequences for cortical bone in the development of osteoporosis is the 
‘trabecularisation’ of the cortical bone, with the endosteal surface being transformed into a 
very porous, spongiform-like structure resembling the trabeculae. This in turn results in the 
thinning of the cortical bone (Parfitt, 1984). Another consequence involves the remodelling 
of Haversian systems, where osteoblasts are not able to replace the resorbed bone cleared 
by the osteoclasts, which results in a thinning of the osteon wall and larger canal sizes (Ortner, 
2003). For the purposes of this study, the changes to the cortical bone in the ribs as a result 
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of systemic osteoporosis will be of particular interest, as these changes not only provide proof 
of skeletal involvement in disease originating in other systems, but also have the potential to 
affect the results of the histological age estimation techniques widely used today. 
 
 
2.1.2 Introduction to Bone Histology 
 
2.1.2.1 Introduction to Bone Histology Methods and Uses 
Once the building blocks of bone biology and microstructure are understood, the next step is 
to observe these microstructures. How these microstructures are observed is through bone 
histology. This involves the cutting of thin cross-sections of bone, between 100 and 75 µm 
thick, to be observed through either transmitted light or polarised light microscopy (Kerley, 
1965). It is also possible to observe bone histologically using a coring method, in addition to 
cross-sections, as this is more practical for certain bones and less destructive (Yoshino, et al., 
1994; Thompson, 1979). While bone histology is, in essence, a destructive methodology, it is 
sometimes the best option for making observations. For example, if the bones have been 
broken, or if the skeleton is largely incomplete, making the use of macro analytical methods 
impossible, histology can be done on the fragments to assess certain aspects of the individual, 
such as age at death (Kerley, 1965). In the case of small fragments of bone where the species 
is not clear from macro observation, histology can also be used to distinguish between animal 
and human bone, an essential distinction in some forensic cases (Mulhern & Ubelaker, 2012).  
 
Scientists have been observing the microstructures of cortical bone via thin sections since the 
1960’s, when Jowsey first published observations and analysis of a femoral cross-section 
(Jowsey, 1960). These early sections involved embedding a piece of a femur in methyl 
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methacrylate, and taking a thin section, approximately 100 µm thick, of a complete cross-
section of the midshaft of femurs. From these thin sections, Jowsey observed changes to the 
Haversian systems dependant on the age of the individual (Jowsey, 1960). These initial 
observations have become the jumping off point for many studies making use of histological 
analysis of dry bone thin sections to estimate the age of individuals at death. 
 
In 1965, Kerley took these observations of age-related changes to the cortical microstructure 
and created some of the first age estimation methods using thin sections of bone (Kerley, 
1965). While there were problems with these early formulae, as discovered by Ahlqvist and 
Damsten in 1969, they provided a starting point for many more studies incorporating other 
bones and newer techniques (Ahlqvist & Damsten, 1969). Kerley later revisited the earlier 
femoral formula, changing the regressions and improving upon the original work (Kerley & 
Ubelaker, 1978). Studies continued to explore the histology of long bones, especially the 
femur. Several studies, including Stout and Gehlert (1982), and Lynnerup and colleagues 
(2006), explored Kerley’s revised method from 1965 and 1978, discussing the effect of field 
size and subjectivity of the methods. From Jowsey and Kerley’s research involving the femur, 
more studies appeared exploring the use of other bones for histological methods. Stout and 
Stanley explored the use of the radius, tibia, and fibula; Uytterschaut (1985), and Thompson 
and Galvin (1983) explored the tibia more in depth; and Yoshino and colleagues (1994) looked 
into the humerus. Pfeiffer and Zehr (Pfeiffer & Zehr, 1996) used research into the histology 
of the humerus to age a Neanderthal. Nor and colleagues (Nor, et al., 2014) considered the 
validity of all the long bones.  
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After the different long bones had all be explored, validation studies began appearing. These 
studies served to enhance and improve the methods. The most important of these were 
population specific studies, as it was found that the original methods, while affective for the 
populations used to develop them, needed to be adapted to accurately age other 
populations. Ericksen (1991) tested femoral methods on samples from North America, the 
Dominican Republic, and Chile. Ruff and colleagues (Ruff, et al., 1984) tested the method on 
a prehistoric Native American population from the coastal region of Georgia. Two other 
population studies involved a population from Sudanese Nubia (Martin, 1983; Mulhern & Van 
Gerven, 1997). Maat and colleagues (2006) then tested femoral methods on a Dutch 
population. Later, Han and colleagues (2009) study tested Maat’s revised method on a Korean 
population. These studies implied that histological age estimation methods increased in 
accuracy when tailored to the observed population. In addition to the differences posed by 
different populations, there also appeared to be differences based on sexual dimorphism of 
the long bones (Mulhern & Van Gerven, 1997; Samson & Branigan, 1987). All of these studies 
moved the use of bone histology for age estimation forward, improving on previous methods, 
creating more and more accurate techniques for estimating age from histology of the long 
bones. 
 
Of course, histological analysis for age estimation was not only tested on the long bones. As 
long bones are of use for macro analysis, it is rare that destructive methods are undertaken 
on these bones. In the early 1990’s, several methods were developed using histology of the 
ribs and clavicles, solving several problems posed by the previous long bone methodologies. 
It is these methods that are explored further in this study. 
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2.1.2.2 Bone Histology and Age Estimation Using Ribs  
In the 1990’s a method for accurately aging skeletal materials using bone histology of rib thin 
sections was developed by Stout and Paine (1992). This method was developed using an 
American sample, including both white and African Americans. In their 1992 paper, they 
describe how by using thin sections of ribs or clavicles it was possible to take measurements 
and counting osteon density, which when inserted into their formula would yield the age of 
the individual (Stout & Paine, 1992). Stout and Paine then revisited the method and improved 
upon the original formulae in 1994 (Stout & Paine, 1994). These formulae were partially 
inspired by the case study Stout did using histology of the 6th rib for age estimation of the 
painter Pizarro in the late 1980’s (Stout, 1986). 
 
Methods using the ribs, such as the Stout and Paine method, while based on Kerley’s method 
from 1965, had several benefits over previous methods involving histological age estimation. 
Firstly, it utilises ribs, which are much more likely to be available for thin sectioning than major 
long bones, as the long bones would most likely be kept intact for standard macro osteometric 
methods (Streeter, 2012). Secondly, as the bones being thin sectioned are much smaller, it is 
reasonably possible to count the true osteon population of the sample, rather than several 
sample population densities from different areas of the sample, as was done with thin 
sections or cores from the leg bones (Kerley, 1965; Thompson, 1979). In addition, although 
Stout and Paine’s method specifies the sixth rib, further study has determined that non-sixth 
mid-thoracic ribs yield similar results (Crowder & Rosella, 2007). This is important as ribs are 
often broken when retrieved in skeletal form, and it is then difficult to determine the exact 
rib placement. By yielding accurate results with easily obtained bone samples, Stout and 
Paine’s method has been found to be useful, especially in instances where other aging 
 51 
methods could not be employed. Through the many validation studies undertaken, and the 
improvements made to the age estimation techniques using rib histology have made these 
methods the most accurate of the histological age estimation methods (Crowder, et al., 2012). 
 
As with the methods utilising long bones, it emerged that population was an important factor 
in developing age estimation formulae. The most significant of these studies came in 2002, 
when Cho and colleagues tested the Stout and Paine formulae for inter-population variability. 
The study found that there was a statistically significant difference between the osteon 
population densities (OPD) of European-American and African-Americans. To remedy this 
oversight in the original study, Cho and colleagues supplied new formulae specific to 
European-Americans and African-Americans, as well as a general formula for samples of 
unknown ethnicity (Cho & al., 2002). Later, Cho and colleagues (2006) revisited these 
populations, this time also comparing for sex, revealing differences in age-related bone loss 
between the groups. Bednarek and colleagues (2009) tested the method on a Polish 
population, developing regressions specific to that population. According to the Polish team, 
uniformity of the methodological process was key to successfully using histology for age 
estimation. Another population study, undertaken by Lee and colleagues (Lee, et al., 2014), 
used a Korean population to test the clavicle formula from the Stout and Paine method. Like 
Cho, they found the Stout and Paine formula ineffective for the Korean population, and 
instead used the original method to develop a Korean population specific formula for the 
clavicle. Pfeiffer and colleagues (2016) tested Cho and colleagues 2002 formulae specific to 
European-American and African-American populations, and their general formula for 
individuals of unknown origin, on a diverse population from South Africa. They found that the 
population specific formulae did not improve the accuracy of the age estimations for the 
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South African population. While they tried creating a new formula specific to this population, 
it did not perform better than the Cho and colleagues’ formulae. They found, rather, that the 
general formula for unknown ethnicity performed relatively well for all groups, reinforcing 
the validity of this formula for widespread use. Validation studies continue, including the one 
associated with this study (Garcia-Donas, 2017), exploring how far these methodologies can 
be pushed toward optimal accuracy. 
 
Although these methods rely upon the changes to the bone microstructure as individuals age, 
certain age-related changes can decrease the reliability of the rib histology formulae. Goliath 
and colleagues (2016) found that advanced age decreased the size of osteons but increased 
the number of osteons per unit as well as the circularity of the osteons. This is likely due to 
age-related osteoporosis, one of the most common causes of osteoporosis (Rosenberg, 
1999). These changes to the bone microstructure fundamentally change the microstructure 
of bone, as the balance of bone metabolism is disturbed. While it is unknown why exactly the 
balance of BMU’s is undone as we age, most likely a combination of factors, up to 20-30% of 
bone can be lost (Brickley & Ives, 2008). Another common cause of changes to the bone 
microstructure is post-menopausal osteoporosis (Rosenberg, 1999).  This is possibly due to 
an estrogen deficiency, which impacts extra-skeletal calcium homeostasis. This in turn causes 
an increase in bone resorption, throwing the normal BMU metabolism out of balance (Riggs, 
et al., 1998). These changes, which not only contribute to cortical bone loss, but also to 
changes in osteon shape and size, impact the fundamental building blocks of the age 
estimation formulae, decreasing their accuracy for individuals of advanced age (Parfitt, 1984; 
Goliath, et al., 2016). 
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Another consideration when implementing these age estimation formulae is degradation of 
the bone due to taphonomy or diagenesis. These changes can appear in both modern and 
archaeological samples exposed to time and the elements. While taphonomy is regularly 
acknowledged as a factor in macro analysis of bone, it also has the ability to make changes to 
the bone microstructure. If the microstructure is to be analysed, especially when estimating 
age for forensic purposes or for assessing pathology, it is essential to understand and 
differentiate the damage done by age, disease, and the environment. Once a body ceases to 
live, several different digenetic processes take place, including hydrolysis, dissolution, and 
microbial attack. These all have the ability to alter the microstructure of the bone as the body 
decomposes and comes to balance with its environment (Kontopoulos, et al., 2016). These 
changes are often centred around the Haversian canals, as the decomposition of the body is 
facilitated by bacteria and microorganisms travelling through the body’s vasculature (Bell, 
2012). These changes can also sometimes be misinterpreted as pathological in nature, called 
pseudopathology (Schultz, 2012). These processes often depend upon the exposure of the 
body, the air, the soil composition, and the temperature (Schultz, 2001). It is not only micro-
organisms in the soil that can affect the bone, but also micro-organisms in the water (Bell, 
2012). In general, the changes made by the environment, flora and fauna that invade the 
body and the skeleton after death during decomposition are discernible from the regular 
bone microstructure, as they often follow their own paths through the tissue. While they can 
enlarge canals, and cause micro-cracks in the cortical bone, these are differentiated from 
normal destructive processes and pathology by the tell-tale ruffles of the Howship’s lacunae, 
and the flowing lamellar pattern of the bone (Bell, 2012; Schultz, 2012; Schultz, 2001). 
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While the above considerations are all common changes to bone that are encountered with 
relative frequency and should reasonably be expected to be incorporated into age estimation 
equations, another less common and more variable consideration is pathology. As the 
equation requires cortical area and osteon population, if there were a pathological or 
metabolic disturbance that had affected the cortical area of the bone or the osteon 
population density, the equation would be rendered inaccurate. This has been discussed in 
several previous studies, although more extensive research is necessary to better quantify 
the changes made to the bone. One such study was Paine and Brenton’s (2006) study on 
pellagra in a South African population, which found sufferers of pellagra had higher instances 
of osteoporosis, impacting the results of age estimation techniques. There are several known 
connections between chronic metabolic diseases and metabolic bone disease, such as 
hyperparathyroidism (McCarthy, 2010; Stein, et al., 2011). As these diseases are the focus of 
this thesis, diseases belonging to each different system and their connections to metabolic 
bone disease will be discussed in the following section. Long-term infectious disease has also 
proven capable of making changes to the bone microstructure (Schultz, 2012; Schultz, 2001; 
Van der Merwe, et al., 2010). While the implications of these micromorphological changes 
have been discussed, more research and quantifications of these changes to the 
microstructure need to be made, and the exact effects of pathology on the efficacy of 
histological age estimation techniques needs to be quantified. 
 
In the context of this study, Stout and Paine’s method for histological aging will be discussed 
alongside the medical history of the subjects, containing known age at death. As Stout and 
Paine’s equations were not created for this population, and therefore do not yield as accurate 
results (Garcia-Donas, 2017), the focus will instead be on the cortical area and OPD of the 
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samples, as these variables are the building blocks used by all histological age estimation 
techniques. By comparing the relationships between these two variables with the actual age 
at death of the individuals, it may be possible to determine the degree of inaccuracy in 
individuals with pathological microstructural changes related to chronic metabolic diseases. 
With respect to forensic methodology, this could help to more accurately assess age at death 
of individuals with disturbances in bone metabolism, regardless of the population. 
 
 
2.2 Chronic Disease and Comorbidities Involving Bone 
 
2.2.1 Introduction to Metabolism 
In essence, metabolism is how the body maintains and sustains itself. While each system may 
have different metabolic rates and processes, these chemical reactions all interact together 
to keep the body growing and maintained. Some tissues may produce chemicals that are 
needed for the maintenance of another organ or system, creating an interconnected system 
in which the body is able to sustain itself (Kusinitz, 2014; Shulman & Peterson, 2017). 
Metabolism functions in one of two ways, anabolic processes (energy capture) during which 
energy is used to produce different substances, like proteins and nucleic acids, and catabolic 
processes (energy release) during which substances are broken down to create energy. These 
systems should be in balance to maintain the body. In terms of physics, the first law of 
thermodynamics is always maintained, with the energy input always equal to the energy 
output and storage (Shulman & Peterson, 2017). In the skeletal system, this can be seen in 
the functions of the BMU, building up and breaking down bone tissue to maintain the osseous 
tissue. If, however, the metabolism of one tissue or system is affected, either by 
environmental issues or pathology, this can cause cascading problems that end up affecting 
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other systems of the body. This is where pathology and bone most often interact. As different 
systems within the body are affected, these cascading consequences eventually find their way 
to the bone, if allowed to continue long enough (Ortner, 2003). This is where the different 
metabolic rates of tissues come in. 
 
2.2.1.1 Different metabolic rates of tissues 
Different tissues have different metabolic rates, with some tissues, such as bone, taking 
months to cycle through the destruction of old tissue and the creation of new replacement 
tissues (Burr & Akkus, 2013). Other tissues cycle through maintenance much faster, such as 
the liver, which is able to regenerate quickly after injury. Due to the liver’s propensity for 
regeneration, most diseases of the liver up until the appearance of fibrosis (cirrhosis) can be 
completely reversed (Crawford, 1999). Due to the fact that bone tissue is the slowest of all 
the tissues to turnover, pathological conditions that affect other tissues do not often reach 
the point of affecting the bone. This is particularly true of acute infections of other tissues. If 
an infection, or disease, is present in the body for less time that it takes for the osseous tissue 
to metabolise, it will not affect the bone. If, however, there is chronic disease in another 
system, present over a period of months or years, it can have the ability to affect the bone 
metabolism (Ortner, 2003). For this reason, this study will focus only on chronic diseases that 
have the potential to negatively affect osseous tissue. 
 
2.2.1.2 How different systems interact 
As stated above, the metabolism of the different systems of the body are all interlinked, 
allowing disturbances in one system to have potentially catastrophic effects on the 
metabolism of another. As different chemicals and substances are produced in certain 
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systems and then used by another, this can create a potentially disastrous chain reaction if 
the metabolic processes are disturbed. One example of this is hyperparathyroidism, and its 
effects on bone. Hyperparathyroidism is usually caused by long periods of hypercalcemia 
resulting in hypersecretion of thyroid hormone. The increased amount of hormone in the 
system reach the osteoblasts, which then stimulate the osteoclasts to begin their activity. This 
causes increased, unbalanced resorption of osseous tissue, resulting in osteoporosis 
(Rosenberg, 1999). The chain reaction following the primary disease of the thyroid eventually 
makes its way to the skeletal system, causing secondary disease there. This is only one of 
many examples of secondary bone disease occurring as a comorbidity of primary disease 
elsewhere in the body. The following sections will discuss the different classes of disease 
found within this study and lay out the potential for each disease to affect the metabolism of 
the osseous tissue. 
 
2.2.2 Pathological Categories and Their Interactions with Bone 
 
2.2.2.1 Cancer 
Cancer, or neoplasms, is one of the most common forms of disease found in the human body. 
It can manifest in any tissue and in any system. Neoplasm means ‘new growth’ and refers to 
the growth of tumours in the body. These include both benign and malignant tumours. The 
tumour, or neoplasm, refers to a mass of tissue whose growth exceeds that of the 
surrounding normal tissue, serving no purpose, and often weakening the host by competing 
with the surrounding tissue for energy and resources. These masses often divert blood 
supplies to the tumours, and can even produce substances, such as hormones, which can 
interfere with the regulation and maintenance of bodily systems. In terms of malignant 
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tumours, tumours that appear in the mesenchymal tissues are classed as sarcomas and 
tumours that appear in the epithelial cells are classed as carcinomas. (Cotran, et al., 1999).  
While there are primary malignant cancers of the bone, such as osteogenic sarcomas or 
osteosarcomas, bone is more often involved as a secondary to a primary tumour elsewhere. 
These are known as metastases (Ortner, 2003).  
 
The effects of cancer are many and widespread, sometimes impeding the function of nearby 
tissues, sometimes synthesising substances, such as hormones, and unbalancing the body’s 
natural production levels, causing bleeding in the area surround the tumour due to ulceration, 
as well as occasional rupture or infarction of the tumour or surrounding tissues. One example 
is hypercalcaemia, caused by paraneoplastic syndrome. This interruption has similar effects 
on bone to hyperparathyroidism (Guise & Mundy, 1998). Individuals with cancer can also 
experience cachexia, leading to loss of body fat and body mass, along with weaknesses, 
anorexia, and anaemia (Cotran, et al., 1999). All of these effects have consequences, not just 
for the affected systems, but for the body as a whole. 
  
Metastatic Cancer 
Metastatic cancer or metastases refer to tumours implanted in tissue away from the primary 
tumour. Metastases automatically classify the primary tumour as malignant, as benign 
tumours never metastasise to other tissues. Most cancers, with the exception of gliomas of 
the central nervous system and basal cell carcinomas of the skin can, and often do, 
metastasise. Often, the larger and more aggressive the primary tumour, the more likely it is 
that it will spread to other parts of the body and metastasise to other tissues (Cotran, et al., 
1999). While bone is more likely to be involved in metastatic, rather than primary, cancer, it 
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is often difficult to tell the difference (Ortner, 2003). Using bone scintigraphy, it has been 
found that up to 85% of individuals with carcinomas will involve metastases to the skeleton 
(Dorfman & Czerniak, 1998). As reactions in bone tend to either imbalance the BMU system 
in favour of the osteoblasts or the osteoclasts, causing either prolific or lytic lesions, 
metastatic lesions are expected to be the same. In the case of metastatic lesions on bone, 
about 75% are lytic lesions, 15% are prolific, and about 10% are a mix of both lytic and prolific 
lesions (Greenspan & Remagen, 1998). Metastases often occur in the axial skeleton, as these 
bones are where hematopoietic marrow are found in adults. The tumour cells can then 
replace the marrow and grow from inside the marrow cavity outward towards the 
periosteum. Often these metastases remain within the marrow cavity and are only discovered 
upon autopsy, however some tumours do move further into the bone, first destroying the 
trabecular scaffolding, and eventually entering the cortical bone. The fastest growing of these 
tumours tend to be lytic in nature, while the slower growing tumours are often prolific. The 
ribs and sternum are the third most likely to be involved, behind the spine and the femur, 
with 25% of skeletal metastases involving the ribs or sternum (Ortner, 2003).  
 
Cancer Therapies 
Unfortunately for many patients, cancer therapies can damage the bone tissue as well as the 
disease they are fighting. Often individuals being treated for cancer are at risk for 
osteoporosis due to a combination of the activities of the cancer itself, as well as the effects 
of chemotherapy, corticosteroids, aromatase inhibitors, and androgen deprivation therapy 
(Drake, 2013). The effects of cancer treatment on bone can generally be divided into two 
categories; cytotoxic, which inhibits the activities of bone building osteoblasts, and hormonal 
where the interference of the therapy with the body’s natural production of hormones can 
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stimulate osteoclast activity (Healey, 1999). One example is in therapies for breast cancer, 
treatments often target oestrogen production and receptors, as oestrogen receptors are 
expressed by about 70% of breast neoplasms. This, however, has a negative effect on BMD, 
similar to postmenopausal osteoporosis, as oestrogen is involved in the stimulation of 
osteoblasts (Hirbe, et al., 2006). In cases of prostate cancer, patients are often treated with 
hormone therapies with the potential to cause hypogonadism. Again, like oestrogen blocking 
treatments and postmenopausal osteoporosis, Gonadotropin-releasing hormone (GnRH) 
agonist treatments affect parathyroid hormone levels, again stimulating osteoclast activity 
(Smith, 2006). Cancer treatment can also have indirect effects on bone, such as mucositis 
caused anorexia, and malnutrition that can contribute to osteoporosis as well (Healey, 1999). 
In all, cancer patients are often at risk for osteoporosis, not only from potential metastatic 
bone involvement, or hormone secreting tumours, but also potentially from the treatments 
they are being prescribed. Often these hormone-related therapies cause chain reactions in 
the body’s metabolism, resulting in marked bone loss for the patient. 
2.2.2.2 Cardiovascular Disease 
Cardiovascular diseases (CVD’s) are now the number one cause of death worldwide. In 
2015, approximately 17.7 million people died of CVD’s, about 31% of all deaths worldwide 
that year. These diseases are on the rise, largely due to modern lifestyle changes including 
poor diet and inactivity. Major risk factors include obesity, diabetes, tobacco use, and 
alcohol abuse, all of which can be avoided by living a healthier lifestyle (World Health 
Organization, 2017). Of particular interest are coronary artery disease (CAD), in particular 
the manifestations of CAD as atherosclerosis and myocardial infarction (heart attack). CAD, 
in particular atherosclerosis and myocardial infarctions, are some of the most common 
forms of cardiovascular disease today. Each of these pathologies are chronic conditions, or, 
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in the case of myocardial infarction, the result of a chronic condition, and therefore have 
the ability to influence the metabolism of bone. 
 
Coronary Artery Disease (CAD) 
Coronary artery disease (CAD), sometimes referred to as coronary heart disease (CHD) or 
ischemic heart disease (IHD), refers to a group of conditions that result from myocardial 
ischemia, an imbalance in the perfusion and demand of oxygenated blood. This often results 
in an insufficiency of oxygen delivered to the body through the vessels, most of the time (90%) 
due to an obstruction in the arteries, also known as atherosclerosis, as well as other 
complicating factors such as intraluminal thrombosis and vasospasm. The end result of CAD 
is often a myocardial infarction, or heart attack, a potentially lethal consequence of years of 
plaque build -up and obstruction (Schoen, 1999). 
  
Atherosclerosis 
Atherosclerosis is characterised by the presence of atheromas or fibrous fatty plaques that 
line the walls of the arteries and protrude out into the lumen, obstructing blood flow (Schoen 
& Cotran, 1999). It is an incredibly common pathology and is one of the top contributors to 
CVD’s place as number one cause of death in the world (World Health Organization, 2017). 
Atherosclerosis is a chronic condition, often beginning in the childhood years, and not 
becoming apparent until later in adulthood. It most often affects the elastic arteries, such as 
the aorta and carotid, as well as muscular arteries, like the coronary and popliteal arteries. As 
it involves the arteries and the blood supply for the entire body, it could potentially affect any 
area or organ, but the most commonly affected places are the heart, brain, kidneys, small 
intestine, and the legs. If the plaques are disrupted, they can precipitate a thrombosis (blood 
clot) obstructing blood flow even further. If untreated and allowed to continue unchecked, 
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atherosclerosis often results in myocardial infarction (heart attack), cerebral infarction 
(stroke), or aortic aneurism, depending on the site of the plaques (Schoen & Cotran, 1999).  
 
Myocardial Infarction 
While myocardial infarctions, otherwise known as heart attacks, are not in themselves a 
chronic disease, they are almost always the result of an underlying chronic cardiovascular 
condition, often CAD and atherosclerosis. Of the samples assessed in this study with a 
myocardial infarction listed as cause of death, most if not all, had CAD and/or atherosclerosis 
as well. A myocardial infarction can be deadly, and many patients die before they are able to 
be treated. A fast medical response is essential to the survival of the patient (Schoen, 1999). 
Of all deaths associated with CVD’s 80% are attributed either to a heart attack or a stroke 
(cerebral infarction) (World Health Organization, 2017). Myocardial infarction refers to the 
cell death in the myocardium, or the heart muscle, usually limited to a specific area or 
ventricle. A myocardial response is triggered as a consequence of arterial obstruction, limiting 
the blood supply to the myocardium. Depending on the severity and the duration of blood 
flow deprivation, this can lead to localised necrosis.  Myocardial infarctions (MI’s) usually 
occur in one of two ways; a transmural MI, in which necrosis has affected the entire, or nearly 
entire, thickness of the ventricular wall, and a subendocardial MI, in which only the inner third 
to one half of the ventricular wall thickness is affected by necrosis (Schoen, 1999).  
 
Comorbidities Involving Bone 
Coronary artery disease and low bone mineral density (BMD) are known to have several 
common risk factors, although scientists are still trying to pinpoint exactly where the two 
interact, and whether the link is direct or indirect. It has been found that patients with low 
bone mass are at higher risk of a cardiac episode or death than patients with normal bone 
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mass (Sprini, et al., 2014; Bagger, et al., 2007; Magnus & Broussard, 2005; Farhat, et al., 2006). 
Marcovitz and colleagues (2005) were able to use low BMD as a predictor of CAD, connecting 
osteoporosis with heart disease predominantly in postmenopausal women. It has also been 
linked to cardiovascular death in men, where osteoporosis and low BMD were also used as a 
predictor (Mussolino, et al., 2003; Trivedi & Khaw, 2001; Van Der Klift, et al., 2002). Although 
previously thought to develop independently from different processes related to aging, it is 
now thought that cardiovascular disease and osteoporosis may develop from common 
pathophysiological risk factors. One possible connection may be the similarity between 
arterial calcification and bone mineralisation. It appears that both processes are relatively 
similar, and they share factors that are also used to stimulate osteogenesis, including bone 
morphogenetic protein (BMP), alkaline phosphatase (ALP), and osteopontin (OPN) (Sprini, et 
al., 2014). In terms of atherosclerosis, bone metabolism can also be affected locally, 
depending whether they are supplied by an obstructed artery (Bagger, et al., 2007). While the 
exact connection is not yet clear, the fact that a pathophysiological connection exists between 
CVD’s and osteoporosis is generally agreed upon. 
2.2.2.3 Diabetes 
Diabetes mellitus, or diabetes as it is commonly known, is a disorder of the pancreas affecting 
carbohydrate, fat, and protein metabolism. This is the result of an inability or deficiency in 
the pancreas’ ability to secrete insulin and therefore impairs the body’s ability to manage 
glucose (Crawford & Cotran, 1999). As of 2014, 422 million people worldwide have been 
diagnosed with diabetes, and in the year 2015 an estimated 1.5 million deaths worldwide 
were attributed to the disease (World Health Organization, 2017). There are two main types 
of diabetes; type 1, previously known as insulin-dependent diabetes mellitus (IDDM), and 
type 2, previous known as non-insulin-dependent diabetes mellitus (NIDDM). Type 1, 
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sometimes also called juvenile-onset diabetes, is an autoimmune disease that accounts for 
about 10% of diabetes cases, and is the result of b-cell destruction, usually due to an 
autoimmune attack. This causes the pancreas to be unable to secrete enough insulin, leaving 
the patient dependent upon injected insulin for survival. Type 2 makes up the 80-90% of other 
patients with diabetes and had previously been known as adult-onset diabetes. Unlike type 
1, type 2 diabetes does not appear to have any link to autoimmune reactions, but instead is 
highly associated with lifestyle, in particular obesity and diet. In type 2 diabetes, for example, 
obesity can contribute to deranged insulin secretion and insulin resistance in the surrounding 
tissue, leading to hyperglycaemia, ultimately resulting in b-cell exhaustion. For this 
manifestation of the disease, it is important to note that it is not necessarily a deficiency of 
insulin which is causing problems, although it can manifest in the later stages of the disease, 
but rather a resistance to insulin in the peripheral tissues, causing elevated serum levels of 
insulin to compensate (Crawford & Cotran, 1999). As diabetes intrinsically involves the body’s 
metabolism it is known to cause a host of cascading effects and has a very long list of 
comorbidities (Crawford & Cotran, 1999; Bouillon, 1991).  
 
Comorbidities Involving Bone 
 
Osteoporosis is a known comorbidity of diabetes, specifically type 1 (Rosenberg, 1999). 
Diabetic bone disease, and especially its effects on juveniles, has long been documented 
(Morrison & Bogan, 1927). While osteoporosis can occur in both type 1 and type 2 diabetes, 
as type 2 is related to age and obesity the mechanism for bone loss is different than for type 
1, and usually much less prevalent (Bouillon, 1991; Vestergaard, 2007; de Liefde, et al., 2005; 
Pérez-Castrillón, et al., 2004). The cascading effects of insulin deficiency from type 1 diabetes 
contribute to hormonal changes, in turn having an effect on the metabolism of bone, most 
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notably affecting vitamin D metabolism, which is vital to the synthesis of osteocalcin. In 
addition to insulin deficiency itself, diabetes also causes other problems associated with 
osteoporosis, including negative protein balance, reduced physical activity, and impaired 
gonadal function, inhibiting hormone production (Bouillon, 1991). In contrast to the effects 
of type 1 diabetes on bone, type 2 often has the opposite effect. Several studies have noted 
that type 2 diabetics actually have increased bone mass and a reduced risk of fracture (Van 
Daele, et al., 1995; Vestergaard, 2007; de Liefde, et al., 2005). While osteoporosis is a risk 
factor for both types of diabetes, BMI and obesity have an effect on the fracture risk of type 
2 diabetics, with increased BMI ameliorating many of the risks associated with diabetic bone 
disease (Vestergaard, 2007). While type 2 diabetics often have higher BMD than average, this 
seems to be independent of their fracture risk, as despite the elevated BMD many type 2 
diabetics show an increased incidence of fracture (Hofbauer, et al., 2007; de Liefde, et al., 
2005; Pérez-Castrillón, et al., 2004). Most studies offer the hypothesis that increased fracture 
risk in type 2 diabetics may be due to complications of long term diabetes, however there is 
little proof thus far (Hofbauer, et al., 2007; de Liefde, et al., 2005). One possible long-term 
complication of diabetes that has the potential to change bone at the tissue level are the 
advanced glycation end products (AGEs). The glycation involved can affect not only turnover 
rates, but all the mechanical integrity of the matrix, leading to more brittle bone tissue, 
regardless of BMD (Viguet-Carrin, et al., 2006).  The samples exhibiting diabetes in this study 
were not categorised as type 1 or 2, however as fracture incidence and decreased BMD is a 
possibility in both types, especially in those individuals of advanced age, an overarching view 
of diabetic bone disease was adopted.  
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2.2.2.4 Hepatic Disease 
The liver has an amazing propensity for healing itself, and as such, recovers remarkably well 
from injury. If, however, the liver is repeatedly injured over a long period of time, it will 
eventually lose the ability to bounce back. While there are many diseases that can affect the 
liver, including infections, circulatory disorders, and congenital anomalies, the fact is that due 
to the function of the liver the pathologies that affect it the most are usually related to 
harmful lifestyle choices. The most common chronic condition encountered with the liver is 
related to chronic alcohol abuse, namely alcoholic liver disease (Crawford, 1999). 
 
Alcoholic Liver Disease 
Alcoholic Liver Disease (hereafter referred to as ALD) encompasses three types of liver disease 
related to alcohol abuse. These range from the relatively mild, reversible hepatic steatosis (or 
fatty liver) to the more serious and largely irreversible cirrhosis of the liver, all of which can 
be confirmed using histological samples of liver tissue (Crawford, 1999). Often the first liver 
disease to arise is hepatic steatosis. This is caused by micro-vesicular lipid droplets forming in 
the hepatocytes. These droplets can grow to form macro-vesicular globules, which in turn can 
displace or compress the nucleus of the hepatocytes. As the disease progresses, the liver 
becomes enlarged, yellow in colour, and greasy in appearance. At this stage, there is usually 
little to no fibrosis formed in the liver tissue. If changes in lifestyle are made, i.e. abstinence 
from alcohol, this stage of liver disease is completely reversible (Theise, 2015). The next 
disease to affect the liver is often alcoholic hepatitis.  During this stage of liver disease there 
is often swelling of the hepatocytes and cell necrosis. The liver often undergoes a neutrophilic 
reaction and Mallory bodies are sometimes present. It is also possible at this stage for fibrous 
tissue to begin development. As with hepatic steatosis, it is possible to completely reverse 
 67 
alcoholic hepatitis, with the exception of tissue fibrosis should it have begun to develop 
(Theise, 2015; Crawford, 1999).  
 
The last, most serious, and irreversible stage of ALD is alcoholic cirrhosis. During the beginning 
stages of cirrhosis, the liver is often yellow, fatty and enlarged, similar to the appearance of 
hepatic steatosis. Over the years, however, the liver becomes brown, shrunken, and non-
fatty. While cirrhosis can develop directly from hepatic steatosis, it can often develop more 
quickly from alcoholic hepatitis. In alcoholic cirrhosis, the most important feature of the 
disease is the development of fibrous tissue within the liver. Over time the liver develops from 
fine fibrous septa to full nodules. These nodules become more prominent, giving the liver a 
“hobnail” appearance (Crawford, 1999). As the fibrous tissue grows and extends into the liver, 
the organ loses fat and visibly shrinks in size. As the disease continues the liver is transformed 
into a combination of macro- and micro-nodules.  Towards the end stages of the disease 
ischemic necrosis and fibrous tissue destroy the nodules, creating extensive areas of scar 
tissue. During this period, bile stasis often develops. Despite having a known cause, by its end 
stages alcoholic cirrhosis is not discernible, either macroscopically or microscopically, from 
other causes of cirrhosis, such as viral hepatitis (Crawford, 1999).  
 
While short-term ingestion of alcohol in amounts up to 80 grams of ethanol can cause 
changes to the liver, such as fatty liver, these changes are reversible. Daily intake of 80 grams 
of ethanol or higher, however, can cause significant changes to the liver and pose a risk for 
serious hepatic injury. Ingestion of upwards of 160 grams of ethanol a day over the course of 
10-20 years is consistently associated with severe hepatic injury. That being said, only about 
10-15% of alcoholics develop cirrhosis of the liver, with females being more likely to have 
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severe hepatic injury. It is also possible for cirrhosis to develop independently of the other 
stages of ALD. For alcoholics with liver disease, the long-term outlook differs significantly 
based on the amount of time abusing alcohol.  Alcoholics with liver disease see a 90% survival 
rate, but this percentage drops heavily to 50-60% in those who continue to abuse alcohol 
(Theise, 2015). In addition to disease and interference with hepatic functions, alcohol often 
becomes a major source of calories to the alcoholic, leading to malnutrition and subsequently 
other secondary metabolic disorders, such as osteoporosis (Feitelberg, et al., 1987; Bikle, et 
al., 1985).  
 
Comorbidities Involving Bone 
 
Chronic alcoholism has long been known to affect bone mineral density, and by extension 
bone microstructure (Rosenberg, 1999). Exactly how it affects the metabolism of bone is a 
matter of debate. Several studies have been done examining the connection between chronic 
alcohol abuse and decreased bone density (Bikle, et al., 1985; Feitelberg, et al., 1987). Diet, 
sun-exposure, 25 hydroxyvitamin D deficiency (Verbanck, et al., 1976; Arnaud, 1982; Herlong, 
et al., 1982; Mobarhan, et al., 1984; George, et al., 2009), as well as liver and renal disease 
have all been examined as possible causes for the increased incidence of osteoporosis and 
osteopenia in patients with chronic alcoholism (Long, et al., 1978; Spencer, et al., 1986; Labib, 
et al., 1989).  Although there is a long list of conditions associated with chronic alcohol abuse, 
there have been cases of decreased bone density in patients without other ethanol-related 
diseases or deficiencies (Baran, et al., 1980; Lalor, et al., 1986; Turner, et al., 1987; Diamond, 
et al., 1990; Gonzalez-Calvin, et al., 1993). Several studies have implied that alcoholics with 
liver disease are more likely to also have decreased bone mineral density, though direct 
correlation has not yet been proven. Increased susceptibility to osteoporosis and osteopenia 
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in alcoholics could also explain the increased incidences of fractures in chronic alcoholics 
(Lindsell, et al., 1982; Diamond, et al., 1990; Peris, et al., 1992). As chronic alcoholism has 
been proven to cause a host of comorbidities, over 200 according to the World Health 
Organisation (2018), it is likely that these conditions, such as the vitamin d deficiency and 
hypogonadism often seen in ALD patients, contribute to cascading metabolic consequences 
that eventually affect the bone, resulting in suppression of the osteoblasts and stimulation of 
the osteoclasts (George, et al., 2009). 
 
2.2.2.5 Pulmonary Disease 
Pulmonary disease is incredibly common, from the common cold, to asthma. Worldwide, 235 
million people suffer from asthma, and more than 3 million people die every year of chronic 
obstructive pulmonary diseases (COPD’s), about 6% of all deaths (World Health Organisation, 
2018). Of concern to this study are primarily obstructive pulmonary diseases, rather than 
restrictive. Many obstructive pulmonary diseases are chronic, and debilitating, even life 
threatening, to the patient. These diseases are characterised by a resistance to normal airflow 
caused by obstruction of the airway. This can be at any level of the respiratory tract, from the 
bronchi to the trachea (Kobzik, 1999). 
 
Chronic Obstructive Pulmonary Disease (COPD) 
Chronic obstructive pulmonary disease (COPD) is actually a term that applies to several 
conditions. All of these conditions share a common symptom, dyspnoea, meaning shortness 
of breath. These conditions are often caused or exacerbated by environmental factors such 
as tobacco smoke, airborne pollutants, and exposure to chemical fumes. While these 
conditions had formerly been categorized as different conditions, as many patients presented 
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with multiple symptoms falling under several different categories, they are now known under 
the umbrella term of COPD. These conditions include emphysema, meaning enlarged 
airspaces that can lead to the destruction of the walls of the airspaces, chronic bronchitis, 
meaning a persistent productive cough with sputum production often obstructing the airway, 
and lastly asthma, meaning an inflammatory disorder characterised by hyperactive episodic 
bronchoconstriction. COPD is a disease of middle to later life and does not usually manifest 
until the fourth or fifth decade (Kobzik, 1999). These three conditions often appear together 
in patients with COPD, and patients diagnosed with asthma as children may develop COPD 
later in life. Urbanisation, and airborne pollutants from industrialised nations, as well as 
smoking, have greatly contributed to the spike in COPD cases worldwide (World Health 
Organisation, 2017; Kobzik, 1999).   
 
Bronchopneumonia 
Like COPD, bronchopneumonia is a disease predominantly seen in later life, although it does 
sometimes appear in the very young as well. While often an acute condition, severe infections 
can linger for months, and in some cases is considered a chronic condition. It is characterised 
as a persistent, lower respiratory tract infection, resulting in patchy consolidation of the lung. 
These infections are most often caused by bacteria, and follow an earlier compromise to the 
immune system, such as bronchitis, chronic disease, or treatment with immunosuppressant’s. 
It is often the case that bronchopneumonia is found at autopsy, especially following long 
periods of illness, such as progressive heart failure, and are often contracted while being 
treated in hospital (Kobzik, 1999).  
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Comorbidities Involving Bone 
COPD and obstructive pulmonary conditions are incredibly debilitating and have a profound 
affect upon the patient’s quality of life, making breathing and any kind of physical activity 
difficult. This leads to a largely sedentary lifestyle, bringing its own complications (Kobzik, 
1999; Jørgensen, et al., 2007). Often, other conditions develop with the progression of the 
disease, including right ventricular heart failure, and osteoporosis (Jørgensen, et al., 2007). 
According to the World Health Organization, prevalence of osteoporosis in COPD patients is 
somewhere between 24-69% (Cavaillès, et al., 2013). Part of the explanation for why 
osteoporosis develops could be the use of gluco-corticosteroids in treatment, a known 
contributor to the development of osteoporosis and osteopenia (Jørgensen, et al., 2007; 
Rosenberg, 1999; Maggi, et al., 2009). Steroid use alone, however, is not sufficient 
explanation for the prevalence of osteoporosis in COPD patients, suggesting another factor 
may be at work (Jørgensen, et al., 2007; Fabbri, et al., 2008; Cavaillès, et al., 2013; Chatila, et 
al., 2008). It has also been found that COPD patients often present with metabolic syndrome 
as one of the many complex comorbidities associated with the disease, possibly contributing 
to the prevalence of osteoporosis in COPD patients, outside the factors of steroid treatment 
and sedentary lifestyle (Fabbri, et al., 2008; Cavaillès, et al., 2013). As time passes, COPD and 
osteoporosis also tend to feed into each other, with vertebral fractures contributing to further 
airway restriction, allowing the consequences of the COPD to worsen (Cavaillès, et al., 2013). 
In a study by Mineo and colleagues (2005), lung volume reduction surgery to improve the 
symptoms of emphysema also contributed to a marked improvement in bone density scores, 
despite the continued use of steroid therapies. Chronic bronchopneumonia, like myocardial 
infarctions, usually culminate following another chronic condition, and therefore has many of 
the same consequences of those conditions, such as CAD and COPD (Kobzik, 1999). It can 
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therefore be expected to also have many of the same complex comorbidities connecting it to 
bone metabolism. 
 
2.2.2.6 Renal Disease 
Renal disease refers to conditions of the kidney. For the purposes of this study, only chronic 
conditions of the kidney were examined. These are defined as decreased kidney function as 
measured by glomerular filtration rate (GFR) as well as markers of kidney structural damage 
(Webster, et al., 2017; Levey & Coresh, 2012). Kidney disease of this kind rarely occurs on its 
own, and often is the result of another chronic condition (Webster, et al., 2017). In many 
cases, the end stage of such a disease is kidney failure (Cotran, et al., 1999). 
 
Chronic Kidney Disease (CKD) 
Chronic kidney disease is an umbrella term that refers to a decrease in function and structure 
of the kidney for a duration of at least three months. It rarely occurs on its own, instead often 
being associated with the later stages of diabetes, which account for 30-50% of all CKD cases, 
as well as hypertension and heart disease. If it does originate in the kidney, it is often caused 
by glomerulonephritis, an inflammation of the glomeruli (Webster, et al., 2017; Cotran, et al., 
1999; Levey & Coresh, 2012). To be clinically diagnosed, a GFR of less than about 60 mL/min 
per 1.73 m2 is necessary (Levey & Coresh, 2012; Webster, et al., 2017). As the symptoms can 
be non-specific, diagnosis is often only picked up by routine blood or urine tests, or the 
disease can go undiagnosed until the symptoms become more severe. CKD can be incredibly 
dangerous, as patients with CKD are five to ten times more likely to die of it, rather than 
progress to the end stages of kidney disease and failure, requiring dialysis or transplantation 
(Webster, et al., 2017; Levey & Coresh, 2012). If the disease does reach its end stages, it is 
characterised by uraemia, or urea in the blood, a sign of final kidney failure as they are no 
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longer able to filter out the waste. The stage of uraemia signals not only the failure of the 
kidneys, but also major changes in metabolic and endocrine function, triggering responses in 
the gastrointestinal, neuromuscular, and cardiovascular systems (Cotran, et al., 1999). End 
stage CKD can also be noted by the development of fibrosis in the kidney as a response to 
chronic injury, characterised by glomerulosclerosis, tubular atrophy, and interstitial fibrosis 
(Webster, et al., 2017). Like many of the diseases discussed in this chapter, it is a disease 
primarily encountered in later life, with the countries reporting the most cases of end stage 
CKD being those with the highest number of elderly citizens, although age is not necessarily 
a prerequisite for disease (Webster, et al., 2017; Levey & Coresh, 2012).  
 
Comorbidities Involving Bone 
As CKD is known to cause major metabolic disturbances, it is likewise a known comorbidity of 
kidney disease. Known as renal bone disease, or renal osteodystrophy, it refers to the effects 
of renal failure on mineral metabolism, namely that renal disease triggers changes to 
phosphorus, calcium, and vitamin D metabolism, as well as parathyroid hormone, all leading 
to secondary hyperparathyroidism, a known factor in the development of osteoporosis 
(Malluche & Faugere, 1990; Williams, 2009; Ott, 2009). This can lead to several different bone 
disorders, including osteitis fibrosa cyctica (high bone turnover), adynamic bone disease (low 
bone turnover), or mixed bone disorder. In any case, the result is bone loss and an increased 
risk of fracture (Williams, 2009; Miller, 2005). To understand the specifics of renal 
osteodystrophy, previous studies have performed biopsies to measure bone turnover and 
resorption rates, mineralisation rates, and volume, as well as the standard dual-energy x-ray 
absorptiometry (DXA) used to diagnose osteoporosis (Ott, 2009; Leonard, 2009). In particular, 
the volume metric measures both mineralised and unmineralised bone, and is directly related 
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to porosity, a major consequence of osteoporosis (Ott, 2009). These metabolic abnormalities 
directly affect the microstructure of the bone, distorting the structure of the trabeculae, and 
thinning the cortical bone. In a study where full thickness biopsies of dialysis patients were 
taken, 45% bone loss was reported, largely due to cortical thinning (Leonard, 2009). An added 
complication is the medications usually prescribed to treat osteoporosis, bisphosphonates, 
are generally discouraged in patients with kidney function measuring less than 35 mL/min. As 
CKD has been described as a disease of advanced age, about 25% of patients of around 70 
years of age have kidney function less than 25 m/min, excluding them from the standard 
treatment for osteoporosis, or putting them at risk for greater kidney injury, perpetuating the 
entire process (Miller, 2005). These multi-pronged factors make renal disease, and CKD in 
particular, a major contributor to not only pathological changes to bone microstructure, but 
to the metabolism of the body as a whole, often with catastrophic results. 
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3. Aims and Objectives 
 
 
The broad aim of this study is to better understand pathology, especially secondary 
pathology, in the context of bone microstructure. While previous studies have observed 
changes to the microstructure in relation to pathological stimuli, there is a need for more 
specific terminology and definitions with regard to the presence and appearance of 
pathological bone micromorphology. The motive for this aim is twofold. First, to better 
understand the connections between diseases in other systems and their effect on bone 
microstructure, purely to improve anatomical knowledge and understanding. The second is 
related to the forensic context, as bone microstructure is an essential ingredient in 
histological age estimation techniques such as those developed by Stout and Paine (1992), 
and Cho and colleagues (2002). As pathology has the ability to change the microstructures 
these formulae rely upon, this study endeavours to quantify which features are most affected, 
and by how much.  
 
To do this, analysis was split into two sections: qualitative and quantitative. 
Qualitative analysis focused on observations of pathological and healthy thin sections from 
comparable populations. The focus was to: 
• Define and quantify the pathological micromorphology. How does it differ from 
healthy micromorphology? How do the different categories of pathological 
micromorphology differ from each other? 
• Analyse the results of these observations and compare with pathological data. Are any 
pathological micromorphology features associated with any particular disease class? 
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Which category of pathological micromorphology appears most often? Could this 
information be used for diagnostic purposes in an unknown sample? 
 
Quantitative analysis focused on metrics taken from pathological and healthy thin sections 
from comparable populations. These metrics were again split into two sections: the standard 
histological metrics used in most age estimation formulae using the entire cross-section of 
the rib, and osteon specific measurements that were taken from four sampled areas of the 
rib cross-section. 
 
For the standard histological analysis, the focus was to: 
• Compare cortical area and osteon population density (OPD) variables with age, as a 
complete data set (to mimic the population used to create the original Stout and Paine 
(1992) method), and separately as pathological and healthy data.  
• Did the relationships between cortical area and age, and OPD and age, seen in 
previous research, improve when the pathological samples were removed? By how 
much? 
 
Finally, for the osteon specific analysis, the focus was to: 
• Analyse the ten osteon specific metrics chosen for the study. Are any of them 
meaningful? 
• How do the osteon specific metrics compare between the pathological and healthy 
samples? Do they support the observations made in the qualitative section? 
• Are there any correlations or significant relationships between any of the metrics and 
age that might be useful for future age estimation formulae? Is there a difference in 
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the significance of these relationships between the pathological and healthy data 
sets? Could these results be used for diagnostic purposes on an unknown sample? 
 
By carrying out the above objectives, it is hoped that the aims of this study pertaining to the 
better understanding of pathological bone microstructure and its effects on current 









4.1.1 Sample Collection 
 
The materials for this study were selected from four separate sources from geographically 
similar regions, including Greece, Cyprus, and Albania. All samples were either selected and 
sent to the University by the forensic departments after being given the criteria of the study 
or were taken from the sampling of a simultaneous population study being done in the same 
lab that was excluding pathological samples. The healthy control samples were also collected 
from this same simultaneous study and work on said samples was done collaboratively. 
Depending on the origin of the sample, the condition upon arrival varied. While some arrived 
as clean dry bone, others arrived fresh, and maceration was required. In either case, once 
processed and prepared as slides, both types of bone were useable for histology. 
 
4.1.1.1 The Cretan Collection 
 
The first source is from the collection at the Department of Forensic Sciences at the University 
of Crete-Medical School. The samples from this collection come from the cemeteries of St 
Konstantinos and Pateles, both located in Heraklion, Crete. These individuals were born 
between 1867 and 1956 and died between 1968 and 1998. In the event that a living relative 
could not pay a rental fee for the individual’s grave, the body would be removed and placed 
in a designated area by the city. Permission to use samples from these individuals for this 
study comes from the local district attorney. Background information, including age at death 
and cause of death were obtained from the Heraklion City Hall census archives, and sex was 
determined by the names recorded on the graves (Kranioti, et al., 2008). Both pathological 
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and healthy control samples were selected from this collection. Samples arrived as clean, dry 
bone and were immediately embedded without need for further cleaning. 
 
4.1.1.2 Forensic Autopsy Samples 
 
Additional pathological samples came from the Department of Forensic Sciences of the 
University of Crete, Greece and the division of Forensic Pathology of the Ministry of Justice in 
Tirana, Albania.  The samples from Department of Forensic Sciences of the University of Crete 
were collected from autopsy with the consent of the families. The individuals included in this 
study died between October 2014 and February 2015 and ranged in age from 22 to 69. Any 
information on medical history, pathologies, and cause of death that were known to the 
forensic pathologists were included with the samples. Some samples also came with a 
corresponding liver sample, thin sectioned and prepared by the Forensic Department as part 
of the autopsy. Both pathological and healthy control samples were selected from this 
collection. Samples arrived both as chemically cleaned (boiled in a mild chemical solution to 
remove any remaining flesh) and as fresh samples requiring cleaning.  
 
The samples from the division of Forensic Pathology of the Ministry of Justice in Tirana were 
also collected from autopsy, with the permission of the Proctor Fiscal, adhering to the ethical 
requirements of Albania.  This study included individuals from this source that died between 
October 2014 and October 2015 and ranged in age from 19 to 59. Like the samples from the 
Forensic Department in Crete, the Albanian samples also included any medical histories, 
pathologies, and cause of death known to the forensic pathologists.  Also like the forensic 
samples from Crete, some of the Albanian samples came with corresponding liver samples, 
again thin sectioned and prepared by the division of Forensic Pathology as part of the autopsy. 
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Due to time constraints and lab accessibility, only pathological samples were selected from 
this collection. These samples, like some of the samples from Crete, arrived fresh and required 
cleaning.  
 
4.1.1.3 The Cypriot Collection 
Samples were also selected from a Cypriot collection similar to the Cretan Collection. The 
Cyprus collection consists of about 200 individuals from the municipal ossuary of the St. 
Nicholas Cemetery in Limasol, Cyprus. According to Cypriot custom, each individual would 
have been buried for five years, exhumed, and then moved to the municipal ossuary. 
Permission to use the collection was given by the priest in charge of the municipal cemetery. 
The collection consists of individuals ranging in age from infants to 100 years old, who died 
between 1976 and 2003. Like the Cretan collection, sex was determined by name of the 
individual. (Kranioti, et al., 2017) As these samples were originally selected for a simultaneous 
population study of age estimation techniques, any obvious pathological conditions had been 
excluded through macro examination before being brought to the University of Edinburgh. 
(Garcia-Donas, 2017) As there were no confirmed pathological cases in this population 
available, samples were selected solely as healthy controls. Samples arrived as clean dry bone, 






4.1.2 Sample Distribution 
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Table 4.1: Sample Age Distribution 
Sample 
Category 
19-30 30-40 40-50 50-60 60+ 
Controls 2 3 6 7 22 
Pathological 2 7 6 13 12 
 
This study included both males and females. Samples were limited to adult individuals. 
Through the Cretan collection and the autopsy samples collected from the Cretan Forensic 
Department, an attempt was made to control for ethnicity. Such control is important, as 
different populations have been shown to need different age estimation formulae. As 
different groups differ in their morphology, inconsistent populations could inadvertently 
insert additional bias into the study. (Stout & Paine, 1992; Stout & Paine, 1994; Cho & al., 
2002). An effort was made to collect left rib midshafts of ribs 4, 5, or 6, however if a left was 
not available, a right midshaft was accepted. This was done for consistency, as most previous 
histological age estimation methods involving the rib have used these ribs. This is likely due 
to the original method by Stout and Paine (1992) using these particular ribs setting the 
standard, leading subsequent validation studies to also use left ribs 4-6. 
 
4.1.2.1 Pathological Samples 
 
For the purposes of this study, pathological samples were selected from medical histories and 
autopsy notes, as well as toxicology reports and histological samples of the liver, where 
available. Samples were collected from individuals suffering from chronic disease, including 
chronic alcoholism and other hepatic diseases, cancer (including brain and lung cancer), 
cardiovascular disease, pulmonary disease, renal disease, and/or diabetes, to guarantee an 
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effect on the osteological microstructure. In total, 40 pathological samples were used. Of 
those 40 samples, 20% (8 out of 40) had multiple pathologies falling into more than one 
category. These samples were separated out into their own disease class, as it is impossible 
to discern which condition affected the microstructure. 
 
Table 4.2: Table showing distribution of pathologies across the entire sample 
Cancer Diabetes Pulmonary Hepatic Cardiovascular Renal Multi 
2 1 2 16 10 1 8 
 
In addition to rib samples, corresponding liver histology samples were taken for the ribs 
collected from autopsies, where available. These slides were prepared as a part of the routine 
histological examination for each autopsy case and were sent along with the rib sections. The 
existence of microscopic evidence of pathology further confirms the suitability of the 
samples. (For example, one may have a history of alcoholism but if the liver is not seriously 
affected bone metabolism may still be normal.)  Liver samples were only used to confirm 
cases of liver disease, and those samples with histories of other pathological conditions were 
confirmed by medical history and the findings of the forensic pathologist, when applicable. 
 
4.1.2.2 Control Samples 
 
For the purposes of this study, healthy control samples were required to be compared to the 
pathological samples. Health was confirmed using medical history and autopsy notes, 
specifically cause of death. If any signs of pathology were noticed upon histological 
examination, those healthy controls were excluded. Control samples were matched according 
to age and sex for better comparison. In total, 40 healthy control samples were used. The 
samples were selected from the Cretan collection and the Cyprus collection as these were 
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collected for another project conducted simultaneously in the lab and they were available at 
the time of this project. The healthy Albanian samples, as they arrived later than the other 
collections, and were then subjected to a six-month quarantine, could not be included. 
Although this might have a small effect on the outcomes, the populations are similar enough 





The methodology used for this study can be divided into four practical areas; slide 
preparation, slide reading, analysis, and statistics. The preparation, reading, and some of the 
slide analysis were based on previous methodologies created for observing bone histology, 
and developed within the collaborative environment of the University of Edinburgh’s bone 
histology lab. The doctoral candidates and MSc students involved in the laboratory prepared 
their sample slides themselves after having been trained by Dr Elena Kranioti and Dr Robert 
Paine, and they worked together to develop new protocols and to improve on old ones. 
Details about the development of the slide preparation protocol can be found in Garcia-Donas 
et al (2017). The methods used to prepare and read the slides created for this study can also 
be seen in Garcia-Donas (2017) as both studies were done simultaneously in the same 
laboratory space. While certain aspects of the analysis were completed using previously 
defined protocols (Stout & Paine, 1992; Cho & al., 2002), others such as those used for 
analysing the micrometrics were developed independently for this study. The statistical 




4.2.1 Slide Preparation 
 
While certain aspects of Paine’s method (2007) were used during the process of this study, 
amendments were made to account for availability of materials, equipment, and time. In 
addition, a new method of adhering samples was used, eliminating the need for removal of 
the sample from a grinding slide to later adhere to a reading slide (Garcia-Donas & al., 2017). 
These changes were made with the intention to save laboratory time and supplies while 
rendering a similarly clear result. Preparations made from 2014-2016 were done in the 
Histology Lab, located in the Anatomy department of the University of Edinburgh, and 
samples prepared in 2017 were prepared in the histology department of Western General 
Hospital in Edinburgh. Both laboratories were set up with the same equipment and supplies. 
Throughout the slide preparation process, care was taken to follow the health and safety 
protocols established by the Health and Safety Department of the University of Edinburgh 
and to follow the guidelines set out in the School of History, Classics and Archaeology’s 
Laboratory User Handbook. All methods of preparation were done with the aim of preserving 
the osseous tissue. By cleaning and embedding the samples prior to slide preparation, the 
samples were able to be preserved and prevented any artefacts from being introduced to the 
samples. 
 
4.2.1.1: Sample Selection 
 
Samples were chosen using several sets of criteria. All samples were left ribs, preferably the 
4th, 5th, or 6th ribs. Medical history was also consulted, for the control samples to confirm 
general good health, or in the case of the pathological samples, to confirm chronic illness. In 
the case of the pathological samples of the alcoholics and those with hepatic disease, 
toxicology and histological liver samples were also consulted to confirm hepatic disease 
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and/or hepatic metabolic disturbance where available. The information on health and 
medical history was derived from the autopsy reports from Albania and Crete (for the autopsy 
samples) and from the Census office for the Cretan collection (Kranioti, et al., 2008). While 
this information had been passed on by the relevant forensic departments, exhaustive 
records were not available, therefore the records sent with the samples were assumed to be 
accurate. Samples selected as healthy controls were determined from autopsy reports 
(Crete), from the Census office (Cretan Collection), and from macro and histological 




In the event that samples needed to be de-fleshed in order to be processed, two different 
processes were used. Earlier samples were cleaned using a boiling method based on previous 
methods, and then modified (R. Paine, pers. comm.) (Fenton, et al., 2003). Maceration of the 
bones using this method was done at the Edinburgh City Mortuary. Before boiling, as much 
of the flesh as possible was removed manually with a scalpel. The ribs were then individually 
wrapped in medical gauze, the ends secured with string. The wrapped ribs were then placed 
in boiling water for 30-40 minutes. After the allotted time, they were removed from the 
boiling water, unwrapped, and any remaining flesh could be easily removed with a scalpel. 
Boiling was the preferred method for preparing samples, as it has the added effect of 
destroying bacteria and other possible artefacts in the bone, ensuring clean slides. 
 
For part of the samples, however, boiling was not an option, as the samples were also to be 
subjected to biomechanical analysis for another project, a process that requires the collagen 
of the bone to remain intact. Therefore, these samples were minimally defleshed, with only 
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a scalpel to remove excess soft tissue, so as to preserve the biomechanical properties of the 
bone. Once the bone had been cleaned, it was then cut in half with a Dremel saw. Half of the 
samples were used in this study for histological examination, and half were used in the 
biomechanical study. Cleaning of these samples was done in the laboratory at Western 
General Hospital. In the case of both cleaning methods, any remaining biological material that 
was removed from the bones was disposed of in accordance with the health and safety 
procedures of the University of Edinburgh (COSHH). Unlike boiling, this method of defleshing 
leaves a certain amount of residue. While not as effective as boiling, the samples were clean 
enough and by embedding in resin during the next stage of the process, any remaining 




First, the ribs were cut down to about 3.5-4 cm in length using a Dremel Saw (see figure 4.1), 
allowing the pieces of rib to fit more easily within Buehler moulds that were made to fit the 
Buehler MetaServTM 250 Grinder-Polisher. 
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Figure 4.1: Dremel Saw 
Once the ribs had been cut down, the moulds were prepared. First, Buehler release agent was 
used to coat the inside of the moulds to make removal of the resin easier upon setting. This 
release agent was left to sit in the moulds for 5 minutes before adding epoxy resin, made by 
mixing Buehler Epothin resin and hardener. Small pieces of plain printer paper were placed 
in the bottom of the moulds with sample ID numbers that would then become embedded in 
the resin with the samples. The epoxy resin used was a Buehler Epothin resin and hardener 
where a ratio resin to hardener of 5:1.95 grams was used to prepare the resin. A new version 
of the Buehler Epothin resin and hardener were obtained partway through the processing, 
and this resin and hardener used a ratio of 2:1 resin to hardener. Once mixed, the epoxy was 
then put inside a vacuum impregnator to eliminate excess air bubbles. A thin layer of the 
epoxy resin was poured into the bottom of the moulds before inserting the samples. Once 
the samples were placed in the moulds, more epoxy resin was poured until the samples were 
covered. The samples were then left to cure for 24-48 hours inside an extractor fume hood. 
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4.1.2.4 Markings and Assignment of Identification Numbers 
 
Each sample came to the department with an identification number. In the case of the 
Albanian autopsy samples, which did not come with numbers, a sample number was assigned 
to them. To ensure that medical records stayed connected to the correct samples, these 
numbers were kept and added to a database. From this point on, all analyses referred to the 
assigned numbers. By using numbers rather than patient names, the individuals in the study 
were allowed to remain anonymous, as dictated by the Human Tissue (Scotland) Act 2006, 
and the guidelines of the Human Tissue Authority (HTA). In the event that more than one slide 
was made with any one sample, the slides would be identified first by their sample number, 
and then a letter (e.g. slide CC196a). Sample numbers from the Cretan collection began with 
‘CC’ and then their individual sample number. Sample numbers from the Cretan forensic 
department were marked ‘FC’, and samples numbers from the Cyprus collection were marked 
‘CY’. The Albanian samples arrived later and were assigned numbers based on the group they 
arrived with. Group A was marked as ‘A’ and then then their individual number, while Group 
B was marked as ‘B’.  While an overall unique numbering system would have been preferable, 
as the samples were shared between several projects, some predating this research, the 
above numbering system was implemented to ensure consistency across the laboratory. 
 
Each rib from the Cretan collection was marked with a coloured marker to indicate 
orientation. Blue was used to indicate the cranial surface, Green was used to indicate the 
interior surface, and pink or red was used to indicate the exterior surface (See figure 4.2). This 
was done to make the cardinal surfaces of the cross-sections more easily identified, for 
example, the cranial edge and the caudal edge (White & Folkens, 2005). 
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Figure 4.2: Coloured labelling of samples (Garcia-Donas, 2017) 
 
In the case of the samples that were not boiled, and therefore not completely dry, markings 
were not applied to the bones, for reasons of hygiene. As marking was not possible, the 
cardinal surfaces of these sections were identified by their morphology. 
 
4.1.2.5 Preparing Samples for Mounting 
 
After the allotted time, the samples were checked to see if the epoxy resin had cured. Once 
the samples were determined to have finished curing, they were removed from the moulds. 
A Buehler MetaServTM 250 Grinder-Polisher (see figure 4.3) with coarse grinding paper was 
then used to remove the sloped edges of the resin from the tops of the samples.  
 
Figure 4.3: Left - Buehler MetaServTM 250 Grinder-Polisher; Right - Buehler IsoMetTM 1000 precision saw 
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After the samples were levelled, a Buehler IsoMetTM 1000 precision saw (see figure 4.3) fitted 
with an Isocut wafering blade was used to trim excess resin from the samples, if needed. The 
samples were then cut in two. One half was put aside for possible use later, while the other 
half was prepared for mounting. 
 
The Buehler MetaServTM 250 Grinder-Polisher was fitted with fine grinding paper to remove 
any evidence of saw marks that might be visible under the microscope, as well as to even the 
surface for mounting. Glass slides were then prepared by using a 15 microns abrasive 
aluminium oxide powder and water on a glass plate. This created a frosted glass surface, 
which would allow the sample to adhere to the slide more easily and securely.  
 
4.1.2.6 Mounting Slides 
 
Once the slides were adequately frosted, the samples were adhered to the slides, once again 
using the same Buehler Epothin epoxy resin that was used for the embedding, with a ratio of 
resin to hardener 5:1.95, or in the case of the replacement resin, 2:1. A small amount of resin 
was placed on the slide and the samples were placed on top of the resin. The sample was 
moved around slightly on the slide to ensure total adherence as well as to get rid of any air 
bubbles that might be present. After this, the samples were placed on a hot plate at 60°C until 
warmed through. The samples were then placed in a weighted bonding jig inside a fume hood 




Once the samples had cured, the excess was cut from the slide. A slide holder chuck was used 
to hold the slide in place on the arm of the IsoMetTM 1000 precision saw. The arm was then 
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moved towards the blade until the slide was flush with the blade surface. The measurement 
of the saw was then zeroed out, and the arm was moved exactly 1mm back from the blade, 
ensuring a 1mm thickness for the sample. Each sample was then cut on this setting. As the 
machine had been set to 1mm sample thickness, it was not necessary for the saw to be 




After the samples had been cut, the grinder was set up with first p800 grinding paper (coarser) 
and then p2500 grinding paper (finer). Slides were ground down using a petrographic slide 
holder, or a slide holding chuck, to approximately 75μm thickness, or until the osteons were 
clearly visible under a transmitted light microscope. Once the grinding was finished, the 
samples were polished with a Tex Met C polishing cloth. The slides were then ready for 
reading under both transmitted light and polarised light microscopes. 
 
4.2.2 Slide Reading  
 
4.2.2.1 Microscopes and Photographic Equipment 
 
The earlier samples were read using a Leica DM750P microscope with Leica MC170 HD 
camera attachment, as it is capable of using both transmitted light and polarised light. 
Additionally, photographs were taken of each sample using the accompanying LAS Leica 
computer programme. After photographs were taken of each section of the sample, the 
photographs were then stitched together within the programme to allow a full view of the 
cross-section. After the move to the histology department at Western General Hospital, the 
 93 
slides were read on an Olympus BX51 double eye-piece microscope, which allows for both 
transmitted and polarised light. The double eye-piece on the microscope also contributed to 
collaboration and inter-observer observations. The later slides were also photographed, using 
a slide scanner, eliminating the need to stitch multiple images together to view a complete 
cross-section, as well as the Leica set-up for close-up field of view photographs that would be 





For the purposes of this study, the pathological samples were assessed both quantitatively 
and qualitatively in comparison with the healthy control samples.  
 
Qualitative analysis allows the observer to identify specific features that indicate the presence 
of pathology. While these are subjective and rely on the observer’s experience, they are 
nevertheless important. By observing signs of pathology in bone, it is then possible to quantify 
the rate of occurrence of these features throughout the sample, as well as helping to identify 
pathological samples for further study and analysis via metrics. The observation of 
abnormalities in the bony structure -that are not attributed to remodelling due to aging- can 
be considered as signs of pathology. These abnormalities can be changes in the shape and 
structure of the microscopic features of bone such as the Haversian systems and canals. 
Qualitative analysis is also essential for the differentiation between potential artefacts and 
actual pathology. For pathology research in particular, it is important to recognise what is 
pathological bone micro-formations, and what could be the result of artefacts in the bone. By 
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analysing each slide qualitatively, any abnormal formations not consistent with pathology 
could be excluded. 
 
Quantitative analysis, on the other hand, allows for more precise analysis, by quantifying size 
differences that can allow for the generation of data that is easily compared and statistically 
analysed. While qualitative analysis requires more experience from the observer, the 
methods described for collecting and analysing quantitative data could be undertaken by 
anyone familiar with the basics of bone histology. 
 
4.2.3.1 Qualitative Analysis 
Qualitative aspects of the samples were assessed visually for microstructural differences 
between the pathological samples and the healthy controls. In terms of qualitative analysis, 
any features that occurred outside the range of normal for healthy samples were observed 
and noted. These differences usually fell into one of three categories.  
 
1. Abnormally shaped osteons and/or canals: Complete Haversian systems that have an 
irregular shape outside the range of normal. This includes osteons and canals that are 
irregularly sized. What is not included are those shapes that are seen within the realm of 
normal, healthy Haversian systems. These would include drifting osteons, branching osteons, 
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and a balanced amount of Howship’s lacunae. For an example of a category 1 osteon and a 
corresponding healthy osteon, see Figure 4.4. 
 
Figure 4.4: Left – Close-up of an abnormal osteon from Sample CC169; Right – Close-up of a normal healthy osteon from 
Sample CC100 (courtesy of Julieta Garcia-Donas) 
 
2. Deranged Haversian systems: Haversian systems that fail to form completely or normally, 
resulting in large, irregularly sized canals, often merging with other nearby deranged systems 
(See figure 4.5). Often these deranged canals have the appearance of irregular, overactive 
Howship’s lacunae. These pathological bone formations can be discerned from diagenesis by 
observing the cement lines and the direction of the lamellar bone.  If the bone flows around 
the canal and there are cement lines present, that is how the bone grew. There may also be 
discernible destructive activity in the form of the rippled edges of a Howship’s lacunae. This 
can also be called the ‘Swiss Cheese Effect’, as the canals in the cortical bone of the cross-
section appear like the holes in Swiss cheese, or a sponge. 
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Figure 4.5: Left – Example of deranged Haversian systems from Sample CC203 (Courtesy of Julieta Garcia-Donas); Right – 
Example of normal, healthy Haversian systems from Sample FC6 
 
3. Bone can also appear as rapid deposits, without forming a Haversian system at all. This has 
been observed before in a case of extra-spinal hyperostosis related to DISH. (Lill, 2013) In that 
case, the rapid linear deposits of bone were clearly visible at the site of the lesion on the 
periosteum (see figures 4.6 and 4.7). It is possible for this pathological formation to occur in 
other areas, related to other pathologies. 
 
Figure 4.6: A hyperostotic lesion showing linear rapid bone deposits on a cross-section of a metatarsal, sample 1MT2 
(100x magnification) (Lill, 2013).  
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Figure 4.7: Left – Close-up image of sample CC193 showing possible category 3 deposits near the periosteum (100x 
magnification), Right – Close-up image of sample CC77 showing no evidence of rapid bone deposits and a healthy 
periosteum (100x magnification) (Garcia-Donas, 2017).  
  
These three categories of pathological bone formation were then scored for each sample. 
Scoring involved being marked present or not present for each slide. Presence was 
determined differently for each category. In the case of category 1 features, as the presence 
of abnormal canals occasionally appears in healthy bone, it was determined that greater than 
50% of the cross-section needed to show abnormal canals to be marked present. For category 
2 features, as the deranged Haversian systems (Swiss Cheese Effect) usually only appear in 
pathological bone, only 20% needed to show the deranged systems to be marked present. As 
with category 2 features, category 3 features are rarer and less likely to appear on healthy 
bone, so they were also scored as present if 20% of the periosteum showed rapid linear 
deposits. This data could then be analysed for frequency chi2 and statistical significance, as 
well as any patterns that might emerge involving pathological groups or specific pathologies. 
 
4.2.3.2 Quantitative and Metric Analysis 
 
The next section involved quantitative and metric analysis. This analysis was then divided into 




First were the standard histological analyses, being the standard analyses used by most bone 
histologists. For this, the samples were measured, and important elements were quantified. 
For a list of each important element and their definitions, please see Table 4.3. 
Table 4.3: Table of standard histological elements and their definitions; as defined by Stout and Crowder (Stout & 
Crowder, 2012) 
Histological Element Definition 
Cortical Area The amount of cortical bone in a cross-
section, expressed in mm2. 
Complete Osteon A secondary osteon with a canal that is 
at least 90% complete. 
Fragmentary Osteon A secondary osteon with a canal that is 
less than 90% complete. 
Total Osteons The sum of the number of complete and 
fragmentary osteons 
Osteon Population Density (OPD) A variable that is equal to the sum of the 
number of complete and fragmentary 
osteons, divided by the cortical area. 
 
The number of complete osteons and fragmentary osteons were noted and used later to 
calculate osteon population density (OPD). These quantifications were done using a 
microscope, while a tally was kept of the complete and fragmentary osteons. Then the cortical 
area was measured, this time from a stitched photograph of the rib cross-section. This too 
was later used to calculate OPD. 
 
The second section involved the osteon specific metrics. Measurements were taken from 
complete secondary osteons, as defined by Stout and Crowder (Stout & Crowder, 2012). (See 




Table 4.4: Table of the osteon specific metrics.  
Metric  Definition 
Osteon Maximum Diameter (OMaxL) The maximum diameter of a complete, 
secondary osteon. Expressed in µm. 
Osteon Minimum Diameter (OMinL) The minimum diameter of a complete, 
secondary osteon. Expressed in µm. 
Osteon Circumference (OPeri) The circumference of a complete, 
secondary osteon. Expressed in µm. 
Osteon Total Area (OTArea) The total area of a complete, secondary 
osteon, including the canal. Expressed in 
µm2. 
Canal Area (CArea) The area of the canal of a complete, 
secondary osteon. Expressed in µm2. 
Osteon Area (OArea) The area of a complete, secondary 
osteon, minus the canal area. Expressed 
in µm2. 
Osteon Circularity (OCirc) A measurement of complete, secondary 
osteon quantifying how close the osteon 
shape is to a perfect circle. Expressed as 
a number between 1 and 0, with 1 being 
perfectly circular. 
Canal Maximum Diameter (CMaxL) The maximum diameter of the canal of a 
complete, secondary osteon. Expressed 
in µm. 
Canal Minimum Diameter (CMinL) The minimum diameter of the canal of a 
complete, secondary osteon. Expressed 
in µm. 
Canal Circularity (CCirc) A measurement of the canal of a 
complete, secondary osteon quantifying 
how close the canal shape is to a perfect 
circle. Expressed as a number between 1 




Figure 4.8: Illustration of measurements taken for micrometrics. Included are osteon maximum and minimum diameter, 
canal maximum and minimum diameter, osteon area, canal area, and osteon perimeter. Not pictured are osteon total 
area, osteon circularity, and canal circularity. 
Measurements were taken using a sampling method, using four field of view photographs 
from each slide. Each field of view photograph was taken using 100x magnification. To create 
consistency in the sampling method, each of the four photographs was taken to represent 
each of the four cardinal edges of the rib cross-section, one each for the cranial surface, 
caudal surface, exterior surface, and interior surface. Metrics were then taken using the 
software ImageJ. The software was run using a 2009 MacBook Pro, and an iPad Air 2. The iPad 
was connected to the MacBook using the Astropad software, allowing the iPad to be used as 
a drawing tablet. As it is currently not possible to automate the process of measuring osteons, 
each osteon was measured individually.  A stylus was used to draw around the cortical area, 
and around the osteons and canals, enabling more accurate measurements to be taken more 
quickly. Measurements were taken by following the cement line around the osteon, or 
around the border of the canal walls. All measurements could be recorded by measuring the 
border of the osteon and the canal. By drawing around the osteon, total osteon area, 
circumference (perimeter in ImageJ), max and min diameter (Feret and minFeret in ImageJ), 
and circularity could be measured. By drawing around the canal, area, max and min diameter, 
and circularity could be measured. True osteon area could then be calculated by subtracting 
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the canal area from the total osteon area. These measurements were taken from every 
complete osteon in each photograph.  
 
Initially, metrics had been taken from every osteon in the complete cross-section of the 
sample, however this was determined to be impractical and prohibitively time-consuming. 
Five samples were compared, using two sets of data from each slide. The first set including all 
metrics from the complete cross-section, the second set included only those metrics present 
within four fields of view from the four edges of the rib. These data sets were then analysed 
using an independent student t-test, and it was determined that there was no statistically 
significant difference between the two sets of data. These results then allowed for the 
sampling method of the metrics to continue. 
 
Once all of this data had been collected, an age at death was estimated using OPD and cortical 
area, for each individual, as defined in Stout and Paine’s histological age estimation method, 





Once the raw data had been collected from the histological samples, statistical analysis was 
run to determine the significance of the various elements that had been quantified and 
measured. This analysis was then split into two sections; the analysis run on the standard 
quantitative data, including numbers of complete and fragmented secondary osteons, 
cortical area and OPD, and the more in-depth, osteon specific data (osteon metrics). 
Statistical models were then applied to these separate sets of data. In terms of analysis, both 
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qualitative and quantitative, of the samples it was important to account for both inter and 
intra-observer error. As the samples used for this study included pathological specimens that 
are often excluded or ignored by most research in histology, it was important to make 
observations that were repeatable and easily recognisable. All statistical analysis was done 
using the RStudio software package. 
 
4.2.3.1 Standard Histology Statistics 
 
For the standard bone histology data, statistics followed several lines of inquiry. As the age 
estimation formulae already in existence did not work for this population, age estimation was 
not prioritised in the statistical analysis. (Stout & Paine, 1992; Cho & al., 2002). 
  
First, comparative statistics were run. The most important relationship to compare was the 
relationship between the various histological elements and true age at death (hereafter 
referred to as age). These comparisons would be run with the complete sample, to simulate 
previous studies that did not separate out pathological samples, and then the data would be 
split into the pathological and control groups with the same comparisons being run on each 
group individually.  
 
4.2.3.1.1 Inter-observer Error Analysis 
 
The standard histological data was also analysed for inter-observer error. One set of data was 
analysed by both the primary observer, and another observer. These analyses would allow 
for a measurement of the accuracy of the collected data, as well as the consistency. This 
follows previous research comparing age estimation methods used on the same population 
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incorporated in this study (Garcia-Donas, 2015). Statistical analyses of inter-observer error 
were calculated using RStudio. 
 
The inter-observer error for the standard histology was done as a collaborative effort and the 
results were used in two studies. Due to the cooperative nature of the lab and the work, 
Julieta Garcia-Donas, another researcher in the department undertaking a population study 
on age estimation at the same time as this study, and the author of this study collaborated 
on the inter-observer error for the standard histology methods as a way to save time and 
resources (Garcia-Donas, 2017). This involved the analysis of 22 slides by both parties using 
standard histological methods to quantify complete and fragmentary secondary osteons. By 
cooperating on one inter-observer study, it was possible to use the results for both projects. 
The two sets of observations were then compared using a paired t-test to test statistical 
significance.  In addition to the paired t-tests used to compare the quantifications, Garcia-
Donas also carried out technical error of measurement analysis, yielding a technical error of 
measurement (TEM), a relative technical error of measurement (rTEM), and an R coefficient 




For correlation statistics, a Spearman’s R test was performed on the data using the RStudio 
package. Spearman’s R was chosen as the method for correlation calculations over the more 
standard Pearson’s r due to the shape of the data distribution. While the complete data 
sample and the healthy group of data both had relatively normal distributions, the 
pathological group had a nonparametric distribution. As Pearson’s assumes a parametric 
distribution, Spearman’s rank correlation was chosen. As stated above, these correlations 
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were calculated for each variable three times, once for the complete data set, once for the 
pathological group, and once for the healthy control group. Once the correlations had been 
calculated for each group, this data was then converted into p-values, and charted in a heat 
map, illustrating significant positive and negative correlations between sets of data. The data 
for the correlation calculations are also available as matrices, two for each group, one with 
the Spearman’s r calculations, and one with the corresponding p-value conversions. 
 
4.2.3.1.3 Regression analysis 
 
Next, regression analysis was performed on the data, once again using RStudio. From the 
correlation results and previous studies (Stout & Paine, 1992; Cho & al., 2002), it was 
determined that cortical area and OPD have the strongest relationships. Based on these 
relationships, linear models were created, comparing age as the independent variable, with 
cortical Area and OPD as the dependent variables. This was done to calculate the strength of 
the variables in their ability to predict age. Once again, the models were done in three groups, 
one for the complete data set to simulate past research, and one each for the pathological 
and healthy control groups. First, cortical area was compared with age, and then osteon 
population density (OPD) was also compared with age. The results for each linear model 
returned several values, including five residuals, four coefficients, residual standard error, 
multiple and adjusted R-squared, the F-statistic, and a p-value. 
 
4.2.3.1.4 Standard Errors 
After the regression analysis, standard errors were calculated for each of the linear regression 
models, using RStudio. The standard error used was the standard error of the estimate (SEE) 
that measures the accuracy of predictions made with the regression line. SEE was calculated 
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for the regression models comparing cortical area and age, and OPD and age, giving an 




Finally bootstrapping was applied to the data as a resampling method, to evaluate the 
accuracy of sample estimates. This was done using RStudio. For the standard histology 
statistics, an ordinary nonparametric bootstrap was used to test the R-squared statistic from 
the regression models comparing age and cortical area and age and OPD. The bootstrap was 
set with 1000 replications. This yielded bootstrap statistics of original, bias, and standard 
error, as well as four confidence intervals; normal, basic, percentile, and bias-corrected and 




4.2.3.2 Osteon Specific Metrics 
 
After the standard histological data had been analysed according to established practices, the 
new data in the form of the osteon specific metrics needed to be evaluated. 5,270 osteons 
were measured, with each osteon having ten metrics taken, as described earlier in this 
chapter. In total, 52,700 measurements were taken. Once compiled, this data needed to be 
statistically evaluated. First, inter- and intra-observer errors were calculated using samples of 
the osteon specific metric data set, to evaluate the accuracy and consistency of the 
measurements taken. Once these assessments had been done, more descriptive statistical 
analyses were applied. As the variables were new in this context, the significance of each 
metric variable needed to be assessed. This was done in two ways; the first evaluating the 
complete data sets of all the samples, both divided into pathological and healthy control 
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groups and as sex and age matched pairs, the second was evaluating the metric means of all 
the variables.  
 
4.2.3.2.1. Inter and Inter-observer Error 
 
Inter and intra-observer errors for the osteon specific metrics were evaluated. The primary 
focus for this evaluation was the accuracy and consistency of the measurements taken for the 
osteon specific metrics. The repeatability of the new methodology required the 
measurements between one and two observers to remain consistent. For both the inter- and 
intra-observer error, the software ImageJ was used to take measurements, and the same 
photographs taken by the primary observer were available to all observers. To test intra-
observer error, the primary observer read and measured five of the slides twice, with the 
above-mentioned sampling method using the four defined fields of view. To test inter-
observer error, measurements taken by the primary observer were compared with a sample 
of nine slides. These sets of data, for both the inter- and intra-observer error, were compared 
using t-tests. The Welch’s t-test was chosen as it is the appropriate test to use for data sets 
of unequal variances, and due to the variability in the number of osteons measured per 
sample, the data sets in question were of unequal variance. 
 
4.2.3.2.1.1 Intra-observer Error 
 
To test inter-observer error, five slides were measured twice by the primary observer. 
Measurements were taken using the sampling method described earlier in the chapter and 
involved all ten metric variables. These two sets of measurements were separated by several 
months, to decrease any chance of bias. Once the two sets of data were complete, they were 
compared using a Welch’s independent two sample t-test as there was unequal variance 
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between the data sets. Each metric variable was tested for statistically significant difference 
between the data sets, returning a t value, df value, p-value, 95% confidence interval, and 
sample estimates for each data set. 
 
4.2.3.2.1.2 Inter-observer Error 
 
A student in Greece volunteered to undertake the inter-observer analysis for the osteon 
specific methods. He was given a detailed description of the methodology and the software 
used to take the metrics of the microstructural elements, as well as high resolution 
photographs of nine slides, including both pathological and healthy control samples. As the 
error comparison took place early in the assessment, the specifics of the methodology later 
changed to include two more variables (osteon and canal circularity) and the sampling 
method. As a result, the second observer measured the complete cross-section of the nine 
slides and evaluated seven of the metric variables including osteon maximum length (OMaxL), 
osteon minimum length (OMinL), osteon total area (OTArea), canal area (CArea), osteon area 
(OArea), canal maximum length (CMaxL), and canal minimum length (CMinL). The second 
observer did not measure osteon circumference. These were then compared to the data 
collected by the primary observer and analysed for error. As with previous data in this study, 
a Welch’s independent two sample t-test had to be used to evaluate the inter-observer data 
as there was unequal variance between the two groups of data accumulated by the observers. 
Each metric variable measured by the second observer was compared with the data from the 
primary observer, returning a t value, df value, p-value, 95% confidence interval, and sample 
estimates for each observer. 
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4.2.3.2.2 Independent T-tests 
 
The first set of t-tests involved comparing the complete set of osteon specific metric data 
from the pathological group with the complete set of data from the healthy control group. A 
Welch’s two sample independent t-test was used to compare the measurements from each 
metric variable using RStudio to evaluate whether there was a statistically significant 
difference between the measurements taken in the pathological group versus the control 
group. Again, a Welch’s t-test was used, due to unequal variance in the sample. Each t-test 
returned a t-value, a df value, a p-value with any value less than 0.05 being deemed as 
significant, a 95% confidence interval, as well as sample estimates for each group.  
 
4.2.3.2.3 Paired Independent T-tests 
 
After the t-tests comparing the complete sets of data between groups, individual pairs of 
samples were compared and assessed. In total, 40 pairs of samples, with each group 
containing the data from one pathological and one healthy control sample were assessed. 
These samples were first matched for age, and then matched for sex, if the data allowed. As 
the healthy controls had been selected for age match, as well as sex match wherever possible, 
it was possible to compare all the pathological samples to a relevant healthy control. Due to 
the need to match for age and sex, several controls were repeated in the comparison, as it 
was determined that an age and sex match was more important for comparison than having 
40 sets of completely distinct pairs. Once again, each pair was evaluated using a Welch’s two 
sample independent t-test. Like the tests comparing the complete sample, the pairs of data 
were of unequal variance, so an independent, rather than a paired t-test, was necessary. For 
each pair, a t-test was done to compare each metric variable, resulting in ten t-tests per pair, 
or 400 tests overall. As above, each test returned a t-value, a df value, a p-value, a 95% 
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confidence interval, and sample estimates for each sample in the pair. These values were then 
put into a table for each pair to allow for easier reading and comparison. 
 
4.2.3.2.4 Metric Means 
 
Once the complete sets of data had been evaluated, the data was broken down into the more 
easily managed means. This was done by taking the mean of each variable for each sample. 
The result of this was that each sample had one mean for each of the ten metric variables. 
This data could then be put into a table along with other relevant variables such as age, sex 
and health status. Once the data had been reorganised, it was possible to evaluate the metrics 
means using correlations and linear regression models. As with the standard histology data, 
the data was split into pathological and healthy control groups, and each variable was 
compared with age to evaluate if there was any significant relationship between the variable 




The pathological group of the metric means data, similar to the standard histological data, 
did not have a normal distribution, so again a Spearman’s rank correlation was chosen over 
Pearson’s to accommodate the distribution. Correlations were run using RStudio, and 
matrices of Spearman’s r and converted p-values were created for both the pathological 
group and the healthy control group. Once these matrices had been created, a heatmap 






To compare the metric means of the variables with age, linear regression models were 
created. Once again, the data for these models were separated into pathological and healthy 
control groups. Within each group, a linear regression model was created comparing age with 
each of the ten metric variables, with the metric variable serving as the predictive variable. 
Each regression model returned five residuals, four coefficients, residual standard error, 
multiple and adjusted R-squared, an F-statistic, and a p-value. The results of each metric 
variable could then be compared across the pathological and healthy control groups for 
predicative strength of the model. Once all of the models had been created, a scatterplot 
showing the sample distribution with lines of regression for the pathological and healthy 





This chapter will recount the results of the research undertaken during the course of this 
study. Osteology has long relied upon a mix of observational or qualitative methods, as well 
as quantitative techniques. Likewise, the data generated for this project has been considered 
using both qualitative and quantitative methods. For the purposes of this study, qualitative 
refers to observable features, and quantitative refers to the metric and statistical analysis of 
the cross-sections and Haversian systems.  
 
Qualitative analysis allows the observer to identify specific features that indicate the presence 
of a pathology. By observing signs of pathology in bone, it is then possible to quantify the rate 
of occurrence of these features throughout the sample, as well as helping to identify 
pathological samples for further study and analysis via metrics. The observation of 
abnormalities in the bony structure, that are not attributed to remodelling due to aging, can 
be considered as signs of pathology. These abnormalities can be changes in the shape and 
structure of the microscopic features of bone such as the Haversian systems and canals.  
 
Quantitative analysis, on the other hand, allows for more precise analysis, by measuring size 
differences that can be easily compared statistically. While qualitative analysis requires more 
experience from the observer, the methods described for collecting and analysing 
quantitative data could be undertaken by anyone familiar with the basics of bone histology.  
 
For these reasons, both qualitative and quantitative data needed to be collected and analysed 
for the current study.   
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5.1 Qualitative Analysis 
 
 
Having previously defined the types of features it is possible to see in samples effected by 
pathology, the features observed in the sample data will now be shown, as well as their 
distribution throughout the sample. This will include a description of the features observed 
in the sample, the quantity of features observed in each category, if any samples exhibited 
characteristics belonging to more than one category, and if there was any significant 
relationship between the pathology class or age group and the pathological features. 
 
For the purposes of qualitative analysis, this section is only remarking upon observable 
changes in the cortical bone, and as such, primarily concerns the pathological samples, as all 
healthy controls were selected to represent healthy bone microstructure. Any controls that 
exhibited evidence of pathology inconsistent with age were excluded. These assessments are 
reliant upon the observations of the observer and are not to be confused with the metric 
analyses of the osteons and canals that are included further in this chapter under quantitative 
analysis. As changes to the bone microstructure can be quite subtle, these observations rely 
upon the expertise of the observer. By creating categories of pathological samples and 
defining criteria for each category, an attempt was made to standardise this observational 
method and limit its subjectivity.  
 
In addition to the assessment of the pathological samples, the healthy control samples were 
also observed and assessed based on the same criteria as the pathological group. This was 
done to confirm the prevalence of the defined pathological features in the pathological group 
as opposed to the healthy control group. These groups were further split into six age groups 
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for assessment, as the age of the individual, regardless of health status, could influence the 
appearance of the cortical bone microstructure (Parfitt, 1984). Specifically, this was done to 
account for the possibility of age-related osteoporosis occurring in the older members of the 
healthy control sample. The consequences of these age-related effects are that the difference 
between the pathological group and the healthy control group becomes less pronounced in 
the older samples. 
 
5.1.1 Qualitative Features 
 
 
5.1.1.1 Category 1: Abnormally Shaped Osteons and Canals 
 
Abnormally shaped osteons and canals were the most common features observed in this 
study. This includes osteons outside the norm of shape, including circularity of the osteon and 
the canal. An example of these features can be seen in Figure 5.1. These do not appear in the 
healthy control of similar age.  
Changes to the size and shape of secondary osteons and canals have been previously 
connected to pathology before, for example in Paine and Brenton’s 2006 study on pellagra 
(Paine & Brenton, 2006).  These changes to the Haversian systems most often accompany a 
Figure 5.1: Left - Close-up of sample CC169, a 78-year-old male who suffered from coronary disease, diabetes, and 
COPD showing Category 1 pathological features (exterior surface, 100x magnification) Right -  close-up of sample 
number CY39. The sample comes from a 75-year-old male in the healthy control group. (interior surface, 100x 
magnification) (courtesy of Julieta Garcia-Donas) 
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noticeable thinning of the cortical bone, and may present a connection to osteoporosis or 
osteopenia (Parfitt, 1984; Ortner, 2003). It is also important to note that these features may 
appear in either the entire cross-section, or in more concentrated areas of the cross-section. 
If 50% or more of the cross-section was affected, it was counted as present. If less than 50%, 
or none, of the cross-section was affected, it was marked as absent. It is possible for cross-
sections showing pathological features from category 1 to overlap with features from 
category 2 or 3, with all three categories occasionally occurring simultaneously in the same 
sample. Figure 5.1 is a close-up of pathological sample number CC169, and a healthy control. 
Sample CC169 belongs to a 78-year-old male, who suffered from coronary disease, diabetes, 
and COPD. These diseases fall into the cardiovascular, diabetes, and pulmonary classes of 
diseases, as defined for the purposes of this study. This picture illustrates not only the 
increase in porosity caused by the abnormally large canals, but also the thinning of the cortical 
bone that often accompanies the features seen in category 1. In addition, the size and shape 
of the osteons is quite variable, showing the imbalanced activity of the osteoclasts. 
 
The following images are two sets of close-up photographs of samples showing visual 
evidence of category 1 pathological features. Though not all, many of the pathological 
samples observed also have a distinctive thinning of the cortical bone, in addition to the 
defined pathological features. Between the thinning of the cortical bone, and the increased 
porosity of the cortical bone caused by the category 1 features, these samples should be 
visually identifiable as pathological. Following each pathological image will be a close-up of 
an age and sex matched sample from the healthy control group. This will allow for better 
visualisation of the pathological features, when compared with the healthy control.  
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Figure 5.2: Left - Close-up of sample FC2 showing Category 1 pathological Features (interior surface, 100x magnification); 
Right – Close-up of sample CY198, healthy control (interior surface, 100x magnification) 
Figure 5.2 shows a pathological sample belonging to a 68-year-old male with hypertension 
and CAD, and a healthy control sample from a 65-year-old female. The pathological sample 
shows a thinning of the cortical bone, as well as the category 1 pathological features, namely 
irregularly shaped and sized Haversian systems, compared to a normal, healthy sample. These 
changes are visually observable, and do not require histomorphometrics to be recognised. 
 
 
Figure 5.3: Left - Close-up of the interior surface of sample B28, showing category 1 features(100x magnification); Right–
Close-up of sample CY191, healthy control (exterior surface, 100x magnification) (image of sample CY191 courtesy of 
Julieta Garcia-Donas) 
Figure 5.3 shows another pathological sample, this one belonging to a 50-year-old male with 
fat deposits in the liver, and a healthy control sample belonging to a 48-year-old male. Again, 
the pathological sample, while perhaps having slightly thinner cortical bone than one would 
normally expect for a male this age, most certainly shows signs of category 1 pathological 
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features, the effect of which is that the cortical bone appears much more porous than the 
comparative healthy control. 
5.1.1.2 Category 2: Deranged Haversian Systems (Swiss Cheese Effect) 
 
The second most encountered category of pathological features were Deranged Haversian 
Systems. In addition to the increased porosity seen in the first category of pathological 
features, the Deranged Haversian Systems shows a sharp increase in osteoclast activity. The 
metabolism of the bony tissue has been disrupted, hindering the ability of the cortical bone 
to remodel in a normal way (Parfitt, 1984). This is then expressed as overly large canals, often 
connecting and branching to meet the canals of neighbouring osteons, and oddly shaped 
osteons and canals, to the point where the osteons are almost no longer identifiable. This can 
also be called the “Swiss Cheese Effect” as the cortical bone cross-section begins to resemble 
that of the eponymous cheese. Similar malformations of Haversian systems have been seen 
in other pathologies present in other bones, such as cribra orbitalia in the orbital roof, syphilis 
in the long bones, and extra-spinal hyperostosis related to DISH (Schultz, 2012; Lill, 2013). 
While some samples have the involvement of nearly the entire cross-section, samples were 
noted as having category 2 features if approximately 20% or more of the observed cross-
section was involved. 
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Figure 5.4: Top – Stitched full cross-section of sample CC203 showing Category 2 pathological features; Bottom Left – 
Close-up of the exterior surface of sample CC203 showing Category 2 pathological features, 100x magnification; Bottom 
right – Close-up of the interior surface of sample CC187, healthy control, 100x magnification. (All images courtesy of Julieta 
Garcia-Donas) 
In figure 5.4 shows a full cross-section and a close-up of sample number CC203, as well as a 
close-up of a similarly aged healthy control for comparison. This pathological sample 
belonged to an 85-year-old male suffering from chronic obstructive pulmonary disease 
(COPD), placing this sample in the pulmonary class of pathologies. This sample is a good 
example of full cross-section involvement of category 2 pathological features, as seen in the 
first image. The disorganised canals have completely taken over the entre cross-section of the 
rib, showing the extreme extent of the inhibition of the metabolic function of the bone. This 
is even more visible in the close-up photograph, showing the extent of the abnormal 
osteoclast activity in the bone. While not necessarily thinning overall, with the exception of 
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the area to the right of the full cross-section, the bone is extremely porous, owing to the 
abnormal bone remodelling. 
 
The features seen in this pathology category often only cover part of the cross-section and 
are concentrated in one or two areas. These features also sometimes occur near a lesion, 
particularly lytic lesions. Due to the deranged remodelling seen in this category of features, it 
is immediately obvious to the observer that something is wrong with the cortical bone, 
making this category of features easy to identify even by those observers less experienced in 
bone histology, unlike those features seen in category 1. It is also possible for features in 
category 2 to appears alongside features from category 1 or category 3, and occasionally all 
three categories are present at once. 
 
The following images are two close-up photographs of samples showing visual evidence of 
category 2 pathological features. Unlike the category 1 features, category 2 features are much 
more difficult to quantify and measure, and for that reason are not comparable to the metric 
analysis in the Quantitative Analysis section of this chapter. As in the previous section, 
following each pathological image will be a close-up of an age matched sample from the 
healthy control group. This will allow for better visualisation of the pathological features, 




Figure 5.5: Left - Close-up of interior surface of sample FC16, (59 years old) showing signs of category 2 features (100x 
magnification): Right - Close-up of interior surface of sample CY190 (57 years old), healthy control (100x magnification). 
Figure 5.5 shows a pathological sample with category 2 features, as well as a similarly aged 
healthy control. The pathological sample is from a 59-year-old male with a myocardial 
infarction and a history of CAD. The comparative sample is from a 57-year-old healthy male. 
Once again, the cortical bone of the pathological sample appears more porous, and the 
Haversian systems more irregular than the healthy control. It is also observable that the 
pathological sample has thinning cortical bone, when compared with the healthy control. 
 
5.1.1.3 Category 3: Striations of Rapid Bone Deposits 
 
 
The third category of pathological features is the least commonly observed in this study. This 
category does not involve the Haversian systems of the cortical bone, but rather refers to 
striations of bone. These striations are formed by overactive osteoclasts, once again 
interrupting the regular metabolic processes of cortical bone. This interruption of metabolic 
activity causes the osteoblasts to rapidly deposit bone in layers, usually near the periosteum, 
without following the pattern of the normal Haversian system, and therefore not creating 
osteons. Evidence of these striations of rapidly deposited bone have also been seen in relation 
to other pathologies in different bones, such as syphilis in the long bones, and extra-spinal 
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hyperostosis related to DISH (Schultz, 2012; Lill, 2013) These features are usually 
concentrated in only one or two areas of the cross-section, and are most often seen in 
proximity to prolific lesions.  Like the features present in category 2, these striations very 
clearly fall outside the range of normal for cortical bone microstructure, making them easily 
identifiable. The features in category 3 can also occur simultaneously alongside features from 
categories 1 and 2. As in the previous category, samples were counted as having category 3 
features if there was approximately 20% involvement, this time of the periosteum rather than 
the entire cross-section, as category 3 features occur primarily along the periosteum. 
 
The following is an image of the only sample with possible Category 3 pathological features, 
compared with a sex and age matched healthy control sample. As the rarest category of 
pathological features, it would be beneficial in the future to increase sample size in order to 
have more samples with these features to be compared. Like the features in category 2, 
category 3 features should be easily identifiable, once the observer knows what to look for. 
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Figure 5.6: Close-up of exterior surface of sample CC193, showing possible Category 3 pathological features, arrow 
pointing to striations, 100x magnification 
 
Figure 5.6 is a close-up of sample number CC193. This sample belonged to a 62-year-old male 
suffering from liver cirrhosis, placing this sample in the hepatic class of pathologies. This 
sample shows clear evidence of category 1 pathological features, and possible visual evidence 
of category 3 pathological features. In this close-up, there appears to be a thin layer of rapidly 
deposited bone. This occurs when the metabolic processes of the bone are disrupted, and the 
osteoblasts begin creating bone in the wrong place, usually along the periosteum, sometimes 
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near the site of a lesion. That does not appear to be the case with this sample. It may be that 
another study focusing more on infectious disease might encounter these features more. 
 
Figure 5.7: Close-up of interior surface of sample CY198 (65-year-old, F), a healthy control, 100x magnification 
Figure 5.7 is from sample number CY198. This sample belonged to a 65-year-old female in the 
healthy control group.  Again, this sample is a good example of healthy bone for this age 
group. Compared with the previous pathological sample, this sample shows relative 
consistent osteon size and shape, and shows no signs of any of the 3 categories of bone 
pathological features. While the periosteum is slightly irregular, there is no evidence of rapidly 
deposited bone. Furthermore, unlike the matched pathological sample, the cortical bone is a 
normal thickness, and does not show any signs of unusual bone thinning. 
 




5.1.2.1 Distribution and Analysis by Pathology 
 
 
To measure the distribution of the three categories of qualitative features, the pathological 
samples were separated into six classes of pathology based on the specific conditions noted 
in their medical records. These classes are cancer cardiovascular, diabetes, hepatic, 
pulmonary, and renal. Some individuals had multiple pathologies in two or more classes, and 
these were also noted. Once separated into classes of pathology, observations of each sample 
were counted and recorded.  
 
The following table (see table 5.1) illustrates the results of these observations. As some 
samples had multiple pathologies in two or more classes, they were counted in the Multiple 
Classes row, instead of being counted multiple times in the other disease classes. This was to 
see if having conditions in multiple classes had any bearing on the manifestation of 
pathological features in any particular category. It was also noted if any samples had features 
falling into more than one category. While it is possible for a single cross-section to have 
features that fall into all three categories, none of the pathological samples in this study had 
features that fell into more than two categories. Lastly, the healthy control samples were also 
counted, to see how many of them showed evidence of pathological bone in any category. 
While some may show small amounts of pathological bone, this is most likely due to age, as 








Table 5.1: Distribution of feature categories by disease class 
 
Overall, category 1 features were the most widespread across all classes of pathology. In four 
of the six individual classes, category 1 features were present in 100% of cases, while in the 
remaining two classes, category 1 features were present in greater than 81.25% of cases. In 
samples with multiple classes category 1 features were present in 100% (8 of 8) of cases. 
Category 2 features were the second most common in the pathological group. These features 
were present in five of the six classes of pathology. In samples with multiple classes, category 
2 features were present in 25% (2 of 8) of cases. Finally, category 3 features were the rarest 
of three types of features seen in the Pathological group. They were present in only the 
hepatic class of the six pathology classes. Of the sixteen samples in the hepatic class, category 




Cases Category 1 Category 2 Category 3 2 Categories 3 Categories 
Cancer 2 2 (100%) 1 (50%) 0 (0%) 1 (50%) 0 (0%) 
Cardiovascular 10 9 (90%) 4 (40%) 0 (0%) 3 (30%) 0 (0%) 
Diabetes 1 1 (100%) 1 (100%) 0 (0%) 1 (100%) 0 (0%) 
Hepatic 16 13 (81.25%) 3 (18.75%) 1 (6.25%) 3 (18.75%) 0 (0%) 
Pulmonary 2 2 (100%) 2 (100%) 0 (0%) 2 (100%) 0 (0%) 
Renal 1 1 (100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Multiple Classes 8 8 (100%) 2 (25%) 0 (0%) 2 (25%) 0 (0%) 
Healthy Controls 37 4 (10.81%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
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In some of the cases, features in more than one category were present in the sample. While 
there were cases with features in two categories, there were no samples exhibiting features 
in all three categories. In all but one of these cases, the features exhibited were category 1 
and category 2 features. A single case in the hepatic class showed evidence of category 1 and 
category 3 features. Multiple categories of features were present in five of the six classes of 
pathology, as well as in the multiple class category. 
Table 5.2: Distribution of pathological features across age groups in the pathological sample 
Age Group No. Samples Category 1 Category 2 Category3 
<20 1 1 (100.00%) 1 (100.00%) 0 (0.00%) 
21-30 1 1 (100.00%) 0 (0.00%) 0 (0.00%) 
31-40 7 4 (57.14%) 3 (42.86%) 0 (0.00%) 
41-50 7 7 (100.00%) 1 (14.29%) 0 (0.00%) 
51-60 13 12 (92.31%) 4 (30.77%) 0 (0.00%) 
>60 11 11 (100.00%) 4 (36.36%) 1 (9.09%) 
 
In addition to analysing the samples by class of pathology, the pathological samples were also 
separated into age groups (see table 5.2). This was done to better compare with the healthy 
control group. Although the healthy control was selected specifically to not show any 
observable signs of pathology, this was done with the caveat that normal age-related changes 
would not be discounted. While several samples in the older age groups of the healthy control 
sample were found to show pathological features, these were much more restrained in their 
prevalence when compared with the pathological group. 
 
5.1.2.1.1 Pathological features in the Healthy Control group 
 
 
As well as the pathological samples, the healthy control samples were also observed, and 
presence of any of the categories of pathological features was noted (see table 5.3). High 
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prevalence of these features was not expected, as they had been pre-screened by another 
researcher for use in another project. It is possible, however, that some of the older samples 
might be expected to have some pathological features, due to an age-related decrease in 
bone density (see figure 5.8). All controls were selected from the databases of two 
osteological collections. Controls were selected from those individuals with no record of 
pathology at the time of their death, however it is possible some individuals may have had 
undiagnosed conditions that were never recorded. 
 
Table 5.3: Table showing the distribution of pathological features in the Healthy Control group, separated by age group 
Age Group No. Samples Category 1 Category 2 Category3 
<20 1 0 (0.00%) 0 (0.00%) 0 (0.00%) 
21-30 1 0 (0.00%) 0 (0.00%) 0 (0.00%) 
31-40 4 0 (0.00%) 0 (0.00%) 0 (0.00%) 
41-50 4 1 (25.00%) 0 (0.00%) 0 (0.00%) 
51-60 8 1 (12.50%) 0 (0.00%) 0 (0.00%) 
>60 19 2 (10.53%) 0 (0.00%) 0 (0.00%) 
Total 37 4 (10.81%) 0 (0.00%) 0 (0.00%) 
 
The results of this analysis were overall concurrent with expectations. There were no cases of 
pathological features in individuals under 46 years of age, and those samples that did show 
signs of pathological features were limited to the first category of features, the most common 
category. Category 1 features most notably imply an increase in bone porosity due to the 
larger area of the canals 3observed and are often found in conjunction with thinning cortical 
bone. That said, there were cases in the older age groups of the healthy control group that 
had thinning cortical bone, but seemingly normal sized and shaped osteons (see figure 5.9). 
Overall, only 10.81% (4 of 37) of the control samples showed signs of pathological features, 
compared with 95% (38 of 40) pathological samples. It may also be worth mentioning that 
three of the four samples with observed pathological features in the healthy control group 
were female, a demographic more likely to suffer from age-related and/or postmenopausal 
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osteoporosis and osteopenia, a possible contributing factor to the appearance of said 
pathological features. 
 
Figure 5.8: Top – Cross-section of sample CC26 from the healthy control group, belonging to a healthy 90-year-old female; 
Bottom –Cross-section of sample CC53 from the healthy control group, belonging to a healthy 19-year-old female. (Both 
images courtesy of Julieta Garcia-Donas) 
 
5.1.2.1.2 Pathological features in the Cancer class 
 
 
The cancer class consisted of two samples, one with cancer of the brain, and one with cancer 
of the lungs. It is unknown from the available medical history what stage of cancer or if the 
cancer had metastasised anywhere outside the sample. Neither sample in the cancer class 
 128 
had metastatic lesions present on the ribs, although this could be a possibility in other cancer 
samples, as skeletal involvement is common in most malignant neoplasms (Ortner, 2003).  
 
While the number of samples with cancer was very small, there was a certain amount of 
information that could be obtained. Of the two samples with pathologies in the cancer class, 
category 1 features were present in 100% (2 of 2) of cases and category 2 features were 
present in 50% (1 of 2) of cases. There were no observable category 3 features present, 
however this does not exclude the possibility of their presence in other samples. Of the two 
samples in the cancer class, two categories of features were present in 50% (1 of 2) of cases, 
specifically, two categories of pathological features were seen in the sample with brain 
cancer, while only category 1 features were present in the patient with lung cancer. Due to 
the small sample size and the lack of information regarding the stage and progression of the 
disease, more research will be needed to draw meaningful conclusions.  
 
 
Figure 5.9: Left – Close-up of the interior surface of sample CC45, from a 64-year-old female suffering from lung cancer 
(image of sample CC45 courtesy of Julieta Garcia-Donas); Right – Close-up of the interior surface of sample CY198, from a 
65-year old healthy female, 100x magnification. 
 
5.1.2.1.3 Pathological features in the Cardiovascular class 
 
The cardiovascular class consisted of ten samples. These samples include those patients with 
coronary artery disease (CAD), including atherosclerosis and myocardial infarction, 
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hypertension, cerebral haemorrhage, and endocarditis. Amongst these conditions, CAD was 
the most common. As the heart is adjacent to the ribs, it is possible for periosteal lesions to 
appear on the bones adjacent to the diseased heart, namely ribs and thoracic vertebrae 
(Schultz, 2001). Recently, it has also been discussed that there is a possibility of correlation 
between heart disease and osteoporosis (Sprini, et al., 2014; Bagger, et al., 2007; Magnus & 
Broussard, 2005).  
 
The cardiovascular class was one of the larger disease sample sizes at ten samples. This 
sample size, however, is still relatively small, and any conclusions drawn from these results 
would require further enquiry. Of the ten samples with pathologies in the cardiovascular 
class, category 1 features were present in 90% (9 of 10) of cases, and category 2 features were 
present in 40% (4 of 10) of cases. There were no observable category 3 features, however this 
does not exclude the possibility of these features appearing in other samples. Of the ten 
samples in the cardiovascular class, two categories of features were present in 30% (3 of 10) 




Figure 5.10: Left – Close-up of the exterior surface of sample FC18, a 57-year-old male with a myocardial infarction, CAD, 
and generalised atherosclerosis, 100x magnification; Right – Close-up of the interior surface of sample CY190, a healthy 
57-year-old male, 100x magnification. 
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5.1.2.1.4 Pathological features in the Diabetes class 
 
The diabetes class consisted of only one sample. It is unknown which type of diabetes the 
patient suffered from. As diabetes is a metabolic disorder, it likewise can influence the 
metabolism of other tissues in the body, including bone (Vestergaard, 2007; de Liefde, et al., 
2005). As the sample size is incredibly small for this disease class, it is more useful to regard 
this sample as a case study, and to put off drawing any specific conclusions until further 
research has been conducted. In the single case of diabetes, both category 1 and category 2 
features were present.  
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Figure 5.11: Top – Full cross-section of sample CC189, a 94-year-old male with diabetes; Middle Left – Close-up of sample 
CC189 exterior surface, 100x magnification; Middle Right – Close-up of sample CC83 exterior surface, a healthy 90-year-
old female, 100x magnification; Bottom – full cross-section of sample CC83. (Pictures of CC83 courtesy of Julieta Garcia-
Donas) 
 
5.1.2.1.5 Pathological features in the Hepatic class 
 
 
The hepatic class was the largest of the disease classes, consisting of sixteen samples. This is 
due in part to the fact that the project initially intended to only analyse individuals with 
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hepatic disease. While with sixteen cases the hepatic class is the largest disease sample size, 
it is still a relatively small sample size, and further research would be needed to draw specific 
conclusions from these results. The hepatic class included individuals with liver cirrhosis, 
hepatomegaly, possible hepatitis, and fatty liver. There has long been an acknowledged 
connection between chronic hepatic disease and disruptions to bone metabolism, especially 
as it relates to chronic alcohol abuse (George, et al., 2009; Diamond, et al., 1990; Bikle, et al., 
1985; Schnitzler & Soloman, 1985; Verbanck, et al., 1976; Gonzalez-Calvin, et al., 1993; 
Spencer, et al., 1986; Lindsell, et al., 1982). Often this takes the form of osteoporosis and 
osteopenia, leading to a thinning and weakening of the bone inconsistent with the age of the 
individual. 
  
Of all the disease classes, the hepatic class’s larger sample size provides the best opportunity 
for analysis. Of the sixteen samples with pathologies in the hepatic class, category 1 features 
were present in 81.25% (13 of 16) of cases, and category 2 features were present in 18.75% 
(3 of 16) of cases. Category 3 features were the rarest of three types of features seen in the 
pathological group. They were present in only the hepatic class of the six pathology classes. 
Of the sixteen samples in the hepatic class, category 3 features were present in only 6.25% (1 
of 16) of cases. The single case of category 3 features occurred in an individual suffering from 
liver cirrhosis.  Of the sixteen samples in the hepatic class, two categories of features were 
present in 18.75% (3 of 16) of cases. These included one sample with category 1 and 3 
features, and two samples with category 1 and 2 features. The samples with category 1 and 
2 features suffered from fatty accumulation.  
 133 
 
Figure 5.12: Left – Close-up of the exterior surface of sample B41 exterior surface, a 53-year-old male with generalised 
fatty liver; Right – Close-up of the interior surface of sample CY61 interior surface, a healthy 51-year-old female, 100x 
magnification. (image of sample CY61 courtesy of Julieta Garcia-Donas) 
5.1.2.1.6 Pathological features in the Pulmonary class 
 
 
The pulmonary class consisted of two samples, one with COPD (chronic obstructive 
pulmonary disorder), and one with chronic bronchopneumonia. From the literature, it is 
known that pulmonary conditions can affect the ribs due to their proximity to the site of 
primary disease (Schultz, 2012). In addition, it is possible for osteoporosis to occur alongside 
chronic pulmonary diseases, such as COPD (Jørgensen, et al., 2007; Cavaillès, et al., 2013; 
Chatila, et al., 2008). 
 
As there are only two samples in this disease class, more research would be needed to 
connect any category of features definitively to pulmonary disease, however the following do 
have value and can be seen as case studies. Of the two samples with pathologies in the 
pulmonary class, category 1 features are present in 100% of cases, and category 2 features 
were also present in 100% of cases. This means that of the two samples in the pulmonary 
class, two categories of features were present in both cases. There were no cases showing 
category 3 features, however this does not exclude them from appearing in other samples. 
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Figure 5.13: Left – Close-up of the exterior surface of sample CC203, an 85-year-old male with COPD, 100x magnification; 
Right – Close-up of the interior surface of sample CC187, a healthy 81-year-old male, 100x magnification. (Both images 
courtesy of Julieta Garcia-Donas) 
  
5.1.2.1.7 Pathological features in the Renal class 
 
 
Like the diabetes class of disease, the renal class consisted of only one case. In this case, the 
individual suffered from uraemia, indicating possible kidney failure (Cotran, et al., 1999).  In 
many patients with chronic kidney disease, there is a marked development of bone 
abnormalities, especially as it pertains to mineral metabolism (Williams, 2009; Ott, 2009; 
Leonard, 2009; Miller, 2005). Like some of the other disease classes with very few samples, it 
would be best to treat this disease class as a case study, rather than to extrapolate from its 
results. Category 1 features were present in the single sample, but there were no indications 
of features from category 2 or 3. Likewise, there was not a case with multiple categories of 
features present. While these categories were not present in this sample, it is possible that 
these features could appear in another sample with renal pathology. Further research into 
the microstructure of ribs in cases with renal pathology must be made to further understand 
the significance of the features seen in this sample. 
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Figure 5.14: Left – Close-up of the exterior surface of sample CC6, a 58-year-old female with uraemia, 100x magnification; 
Right – Close-up of the interior surface of sample CY190, a 57-year-old healthy male, 100x magnification.   
 
5.1.2.1.8 Pathological features in the Multiple class group 
 
 
In addition to the samples with pathologies related to only one class of disease, there were 
eight samples with multiple pathologies belonging to more than one class of disease. These 
ranged from samples with disease in two classes, to a sample with disease in five different 
classes. For example, sample A10 came from an individual suffering from hypertension, 
diabetes, heart ischemia, left ventricular hypertrophy, hepatic steatosis, pyelonephritis, and 
bronchopneumonia. These conditions would fall in to multiple classes, in this case 
cardiovascular, diabetes, hepatic, renal and pulmonary. These samples were separated out 
from the samples with conditions that fell within only one disease class, as it was not possible 
to account for interactions between the diseases, or to know which condition or combination 
of conditions could have caused the changes to the bone microstructure. All the conditions 
involved in the multiple class group were also represented by single samples in the above 
sections, there were no disease classes that were present in the multiple class group that did 
not also appear in the rest of the pathological sample. 
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The multiple class category was one of the larger sample sizes available, with eight cases. In 
samples with multiple classes, category 1 features were present in 100% (8 of 8) of cases, and 
category 2 features were present in 25% (2 of 8) of cases. There were no samples with 
evidence of category 3 features, but it is possible for these features to appear in other 
samples. More research is needed. Of the samples with pathologies in multiple classes, 
features from two categories were present in 25% (2 of 8) of cases. 
           
 
Figure 5.15: Left - Close-up of the interior surface of sample FC13 (52-year-old male), from an individual suffering from 
hypertension, coronary disease, and pulmonary complications of chronic heavy smoking, showing signs of category 2 
features. (100x magnification); Right - Close-up of the interior surface of sample CY191, (48-year-old male) healthy control. 
(100x magnification) (image of sample CY191 courtesy of Julieta Garcia-Donas). 
 
5.1.2.1.9 Analysis of Pathological Categories 
 
 
Once each sample had been observed and evaluated, several chi squared tests were carried 
out to examine the relationships between the various disease classes and age groups with the 
different categories of pathological features. In all cases, a chi squared test for independence 
was used. This tests the null hypothesis that the variables are independent of each other. This 
is done by comparing expected values with the observed values. First, the expected values 
were calculated using the totals from each tested group. Then the chi squared test was 
performed on three tables of data and a p-value was returned. This p-value would then 
indicate whether the variables were independent or not. 
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The first to be tested were the healthy samples tested against their age group. This test was 
simpler than the others as there were very few samples with any sign of pathology, and all 
that did exhibit pathological features were exclusively in the first category, therefore only the 
first column of the table was able to be tested. The chi squared test returned a p-value of 
0.9225, indicating that there is almost no chance that the variables of category 1 pathological 
features and age are independent of each other.  
 
The next to be tested were the pathological samples tested against their age groups. Unlike 
the first-test conducted with the healthy samples, this test was carried out across the entire 
table, as all three categories of pathological features were represented, as well as by 
individual age group. The chi-squared test for the entire table returned a p-value of 0.7770, 
which while also indicating a very strong relationship between the pathological features and 
age, is slightly less than the results of the same test on the healthy samples. Below is a table 
of the results returned per age group. 
Table 5.4: Table of chi squared test results comparing categories of pathological features between the pathological and 
healthy control groups, further separated by age group 
Age Group p-value 
Less than 20 years old 0.4872 
21-30 years old 0.8348 
31-40 years old 0.5364 
41-50 years old 0.6165 
51-60 years old 0.8417 
Greater than 60 years old 0.3527 
  
The final variables to be tested were the disease classes. Again, as all categories of 
pathological features were represented, the chi squared test was carried out across the entire 
table, as well as for each individual disease class. The test for the entire table returned a p-
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value of 0.6202, indicating a strong relationship between the categories of pathological 
features, and the different classes of disease. Below is a table of the results returned per 
disease class. 
Table 5.5: Table of chi squared test results comparing categories of pathological features with disease classes 







Multiple Groups 0.9345 
 
5.2 Quantitative Analysis 
 
 
Quantitative analysis for this study was separated into two groups. The first involved the 
standard histological practices for bone as developed by Stout and Paine (1992), and Cho and 
colleagues (2002). This involves the measurement of the cortical area, quantifying the 
number of secondary osteons in the cross-section (both complete and fragmented), and then 
calculating for osteon population density (OPD). These metrics can then be used in any age 
estimation formula previously developed, and then compared. It would also allow the study 
to compare age with cortical area and OPD, as previous studies have noted a significant 
relationship between age and these two variables (Stout & Paine, 1992; Stout, et al., 1996; 
Cho, et al., 2002). With these variables, it was possible to use previously developed age 
estimation, however since these formulae were not developed for this population, and had a 
very high level of inaccuracy, it was determined that directly comparing actual age to cortical 
area and OPD through correlation and regression would be more informative and beneficial.  
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The second group of data this study employed for the purposes of Quantitative analysis are 
the osteon specific data. These were measurements taken of individual osteons and canals 
from four sampled areas within each cross-section. These metrics were created for this study 
with the purpose of quantifying some observable changes in bone microstructure, such as the 
increased cortical bone porosity seen in osteoporosis and osteopenia. These are non-
standard measurements, and therefore no outside comparisons can be drawn. The metrics 
chosen for this study include maximum and minimum osteon diameter, osteon 
circumference, osteon total area, canal area, osteon actual area (minus the canal area), 
osteon circularity, maximum and minimum canal diameter, and canal circularity. 
 
5.2.1 Standard Bone Histology 
 
The first section of the Quantitative Analysis section is the Standard Bone Histology. This 
includes the tried and tested measurements and quantifications that have been used as a 
standard for rib histology as first described by Stout and Paine (1992). Using this data, it was 
then possible to run statistics using the R statistical package. For this data, the statistical 
analysis was concentrated on correlations, regression analysis, inter-observer, and 
bootstrapping. All of these statistics were done on the pathological samples, the healthy 
samples, and then again on all the samples together. This is because previous studies have 
not separated out pathological samples, and it was the aim of this study to prove that 
removing pathological samples would lead to better, more accurate results when 
implementing population appropriate age-estimation formulae. 
 




The error rates for the standard histological analysis were conducted using inter-observer, to 
test the accuracy of quantification between two readers. Inter-observer error was done by 
each reader quantifying the same slide separately, and then comparing. By doing these tests, 
the accuracy of the quantifications can be determined. 
 
Inter-observer errors for standard histology were conducted in conjunction with another 
study being undertaken at the University of Edinburgh. These tests were done using samples 
from the pooled collection of histological samples including both pathological and healthy 
individuals from Crete and Cyprus. There were two readers involved in the error testing, the 
author of this study, and Julieta Garcia-Donas. The quantifications from the other reader were 
not viewed until after all quantifications had been made, to decrease the incidence of bias.  
These quantifications were then subjected to a paired t-test to test for statistically significant 
differences between the two readers.  
 
The first variable to be tested was the number of intact osteons per cross-section. The same 
22 slides were examined by each reader, and the intact osteons quantified. A paired t-test 
was then performed. The t-value for these sets of data was calculated as 1.7091. The p-value 
was quantified as 0.1022. The 95% confidence interval was between -0.5912 and 6.04570. 
Lastly, the mean of the differences was 2.7273. 
 
The next variable to be tested was the number of fragmented osteons per cross-section. The 
t-value for these sets of data was calculated as 3.6023. The p-value was calculated as 0.0017. 
The 95% confidence interval was between -19.788 and -5.3029. Lastly, the mean of the 
differences was -12.5455. 
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Finally, the last variable to be tested was the number of intact osteons per cross-section. The 
t-value for these sets of data was calculated as -2.1879. The p-value was calculated as 0.0401. 
The 95% confidence interval was between -19.1503 and -0.4861. Lastly, the mean of the 
differences was -9.8182.  
 
These same sets of data were also assessed using TEM, rTEM, and associate R values by Julieta 
Garcia-Donas. Overall, these tests showed high repeatability, with most variables not 
exceeding the 5% acceptance threshold, with the exception of the number of fragmented 
osteons which was shown to have a 12% variance due to measurement error between 





For the purposes of this study, correlations were done using Spearman’s r correlations. These 
were then converted to give p-values for significance. Full tables of both Spearman’s r 
correlations and converted p-value correlations are available in the Appendix. While 
correlation does not equal causation, they provide a starting point from which to explore 





Figure 5.16: Heat map of Spearman’s correlations using the entire sample, and the converted p-values 
 
The above image is a heat map showing correlations between different factors, including Age, 
Sex, Status, Complete Osteons, Fragmented Osteons, Total Osteons, Cortical Area, and OPD. 
On the one side, colours and shades indicate positive correlation (blue) and negative 
correlation (red). The darker the shade, the stronger the correlation. On the other half, a pie 
chart for each factor intersection gives the strength of the correlation. Some correlations, 
including Age Estimation and OPD, and Complete or Fragmented Osteons and Total Osteons 
have strong correlations because one of the factors is a part of the other one. For example, 
Complete and Fragmented Osteons are added together to get Total Osteons. For the 
purposes of this study, the most important correlations to consider are those factors with 
strong correlations to Age. In this case, the strongest correlated factors with Age are Cortical 
Area, and OPD. Using Spearman’s r, Age and Cortical Area correlation was valued at -0.51 (p-
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value <0.0001). Using Spearman’s r, Age and OPD correlation was valued at 0.47 (p-value 
<0.0001). All of these correlations, however, include both healthy and pathological samples.  
 
Figure 5.17: Heat map showing Spearman’s correlations for only pathological samples, and converted p-values 
The above image is a heat map showing correlations between the different factors, this time 
using only the pathological samples. Overall, the heat map appears much lighter, indicating 
that the strength of correlations is much weaker. This is again reinforced by the pie charts on 
the right of the image. Again, some correlations, such as Age Estimation and OPD, and 
Complete and Fragmented Osteons and Total Osteons, are strongly correlated due to a 
functional relationship. These correlations can then be excluded. Those factors that were 
strongly correlated with Age in the previous image are now far weaker. Using Spearman’s r, 
Age and Cortical Area are now correlated at -0.35 (p-value 0.28), and Age and OPD are now 




Figure 5.18: Heat map showing Spearman’s correlations using only Healthy Samples, and converted p-values 
 
The above image is a heat map showing correlations between different factors using only the 
healthy control samples. This map appears much brighter than the previous map showing the 
results of calculations using only the pathological samples. Looking at the pie charts to the 
left of the image, Age is shown to be very strongly correlated to OPD and Cortical Area. Using 
Spearman’s r, Age and Cortical Area are now correlated at -0.66 (p-value <0.0001), and Age 
and OPD are now correlated at 0.70 (p-value <0.0001). These are not only stronger 
correlations than the pathological samples, but also stronger than the mixed correlations. 
 
5.2.1.3 Regression Analysis 
 
 145 
Building on the correlations between Age and Cortical Area, and Age and OPD, regression 
analysis was done on both the pathological and healthy samples and plotted to show the 
distributions and lines of regression for each. Full regression outputs can be found in the 
Appendix. 
 
Included in the results from this calculation were coefficients, residual standard error, 
multiple R-squared, adjusted R-square, and p-value. As with the correlations, regressions 
were calculated first with all samples, and then separated into pathological and healthy 
control samples. 
 
Figure 5.19: Scatterplot of Age compared to Cortical Area for the entire sample with the line of regression 
First, regression was calculated using all samples. This would reflect previous research in the 
field, where pathological samples were not separated out. First, coefficients were calculated. 
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The Estimate coefficient was calculated as intercept 82.1126 and slope -1.2744. The Standard 
Error coefficient was calculated as from the intercept 5.1013 and from the slope 0.2514. 
Multiple R-squared was calculated as 0.2477, and Adjusted R-squared was calculated as 
0.2381. Finally, p-value was calculated as <0.0001. 
 
Figure 5.20: Scatterplot of Age compared to Cortical Area, separated by health status, with lines of regression 
The above image is a scatterplot showing the distribution of both healthy and pathological 
samples with regard to the Age and Cortical Area factors. The downward slant of the 
regression lines shows the negative correlation between Age and Cortical Area. This also 
shows the red regression line (healthy) as a better fit to the line of regression than the blue 
regression line (blue). 
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Next, regression was calculated using only the pathological samples. The Estimate coefficient 
was calculated as intercept 72.0406 and slope -0.8615. The Standard Error coefficient was 
calculated as from the intercept 8.5843, and from the slope 0.3961. Multiple R-squared was 
calculated as 0.1107 and Adjusted R-squared was calculated as 0.0873. Lastly, p-value was 
calculated as 0.03593. 
 
Lastly, regression was calculated for only the healthy control samples. First, the coefficients 
were calculated. The Estimate coefficient was calculated as intercept 87.3396 and slope -
1.4886. The Standard Error coefficient was calculated as 13.598 from the intercept, and 
0.3416 from the slope. Multiple R-squared was calculated as 0.3333 and Adjusted R-squared 
was calculated as 0.3157. Finally, p-value was calculated as <0.0001. 
 
The results included in this calculation are the same as those for the Age and Cortical Area 
regression. As with the regressions for Age and Cortical Area, regressions were calculated first 
with all samples, and then separated into pathological and healthy control samples. 
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Figure 5.21: Scatterplot of Age compared to OPD for the entire sample with the line of regression 
The above image is a scatterplot showing the distribution of the entire sample with regard to 
the Age and OPD factors. The upward slant of the regression lines shows the positive 
correlation between Age and OPD. 
 
Regression was calculated for all samples. First the coefficients were calculated. The Estimate 
coefficient was calculated as intercept 28.0238 and slope 2.1234. The Standard Error 
coefficient was calculated as 6.5226 from the intercept and 0.4481 from the slope. Multiple 
R-squared was calculated as 0.2235 and Adjusted R-squared as 0.2135. Finally, the p-value 
was calculated as <0.0001. 
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Figure 5.22: Scatterplot of Age compared to OPD, separated by health status, with lines of regression 
The above image is a scatterplot showing the distribution of both healthy and pathological 
samples with regard to the Age and OPD factors. The upward slant of the regression lines 
shows the positive correlation between Age and OPD. This also shows the red regression line 
(healthy) as a better fit to the line of regression than the blue regression line (blue). 
 
First, regression was calculated for only the pathological samples. First the residuals were 
calculated. The Estimate coefficient was calculated as intercept 47.1246 and slope 0.5312. 
The Standard Error coefficient was calculated as 10.4336 from the intercept and 0.7643 from 
the slope. Multiple R-squared was calculated as 0.01255 and Adjusted R-squared was 
calculated as -0.01343. Lastly, the p-value was calculated as 0.4913. 
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Finally, regression was calculated for only the healthy samples. First, the coefficients were 
calculated. The Estimate coefficient was calculated as intercept 17.5412 and slope 2.9633. 
The Standard Error coefficient was calculated as 7.8482 from the intercept and 0.5095 from 
the slope. The Multiple R-squared was calculated as 0.471, and the Adjusted R-squared was 
calculated as 0.4571. Lastly, the p-value was calculated as <0.0001. 
 
5.2.1.4 Standard Errors 
 
For the standard bone histology data, standard errors were calculated for each of the linear 
regression models. The standard error used in this section is the standard error of the 
estimate, or SEE, which measures the accuracy of predictions made with the regression line. 
For the SEE, a value closer to zero indicates a more accurate result. SEE was then calculated 
for the regression models comparing cortical area and age, and OPD and age. 
 
Table 5.6: Table of SEE calculations for linear regression comparing cortical area and age, and OPD and age 
Standard Error Complete Data Pathological Data Healthy Data 
SEE -Cortical Area 15.46 15.52 15.36 
SEE-OPD 15.71 16.36 13.68 
 
These standard errors give an indication of the accuracy of the regression predictions, which 
can then be compared with the standard errors of other studies that use cortical area and 






For the purposes of this study, bootstrapping was used as a sampling and replacement 
method. Bootstrapping allows for assigning measurements of accuracy to the statistical 
estimates made earlier in the chapter. Specifically, bootstrapping was used to test the R-
squared statistic for the regression analysis done in section 5.2.1.3. As in the regression 
section, resampling was applied to the R-squared statistic using the regression formula for 
each group comparing Age and Cortical Area, and Age and OPD. The standard for each 
resampling was 1000 replications. These were then plotted, and 95% confidence intervals 
calculated.  
 
Figure 5.23: Plot of R-squared of Age and Cortical Area regression bootstrapping using All Samples 
Using the complete set of sampled data, bootstrapping was applied to the Age and Cortical 
Area regression. The original R-squared, as reported in the above regression section was 
0.2477. The bias was calculated as 0.0073. The standard error was calculated as 0.0760. Next, 
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95% confidence intervals were calculated. The Normal confidence interval was calculated as 
between 0.0914 and 0.3894. The Basic confidence interval was calculated as between 0.0893 
and 0.3884. The Percentile confidence interval was calculated as between 0.1071 and 0.4062. 
Finally, the BCa confidence interval was calculated as between 0.0946 and 0.3842. 
 
Figure 5.24: Plot of R-squared of Age and Cortical Area regression bootstrapping using only pathological samples 
Next, using only the pathological samples, bootstrapping was applied to the Age and Cortical 
Area regression. The original R-squared, as reported above in the regression section, was 
calculated as 0.1107. The bias was calculated as 0.0212. the standard error was calculated as 
0.1017. Following these bootstrap statistics, the 95% confidence intervals were calculated. 
The Normal confidence interval was calculated as between -0.1098 and 0.2889. The Basic 
confidence interval was calculated as between -0.1549 and 0.2198. The Percentile confidence 
interval was calculated as between 0.0016 and 0.3763. Finally, the BCa confidence interval 
was calculated as between 0.0007 and 0.3590. 
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Figure 5.25: Plot of R-squared of Age and Cortical Area regression bootstrapping using only healthy control samples 
 
Finally, bootstrapping was applied to the Age and Cortical Area regression using only the 
healthy control samples. The original R-squared, as reported above in the regression analysis 
section, was calculated as 0.3333. The bias was calculated as 0.0095. The standard error was 
calculated as 0.0807. Following these bootstrap statistics, 95% confidence intervals were 
calculated. The Normal confidence interval was calculated as between 0.1655 and 0.4820. 
The Basic confidence interval was calculated as between 0.1532 and 0.4790. The Percentile 
confidence interval was calculated as between 0.1875 and 0.5133. Lastly, the BCa confidence 
interval was calculated as 0.1704 and 0.4893. 
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Figure 5.26: Plot of R-squared of Age and OPD regression bootstrapping using All Samples 
After bootstrapping the regression for Age and Cortical area, bootstrapping was then applied 
to the R-squared statistic from the Age and OPD regression. As with the bootstrapping of the 
Age and Cortical Area regression, bootstrapping for the Age and OPD regression began with 
testing the R-squared statistic using all the sampled data. The original R-squared, as stated in 
the above regression analysis section, was calculated as 0.2235. The Bias was calculated as 
0.006. The Standard Error was calculated as 0.0858. Following these bootstrap statistics, the 
95% confidence intervals were calculated. The Normal confidence interval was calculated as 
between 0.0493 and 0.3855. The Basic confidence interval was calculated as between 0.0316 
and 0.3717. The Percentile confidence interval was calculated as between 0.0753 and 0.4154. 
Lastly, the BCa confidence interval was calculated as between 0.0758 and 0.4157. 
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Figure 5.27: Plot of R-squared of Age and OPD regression bootstrapping using only pathological samples 
Next, bootstrapping was applied to the R-squared statistic from the regression of Age and 
OPD using only the pathological samples. The original R-squared, as stated in the above 
regression analysis section was calculated as 0.0126. The bias was calculated as 0.0224. The 
standard error was calculated as 0.0442. Following these bootstrap statistics, the 95% 
confidence intervals were calculated. The Normal confidence interval was calculated as 
between -0.0964 and 0.0767. The Basic confidence interval was calculated as between -
0.1338 and 0.0251. The Percentile confidence interval was calculated as between 0.0000 and 
0.1589. Lastly, the BCa confidence interval was calculated as between 0.0000 and 0.1280. 
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Figure 5.28: Plot of R-squared of Age and OPD regression bootstrapping using only healthy control samples 
Finally, bootstrapping was applied to the R-squared statistic of the Age and OPD regression, 
this time only using the healthy control samples. The original statistic, as stated in the above 
regression analysis section, was calculated as 0.471. The bias was calculated as 0.0099. The 
standard error was calculated as 0.1142. Following these bootstrap statistics, the 95% 
confidence intervals were calculated. The Normal confidence interval was calculated as 
between 0.2373 and 0.6849. The Basic confidence interval was calculated as between 0.2451 
and 0.6871. The Percentile confidence interval was calculated as between 0.2549 and 0.6969. 
Lastly, the BCa confidence interval was calculated as between 0.2295 and 0.6616. 
 




Building upon the metrics and quantifications of the Standard Histology analysis, this study 
took the measurements further by taking metrics of individual osteons. The osteons were 
sampled from the entire cross-section, using four fields of view from the four cardinal points 
of the rib cross-section. Ten metrics were taken per osteon. These metrics include the 
maximum and minimum osteon length, the osteon perimeter, the total osteon area, the canal 
area, the osteon circularity, maximum and minimum canal length, and canal circularity. In the 
case of the total osteon area, this measurement has been defined as the area of the entire 
osteon, including the canal. The osteon area has been defined as the total osteon area minus 
the canal area. The circularity metrics measure how close the shape of the osteon or canal 
are to a perfect circle, a perfect circle being 1, and anything less than a perfect circle being 
between 1 and 0. A total of 52,700 measurements were taken. Inter and Intra-observer error 
were calculated for the micrometrics. The data was then analysed for correlation, for 
significance through the use of t-tests, by taking the mean value of each metric and comparing 
it to age divided by health status. 
 
5.2.2.1 Inter and Intra-observer Error 
 
 
5.2.2.1.1 Inter-observer Error 
 
 
Inter-observer error for the osteon metric means was carried out by the author of this study, 
and an undergraduate volunteer. As this was carried out early in the process of gathering 
metric data, not all the metrics were accessed, specifically the osteon and canal circularity 
were not measured. In addition, the undergraduate volunteer only measured a small number 
of osteon perimeters, so this metric was excluded from the inter-observer analysis due to 
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insufficient data. Measurements were taken using the software ImageJ, and stitched 
photographs of the entire cross-section of the rib samples.  The entire cross-section was used, 
as at the time of the inter-observer analysis, it had not yet been determined that sampled 
data would be a more efficient use of time and resources. It had also not yet been determined 
that the most accurate method for taking the measurements was with a stylus and tablet. In 
the future, the same measurement method and sampled data would be used by both 
observers, to yield more accurate results. 
 
Table 5.7: Table showing results of independent t-test comparing two observers 
Sample OMaxL OMinL OTArea CArea OArea CMaxL CMinL 
CC15 <0.0001 0.0009 0.5331 0.05114 0.301 0.0052 0.0077 
CC169 <0.0001 0.569 0.0602 0.1108 0.0706 0.0063 0.2009 
CC196 <0.0001 <0.0001 0.0386 0.5437 0.0137 0.1987 0.0458 
FC2 0.03349 0.1724 0.5888 0.2348 0.7144 0.149 0.1217 
FC3 0.0014 0.005 0.0164 0.2116 0.0117 0.0353 0.0701 
FC6 <0.0001 <0.0001 <0.0001 0.0002 <0.0001 <0.0001 <0.0001 
FC10 <0.0001 <0.0001 <0.0001 0.0495 <0.0001 0.009 0.0432 
FC13 0.0250 
 
0.0921 0.9357 0.6701 0.8818 0.1617 0.0094 
 
Above is a table showing the p-value results of a Welch’s independent t-test comparing the 
data from eight samples analysed by the two observers. Those p-values shown in red indicate 
a statistically significant difference between the metric data obtained by each observer. Those 
p-values shown in black indicate no statistically significant difference between the data 
obtained by the observers. 
 
5.2.2.1.2 Intra-observer Error 
 
 
Intra-observer error was conducted by the author. This was done to determine the 
consistency of the measurements. The original metrics were compared with a second set of 
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metrics taken several months later of the same slides. These were done using the sampled 
material, not the complete cross-sections, as was used in the inter-observer error section 
above. In addition, all variables were tested, as opposed to only some of the variables. This 
was possible as the second measurements were done after the first set of complete 
measurements was finished. A Welch’s independent t-test was used to evaluate the data, as 
although the same slides were observed twice, there may be a small difference in the number 
of osteons measured per sample.  
 
Table 5.8: Showing p-values results from the t-tests for intra-observer error 
Sampl
e 
OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
FC14 0.2819 0.057 0.1718 0.2065 0.7179 0.1213 0.1811 0.7883 0.8955 0.9368 
CC203 0.0795 0.2613 0.2027 0.1857 0.7376 0.1395 0.6048 0.8117 0.5409 0.8078 





0.0006 0.08274 0.0019 0.0002 0.0297 0.0248 0.3349 
CY183 0.121 0.2495 0.137 0.2099 0.417 0.2177 0.0327 0.4035 0.3232 0.9721 
 
Above is a table showing the p-value results of the Welch’s independent t-tests. A t-test was 
run for each variable comparing the data for each slide’s two sets of readings. The p-values 
shown in red indicate a statistically significant difference between the two sets of metrics 
taken by the observer. Those values shown in black indicate no statistically significant 
difference between data sets. With the exception of one slide, this difference is minimal, 
indicating consistent metric values.  
 
5.2.2.2 Independent T-tests (Full Sample) 
The ten osteon specific metrics were divided into pathological and healthy control groups. 
These groups were then compared to see if there was a statistically significant difference 
between the pathological and healthy control samples for any of the metric variables. This 
was done by using a Welch two sample independent t-test. A Welch two sample t-test was 
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used as there was unequal variance between the healthy set of metrics and the pathological 
set of metrics. 
Table 5.9: Welch two sample t-test results comparing the complete healthy set with the complete pathological set 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 2.7563 0.18715 -0.90944 -0.39725 2.4604 -0.5317 -
0.36434 
2.7824 4.1266 5.2874 









































237.2156 226.6027 822.9777 34816.90 3738.503 31078.40 0.8967 87.5119 49.6454 0.8136 
 
Of the ten variables tested, five exhibited a statistically significant difference between the 
healthy and pathological samples. These variables included osteon maximum length, canal 
area, canal maximum length, canal minimum length, and canal circularity. 
 
5.2.2.3 Paired Independent T-tests (40 pairs, sex and age matched) 
 
After all the metric variables were tested, 40 pairs of samples were compared. This was again 
done using an independent t-test, as due to the variability of the number of osteons per cross-
section prevented a true paired t-test. Each of these pairs includes one pathological sample 
and one healthy control sample. These samples were paired based on age and sex, wherever 
possible. Some healthy controls were repeated, as the pairs were created based on the best 
match, rather than a one-to-one match across all samples. These samples were then further 
broken down into five age groups: under 30 years of age, ages 31-40, ages 41-50, ages 51-60, 
and over 60 years of age. Due to the distribution of the sample, there are fewer pairs in the 
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younger age groups, and more pairs in the older age groups. Note, when pairs are presented, 
the pathological sample appears first, followed by the healthy control sample. 
 
Age Group 1: Under 30 
 
 
Pair 1: A14 and CC53 
 
The first pair to be compared was pathological sample A14, and healthy control CC53. A14 is 
from a male individual, aged 19. As there were no male healthy samples of analogous age to 
compare with, sample CC53 from a healthy 19-year-old female was selected. Below are the 
results of the comparative t-tests. There were no significant differences between the samples 
from the selected osteon metric variables. 
Table 5.10: Pair 1 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 0.47588 0.55034 0.77832 0.56846 0.22467 0.61669 -1.3531 0.96009 0.55515 -
0.43465 











































238.2060 171.4996 643.2787 32735.57 3708.972 29026.59 0.9218 85.1931 49.9952 0.8385 
 
 
Pair 2: B1 and FC3 
 
The next pair to be compared was pathological sample B1, and healthy control FC3. B1 is from 
a male individual, aged 24. Sample FC3 is from a healthy 28-year-old male. Below are the 
results of the comparative t-tests. Only the variable canal circularity (CCirc) showed a 
statistically significant difference between the samples. 
 
 162 
Table 5.11: Pair 2 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 

































































Age Group 2: 31-40  
 
Pair 3: B12 and CC7 
 
The third pair to be compared was pathological sample B12, and healthy control CC7. Sample 
B12 is from a female individual, aged 31. Sample CC7 is from a healthy 38-year-old female. 
Below are the results of the comparative t-tests. There were statistically significant results 
from six of the ten variables, including osteon max length (OMaxL), osteon perimeter (OPeri), 
canal area (CArea), osteon circularity (OCirc), canal minimum length (CMinL), and canal 
circularity (CCirc). 
Table 5.12: Pair 3 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 2.4317 0.9657 2.1068 0.5394 2.7176 0.13177 -2.383 1.7571 2.6105 -2.3691 





































225.4986 161.1061 611.9112 31264.34 2189.462 29074.88 0.9149 72.6111 42.0157 0.8557 
 
 
Pair 4: B20 and CC152 
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The next pair to be compared was pathological sample B20, and healthy control CC152. 
Sample B20 is from a male individual, aged 33. Sample CC152 is from a healthy 34-year-old 
male. Below are the results of the comparative t-tests. There were no statistically significant 
differences between the two samples from the selected osteon metric variables. 
Table 5.13: Pair 4 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -0.212 -0.1385 -0.0796 -0.3518 -0.4129 -0.279 -1.527 -0.0879 -0.7434 -
1.0712 




























































42346.52 4880.99 37465.53 0.9199 54.5567 54.5567 0.8041 
 
 
Pair 5: A11 and CC7  
 
The fifth pair to be compared was pathological sample A11, and healthy control CC7. Sample 
A11 is from a female individual, aged 35. Sample CC7 is from a healthy 38-year-old female. 
Below are the results of the comparative t-tests. There were three variables that showed 
statistically significant differences between the samples, including canal area (CArea), canal 
maximum length (CMaxL), and canal minimum length (CMinL).  
 
Table 5.14: Pair 5 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 2.8079 2.9752 2.4376 2.0035 1.4606 1.8683 -0.5927 0.7783 1.3035 -
2.828
9 












































































Pair 6: B31 and CC100 
 
The sixth pair to be compared was pathological sample B31, and healthy control CC100.  
Sample B31 is from a male individual, aged 36. Sample CC100 is from a healthy 38-year-old 
male. Below are the results of the comparative t-tests. There were three variables that 
showed statistically significant differences between the samples, including osteon maximum 
length (OMaxL), osteon total area (OTArea), and osteon area (OArea).  
Table 5.15: Pair 6 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -1.9913 -1.0095 -2.1383 -1.7633 1.6246 -2.9989 1.0547 0.3537 0.7819 1.8199 






























































Pair 7: B7 and CC7  
 
The next pair to be compared was pathological sample B7, and healthy control CC7. Sample 
B7 is from a female individual, aged 37. Sample CC7 is from a healthy 38-year-old female. 
Below are the results of the comparative t-tests. Two of the variables returned statistically 
significant differences, including osteon circularity (OCirc) and canal circularity (CCirc). 
Table 5.16: Pair 7 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 1.7456 -0.6172 1.2804 -
0.30282 
0.56952 -0.3536 -3.3903 0.59782 -0.6097 -3.6355 
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Pair 8: FC14 and CC100 
 
The eighth pair to be compared was pathological sample FC14, and healthy control CC100. 
Sample FC14 is from a male individual, aged 39. Sample CC100 is from a healthy 38-year-old-
male. Below are the results of the comparative t-tests. Four of the variables returned 
statistically significant difference, including osteon perimeter (OPeri), osteon total area 
(OTArea), osteon area (OArea), and canal maximum length (CMaxL). 
Table 5.17: Pair 8 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 1.8162 1.0105 2.0447 2.3155 1.5696 2.3026 0.243
7 
2.5184 1.7507 1.4946 






































































Pair 9: A2 and FC6 
 
The next pair to be compared was pathological sample A2, and healthy control FC6. Sample 
A2 is from a female individual, aged 39. Sample FC6 is from a healthy 40-year-old female. 
Below are the results of the comparative t-tests. There were three variables that showed 
statistically significant differences between the samples, including canal area (CArea), canal 
maximum length (CMaxL), and canal minimum length (CMinL). 
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Table 5.18: Pair 9 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 0.3822 0.1808 0.2855 0.4317 6.1083 -0.3008 -
1.8515 
4.5347 7.8382 0.3463 



























































37613.29 1899.202 35714.09 0.8964 71.634 37.5859 0.7884 
 
 
Age Group 3: 41-50 
 
 
Pair 10: B16 and CC184 
 
The tenth pair to be compared is pathological sample B16 and healthy control CC184. B16 is 
from a male individual, aged 44. Sample CC184 is from a healthy 45-year-old male. Below are 
the results of the comparative t-tests. Only one of the variables returned a statistically 
significant result, for osteon maximum length (OMaxL). 
Table 5.19: Pair 10 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 1.9815 1.6775 1.6189 1.8294 1.3989 1.7239 1.6907 -0.1618 1.8647 1.701 

































































Pair 11: A1 and CC184 
 
The next pair to be compared was pathological sample A1, and healthy control CC184. Sample 
A1 is from a male individual, aged 45. Sample CC184 is from a healthy 45-year-old male. Below 
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are the results of the comparative t-tests. There were four variables that returned statistically 
significant differences between the samples. These included osteon maximum length 
(OMaxL), osteon minimum length (OMinL), osteon perimeter (OPeri), and osteon circularity 
(OCirc). 
Table 5.20: Pair 11 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -2.9695 -2.449 -2.8675 -1.797 0.0902 -1.9556 2.9178 -1.7373 -0.3188 0.7126 
































































Pair 12: B40 and CC184 
 
The twelfth pair to be compared was pathological sample B40, and healthy control CC184. 
Sample B40 is from a male individual, aged 45. Sample CC184 is from a healthy 45-year-old 
male. Below are the results of the comparative t-tests. Six of the variables returned 
statistically significant results. These include osteon minimum length (OMinL), osteon 
perimeter (OPeri), osteon area (OArea), canal minimum length (CMinL), and canal circularity 
(CCirc).  
Table 5.21: Pair 12 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -0.3393 -2.0747 -2.6815 -1.9155 1.4084 -2.7971 4.9311 -0.8857 2.0269 4.6773 





























































Pair 13: A10 and CC194 
 
The next pair to be compared was pathological sample A10, and healthy control CC194. 
Sample A10 is from a female individual, aged 49. Sample CC194 is from a healthy 46-year-old 
female. Below are the results of the comparative t-tests. All ten variables return statistically 
significant differences. 
Table 5.22: Pair 13 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -5.2336 -7.5475 -6.0805 -6.0899 -4.5625 -5.8646 -4.4539 -4.3523 -6.9617 -
3.1404 
p-value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.000
1 


























































Pair 14: A15 and CY191 
 
The next pair to be compared was pathological sample A15, and healthy control CY191. 
Sample A15 is from a male individual, aged 49. Sample CY191 is from a healthy 48-year-old 
male. Below are the results of the comparative t-test. Eight of the ten variables returned 
statistically significant differences. These included osteon maximum length (OMaxL), osteon 
minimum length (OMinL), osteon perimeter (OPeri), osteon total area (OTArea), canal area 
(CArea), canal maximum length (CMaxL), and canal minimum length (CMinL). 
Table 5.23: Pair 14 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -7.0264 -8.5783 -7.8562 -7.3257 -2.2442 -7.7105 0.4175 -3.5852 -2.9378 0.5182 

























































850.9878 54316.45 4415.390 49901.06 0.9092 105.64 55.9134 0.8289 
 
 
Pair 15: B28 and CY191 
 
The fifteenth pair to be compared was pathological sample B28, and healthy control CY191. 
B28 is from a male individual, aged 50. Sample CY191 is form a healthy 48-year-old male. 
Below are the results of the comparative t-test. Five of the variables returned statistically 
significant differences. These include osteon maximum length (OMaxL), osteon minimum 
length (OMinL), osteon perimeter (OPeri), osteon total area (OTArea), and osteon area 
(OArea). 
Table 5.24: Pair 15 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -4.5805 -4.6543 -4.9018 -4.7632 0.1923 -5.3449 0.914
7 
-1.4302 0.1154 0.9358 
p-value <0.0001 <0.0001 <0.0001 <0.0001 0.8478 <0.0001 0.361
8 































































Age Group 4: 51-60 
 
 
Pair 16: FC13 and CC87 
 
The next pair to be compared was pathological sample FC13, and healthy control CC87. 
Sample FC13 is from a male individual, aged 52. Sample CC82 is from a healthy 53-year-old 
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male. Below are the results from the comparative t-test. Nine of the ten variables returned 
statistically significant differences. The only variable without a statistically significant 
difference between the samples was osteon circularity (OCirc). 
Table 5.25: Pair 16 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 3.3421 3.072 3.0146 2.7764 2.0833 2.4564 -
0.3074 
2.9756 2.6267 2.4914 
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2333.532 22906.48 0.9131 69.5779 39.8871 0.8274 
 
 
Pair 17: B29 and CC87 
 
The next pair to be compared was pathological sample B29 and healthy control CC87. Sample 
B29 is from a male individual, aged 53. Sample CC87 is from a healthy 53-year-old male. Below 
are the results of the comparative t-test. Only one of the variables returned a statistically 
significant result. This variable was canal circularity (CCirc). 
Table 5.26: Pair 17 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -0.7841 -0.8334 -0.8102 -0.98 -1.5335 -0.07698 1.0691 -1.2117 -2.0915 -4.249 
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Pair 18: B41 and CC87 
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The next pair to be compared was pathological sample B41, and healthy control CC87. Sample 
B41 is from a male individual, aged 53. Sample CC87 is from a healthy 53-year-old male. Below 
are the results of the comparative t-test. Three of the results returned statistically significant 
differences. These include osteon area (OArea), osteon circularity (OCirc), and canal 
circularity (CCirc). 
Table 5.27: Pair 18 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 1.9603 0.8359 1.8087 1.1898 -1.3338 2.9625 2.1291 -0.8018 -1.827 -
3.4945 
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Pair 19: CC22 and CC202 
 
The next pair to be compared was pathological sample CC22, and healthy control CC202. 
Sample CC22 is from a male individual, aged 55. Sample CC202 is from a healthy 56-year-old 
male. Below are the results of the comparative t-test. Seven of the ten variables returned 
statistically significant differences. These include osteon maximum length (OMaxL), osteon 
minimum length (OMinL), canal area (CArea), osteon area (OArea), canal maximum length 
(CMaxL), and canal minimum length (CMinL). 
Table 5.28: Pair 19 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 2.0129 1.9993 -0.9944 1.4942 -2.7104 3.8832 1.0798 -2.7207 -3.0237 2.2836 
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Pair 20: B33 and CY121 
 
The twentieth pair to be compared was pathological sample B33, and healthy control CY121. 
Sample B33 is from a female individual, aged 56. Sample CY121 is from a 60-year-old female. 
Below are the results from the comparative t-tests. None of the variables tested returned 
statistically significant differences. 
Table 5.29: Pair 20 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -0.8946 -0.7394 0.274 0.5224 -0.0178 0.5654 -1.2125 1.7253 0.394 -1.0477 
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 Pair 21: FC18 and CY190 
 
The next pair to be compared was pathological sample FC18, and healthy control CY190. 
Sample FC18 is from a male individual, aged 57. Sample CY190 is from a healthy 57-year-old 
male. Below are the results from the comparative t-tests. Six of the ten variables returned 
statistically significant differences, including osteon maximum length (OMaxL), osteon 
minimum length (OMinL), osteon perimeter (OPeri), osteon total area (OTArea), osteon area 
(OArea), and canal circularity (CCirc).  
Table 5.30: Pair 21 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 2.3045 3.4296 2.372 2.7488 0.94505 2.9642 1.2894 1.0456 1.5155 2.3071 
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Pair 22: A13 and CY190 
 
The next pair to be compared was pathological sample A13, and healthy control CY190. 
Sample A13 is from a male individual, aged 57. Sample CY190 is from a healthy 57-year-old 
male. Below are the results of the comparative t-test. Eight of the ten variables returned 
statistically significant differences. These include osteon maximum length (OMaxL), osteon 
minimum length (OMinL), osteon perimeter (OPeri), osteon total area (OTArea), canal area 
(CArea), osteon area (OArea), canal minimum length (CMinL), and canal circularity (CCirc). 
 
Table 5.31: Pair 22 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -5.2773 -5.0951 -4.8561 -5.0655 -2.3576 -4.9379 -1.5979 -1.8362 -3.2431 -1.9985 
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Pair 23: B27 and CC89 
 
The next pair to be compared was pathological sample B27 and healthy control sample CC89. 
Sample B27 is from a male individual, aged 58. Sample B27 is from a healthy 58-year-old male. 
Below are the results of the comparative t-test.  Seven of the ten variables returned 
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statistically significant differences. These include osteon maximum length (OMaxL), osteon 
minimum length (OMinL), osteon perimeter (OPeri), osteon total area (OTArea), osteon area 
(OArea), canal maximum length (CMaxL), and canal minimum length (CMinL).  
Table 5.32: Pair 23 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -4.4392 -4.8237 -4.5334 -3.1229 -1.814 -3.4535 -
0.5878 
-3.2467 -2.5389 0.7871 
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Pair 24: FC15 and CC89 
 
The next pair to be compared was pathological sample FC15 and healthy control sample CC89. 
Sample FC15 is from a male individual, aged 59. Sample CC89 is from a healthy 58-year-old 
male. Below are the results from the comparative t-test. Seven of the variables returned 
statistically significant differences. These include osteon maximum length (OMaxL), osteon 
minimum length (OMinL), osteon perimeter (OPeri), osteon total area (OTArea), osteon area 
(OArea), canal maximum length (CMaxL), and canal minimum length (CMinL). 
Table 5.33: Pair 24 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 2.5062 2.9847 2.7241 2.4636 1.76 2.5527 0.0809 3.0352 2.4225 -
0.0564 
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Pair 25: FC16 and CC173 
 
The next pair to be compared was pathological sample FC16, and healthy control sample 
CC173. Sample FC16 is from a male individual, aged 59. Sample CC173 is from a healthy 60-
year-old male. Below are the results from the comparative t-test. Only one of the variables 
returned statistically significant differences, this variable was osteon minimum length 
(OMinL). 
Table 5.34: Pair 25 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 0.79329 2.013 1.1355 0.8034 0.3141 0.9775 0.4737 0.2605 0.8129 1.5393 
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Pair 26: B24 and CC173 
 
The next pair to be compared was pathological sample B24, and healthy control CC173. 
Sample B24 is from a male individual, aged 59. Sample CC173 is from a healthy 60-year-old 
male. Below are the results from the comparative t-test. Seven of the ten variables returned 
statistically significant differences. These include osteon maximum length (OMaxL), osteon 
minimum length (OMinL), osteon perimeter (OPeri), osteon total area (OTArea), osteon area 
(OArea), canal maximum length (CMaxL), and canal minimum length (CMinL). 
Table 5.35: Pair 26 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
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Pair 27: CC17 and CC173 
 
The next pair to be compared was pathological sample CC17, and healthy control CC173. 
Sample CC17 is from a male individual, aged 60. Sample CC173 is from a healthy 60-year-old 
male. Below are the results of the comparative t-test. None of the variables returned 
statistically significant differences between the samples. 
 
Table 5.36: Pair 27 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -0.3324 0.9938 -0.7733 0.9516 -1.0942 0.9673 -
0.905
9 
-0.3237 -1.5898 0.0207 
p-value 0.7403 0.3251 0.4413 0.3459 0.2772 0.338 0.367
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Pair 28: CC6 and CY121  
 
The next pair to be compared was pathological sample CC6, and healthy control CY121. 
Sample CC6 is from a female individual, aged 58. Sample CY121 is from a healthy 60-year-old 
female. Below are the results of the comparative t-test. Two of the variables returned 
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statistically significant differences. These were osteon circularity (OCirc), and canal circularity 
(CCirc). 
Table 5.37: Pair 28 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -0.7878 0.7704 1.4858 0.8271 0.3306 0.8636 -2.4825 1.8094 0.2919 -2.7535 
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Age Group 5: Over 60 
 
 
Pair 29: CC193 and CC173 
 
The twenty-eighth pair to be compared was pathological sample CC193, and healthy control 
CC173. Sample CC193 is from a male individual, aged 62. Sample CC173 is from a healthy 60-
year-old male. Below are the results from the comparative t-test.  Two of the ten variables 
returned statistically significant differences, including canal maximum length (CMaxL), and 
canal minimum length (CMinL).  
Table 5.38: Pair 29 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 1.5547 1.2544 1.4516 1.3981 1.7944 0.7842 0.3782 2.8101 2.854 -
0.2331 























































4             
192.660
5             
743.870
1             
42141.50             6864.108             35277.39             0.8989            113.565
2             
65.267
3           





Pair 30: FC9 and CC173 
 
The next pair to be compared was pathological sample FC9 and healthy control sample CC173. 
Sample FC9 is from a male individual, aged 62. Sample CC173 is from a healthy 60-year-old 
male. Below are the results from the comparative t-test. Eight of the ten variables returned 
statistically significant differences. These include osteon maximum length (OMaxL), osteon 
minimum length (OMinL), osteon perimeter (OPeri), osteon total area (OTArea), canal area 
(CArea), osteon area (OArea), canal maximum length (OMaxL), and canal minimum length 
(CMinL). 
Table 5.39: Pair 30 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 4.2187 6.3949 5.0971 4.6029 2.4432 5.0715 0.9285 3.2733 4.8398 1.0453 
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Pair 31: CC15 and CY202 
 
The thirtieth pair to compared was pathological sample CC15, and healthy control CY202. 
Sample CC15 is from a male individual, aged 63. Sample CY202 is from a healthy 68-year-old 
male. Below are the results of the comparative t-test.  Four of the variables returned 
statistically significant differences, including osteon perimeter (OPeri), osteon total area 
(OTArea), osteon area (OArea), and canal minimum length (CMinL). 
Table 5.40: Pair 31 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 1.6238 -0.2369 2.421 2.0158 -1.133 2.3783 1.3022 -1.9209 -2.4207 -
0.2266 
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Pair 32: CC45 and CC86 
 
The next pair to be compared was pathological sample CC45, and healthy control sample 
CC86. Sample CC45 is from a female individual, aged 64. Sample CC86 is from a healthy 65-
year-old female. Below are the results from the comparative t-test. Six of the ten variables 
returned statistically significant differences. These include osteon minimum length (OMinL), 
osteon perimeter (OPeri), osteon total area (OTArea), canal area (CArea), osteon area 
(OArea), and canal minimum length (CMinL). 
 
Table 5.41: Pair 32 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 1.7291 2.6214 2.1505 2.6088 2.182 2.5785 1.4407 1.756 2.3156 -
0.2744 
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Pair 33: FC2 and CY202 
 
The next pair to be compared was pathological sample FC2, and healthy control sample 
CY202. Sample FC2 is from a male individual, aged 68. Sample CY202 is from a healthy 68-
year-old male. Below are the results from the independent t-test. Only two of the variables 
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returned statistically significant differences. These are osteon area (OArea), and canal 
circularity (CCirc). 
Table 5.42: Pair 33 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -1.7559 -0.0676 -1.7682 -1.828 1.5412 -2.2611 -
1.6759 
1.1105 0.7941 2.072 
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Pair 34: CC27 and CY39 
 
The next pair to be compared was pathological sample CC27, and healthy control CY39. 
Sample CC27 is from a male individual, aged 75. Sample CY39 is from a healthy 75-year-old 
male. Below are the results from the comparative t-test. None of the variables returned a 
statistically significant difference. 
Table 5.43: Pair 34 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -0.4969 -1.1645 -0.5264 -0.5384 -1.3243 -0.3178 -1.7958 -1.4738 -1.4231 -1.5171 
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Pair 35: CC196 and CY39 
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The next pair to be compared was pathological sample CC196, and healthy control sample 
CY39. Sample CC196 is from a male individual, aged 76. Sample CY39 is from a healthy 75-
year-old male. Below are the results from the comparative t-test. All ten variables returned 
statistically significant differences between the samples. 
Table 5.44: Pair 35 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -5.1968 -5.8727 -4.5092 -4.7211 -5.3999 -4.095 -5.8153 -7.4022 -6.9713 -
4.0135 
p-value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.000
1 
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Pair 36: CC169 and CY39 
 
The thirty-fifth pair to be compared was pathological sample CC169 and healthy control CY39. 
Sample CC169 is from a male individual, aged 78. Sample CY39 is from a healthy 75-year-old 
male. Below are the results from the comparative t-test. Eight of the ten variables returned 
statistically significant differences. These include osteon maximum length (OMaxL), osteon 
minimum length (OMinL), osteon perimeter (OPeri), osteon total area (OTArea), osteon area 
(OArea), canal maximum length (CMaxL), and canal minimum length (CMinL). 
Table 5.45: Pair 36 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -4.3902 -6.2825 -3.5233 -4.3876 -3.2566 -4.1827 0.8176
7 
-4.1749 -4.612 -1.852 
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Pair 37: CC23 and CC187 
 
The next pair to be compared was pathological sample CC23, and healthy control CC187. 
Sample CC23 is from a male individual, aged 80. Sample CC187 is from a healthy 81-year-old 
male. Below are the results from the comparative t-test. Only two of the variables returned 
statistically significant differences, including canal area (CArea), and canal maximum length 
(CMaxL).  
Table 5.46: Pair 37 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 1.2604 1.8963 -0.45 0.4543 -2.4059 1.3455 1.3394 -2.0419 -1.5053 1.1583 
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Pair 38: CC203 and CC12 
 
The next pair to be compared was pathological sample CC203, and healthy control sample 
CC12. Sample CC203 is from a male individual, aged 85. Sample CC12 is from a healthy 80-
year-old male. Below are the results from the comparative t-test. Only one of the variables 
returned a statistically significant difference. This was the osteon circularity (OCirc). 
Table 5.47: Pair 38 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
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t value 0.4811 -1.6139 0.0372 -0.9119 -0.7491 -0.8536 -2.4431 0.1723 -1.8953 -
0.9616 
p-value 0.6318 0.1104 0.9704 0.3645 0.4559 0.3958 0.0174
1 
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Pair 39: CC189 and CC195 
 
The next pair to be compared was pathological sample CC189, and healthy control sample 
CC195. Sample CC189 is from a male individual, aged 94. Sample CC195 is from a healthy 98-
year-old female. Below are the results from the comparative t-test. Only two of the ten 
variables returned statistically significant differences. These include osteon circularity (OCirc), 
and canal minimum length (CMinL). 
Table 5.48: Pair 39 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value -0.7645 -1.7343 0.1669 0.5695 -1.0786 0.9155 -10.58 -1.8948 -3.4828 0.9857 
p-value 0.4462 0.0859 0.8678 0.5702 0.2834 0.362 <0.000
1 
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Pair 40: CC45 and CY194  
 
The final pair to be compared was pathological sample CC45, and healthy control CY194. 
Sample CC45 is from a female individual, aged 64. Sample CY194 is from a healthy 65-year-
old female. Below are the results from the comparative t-test. All but two of the variables 
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returned statistically significant differences. These included osteon maximum length 
(OMaxL), osteon minimum length (OMinL), osteon perimeter (OPeri), osteon total area 
(OTArea), canal area (CArea), osteon area (OArea), osteon circularity (OCirc), and canal 
minimum length (CMinL). 
Table 5.49: Pair 40 independent t-test results 
Results OMaxL OMinL OPeri OTArea CArea OArea OCirc CMaxL CMinL CCirc 
t value 2.1897 2.6971 2.4545 2.8354 2.3613 2.8114 2.3974 1.9052 2.2588 -
0.1401 
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5.2.2.4 Metric Mean Values vs Age 
 
Once the osteon metrics were tested for significance between pathological and healthy 
controls using complete sets of data, the metrics were further evaluated using mean values. 
Mean values were calculated by averaging all the measurements of each metric. This was 
done for each sample. From there, the metric means were evaluated for correlations, as well 
as through regression analysis. Both types of analyses were done separately for the 
pathological samples, and the healthy controls, to show the changes in correlation and 
significance between groups. For both the correlation and regression analysis the primary 




As for the standard histological analysis, correlations were done using Spearman’s r 
correlations. These were then converted to give p-values for significance. Full tables of both 
Spearman’s r correlations and converted p-value correlations are available in the Appendix. 
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Again, while correlation does not equal causation, it provides a starting point from which to 
further analyse the data, such as with Regression Analysis. 
 
 
Figure 5.29: Heat map showing p-value correlations between Age and osteon metric means for healthy control samples 
As in the section on correlations for the standard histological analysis, a heat map with 
integrated pie charts was used to illustrate the correlations between age and the various 
osteon metric means. While there are some very interesting correlations between the various 
osteon metrics, of primary interest for the purposes of this study are the correlations with 
age. The strongest correlations with age were (in order) osteon area, osteon total area, 
osteon minimum length, osteon perimeter, and osteon maximum length. All of these 
correlations happened to be negative, as indicated by the red colour on the heat map. Using 
Spearman’s r, osteon area had a correlation of -0.64 (p-value <0.0001) with age, osteon total 
area had a correlation of -0.56 (p-value 0.0003), osteon minimum length had a correlation of 
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-0.48 (p-value of 0.0028), osteon perimeter had a correlation of -0.47 (p-value of 0.003), and 
osteon maximum length also had a correlation of -0.47 (p-value of 0.0036). All other 
correlations with age were not statistically significant. 
 
 
Figure 5.30: Heat map showing p-value correlations between Age and osteon metric means for pathological samples 
As in the previous image, a heat map was used to illustrate the correlations between age and 
the various osteon metric means of the pathological samples. Once again, there are some 
interesting correlations between osteon metrics means, but for the purposes of this study, 
correlations with age were the main focus. Unlike the healthy control samples, the 
pathological samples appear to have much weaker correlations with age. Only three of the 
ten osteon metrics had a statistically significant correlation with age. These were (in order) 
osteon maximum length, osteon area, and osteon minimum length. Again, all of these 
correlations were negative, as shown by the colour of the heat map. Using Spearman’s r 
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osteon maximum length had a correlation of -0.36 (p-value 0.0263) with age, osteon area had 
a correlation of -0.33 (p-value 0.0375), and osteon minimum length had a correlation of -0.32 
(p-value 0.0493). All other correlations with age were not statistically significant. 
 
5.2.2.4.2 Regression Analysis 
 
Building on the correlations between age and the five statistically significant osteon metrics 
from the correlations. Regression analysis was done on both the pathological and healthy 
samples and plotted to show the distributions and lines of regression for each. Full regression 
outputs can be found in the Appendix. 
 
Figure 5.31: Scatterplot showing the distribution and lines of regression of osteon area metric means compared with Age 
The above image is a scatterplot showing the distribution of both healthy and pathological 
samples with regard to the Age and osteon area metric means. The downward slant of the 
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regression lines shows the negative correlation between age and osteon area. This also shows 
the red regression line (healthy) as a better fit to the line of regression than the blue 
regression line (blue). Included in the results from this calculation were, coefficients, residual 
standard error, multiple R-squared, adjusted R-square, and p-value.  
 
First, regression for the healthy control samples was calculated. The Estimate coefficient was 
calculated as intercept 104.4 and slope -1.446e-03. The Standard Error coefficient was 
calculated as from the intercept 10.63 and from the slope 3.473e-04. Following the 
coefficients, Residual Standard Error was calculated as 15.65. Multiple R-squared was 
calculated as 0.3314, and Adjusted R-squared was calculated as 0.3123. Finally, p-value was 
calculated as 0.0002. 
 
Next, regression for the pathological samples was calculated. First, coefficients were 
calculated. The Estimate coefficient was calculated as intercept 78.3635 and slope -0.0009. 
The Standard Error coefficient was calculated as 11.1873 from the intercept, and 0.0003916 
from the slope. Following the coefficients, Residual Standard Error was calculated as 15.65. 
Multiple R-squared was calculated as 0.1163, and Adjusted R-squared was calculated as 




Figure 5.32: Scatterplot showing the distribution and lines of regression of osteon total area metric means compared with 
Age 
The above image is a scatterplot showing the distribution of both healthy and pathological 
samples with regard to the age and osteon total area metric means. This shows the red 
regression line (healthy) as a better fit to the line of regression than the blue regression line 
(pathological). As with the regressions for age and osteon area metric means, regression for 
healthy control samples were calculated first, and then calculated for the pathological 
samples. 
 
Regression for the healthy control samples was calculated. First, the coefficients were 
calculated. The Estimate coefficient was calculated as intercept 1.011e+02 and slope -1.156e-
03. The Standard Error coefficient was calculated as from the intercept 1.119e+01 and from 
the slope 3.172e-04. Following the coefficients, Residual Standard Error was calculated as 
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16.29. Multiple R-squared was calculated as 0.2752, and Adjusted R-squared was calculated 
as 0.2545. Finally, p-value was calculated as 0.0009. 
 
Next, regression for the pathological samples was calculated. First, four coefficients were 
calculated. The Estimate coefficient was calculated as intercept 77.2264 and slope -0.0007. 
The Standard Error coefficient was calculated as 11.6661 from the intercept, and 0.0004 from 
the slope. Following the coefficients, Residual Standard Error was calculated as 15.81. 
Multiple R-squared was calculated as 0.0987, and Adjusted R-squared was calculated as 
0.0743. Finally, the p-value was calculated as 0.0515. 
 
 
Figure 5.33: Scatterplot showing the distribution and lines of regression of osteon minimum length metric means 
compared with Age 
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The above image is a scatterplot showing the distribution of both healthy and pathological 
samples with regard to the age and osteon minimum length metric means. This shows the 
red regression line (healthy) as a better fit to the line of regression than the blue regression 
line (pathological). As with the previous regressions, regression for healthy control samples 
were calculated first, and then calculated for the pathological samples. 
 
Regression for the healthy control samples was calculated. First, coefficients were calculated. 
The Estimate coefficient was calculated as intercept 137.3212 and slope -0.446. The Standard 
Error coefficient was calculated as from the intercept 23.9512 and from the slope 0.1400. 
Following the coefficients, Residual Standard Error was calculated as 16.85. Multiple R-
squared was calculated as 0.2251, and Adjusted R-squared was calculated as 0.203. Finally, 
p-value was calculated as 0.003. 
 
Next, regression for the pathological samples was calculated. First, the coefficients were 
calculated. The Estimate coefficient was calculated as intercept 103.0467 and slope -0.3010. 
The Standard Error coefficient was calculated as 21.1816 from the intercept, and 0.1299 from 
the slope. Following the coefficients, Residual Standard Error was calculated as 15.56. 
Multiple R-squared was calculated as 0.1267, and Adjusted R-squared was calculated as 
0.1031. Finally, the p-value was calculated as 0.0261. 
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Figure 5.34: Scatterplot showing the distribution and lines of regression of osteon perimeter metric means compared with 
Age 
 
 The above image is a scatterplot showing the distribution of both healthy and pathological 
samples with regard to the age and osteon perimeter metric means. As with the previous 
scatterplots, the red regression line (healthy) as a better fit to the line of regression than the 
blue regression line (pathological). Again, regression for healthy control samples were 
calculated first, and then calculated for the pathological samples. 
 
Regression for the healthy control samples was calculated. First, the coefficients were 
calculated. The Estimate coefficient was calculated as intercept 132.7315 and slope -0.1074. 
The Standard Error coefficient was calculated as from the intercept 22.7861 and from the 
slope 0.0341. Following the coefficients, Residual Standard Error was calculated as 16.89. 
 193 
Multiple R-squared was calculated as 0.221, and Adjusted R-squared was calculated as 
0.1988. Finally, p-value was calculated as 0.0033. 
 
Next, regression for the pathological samples was calculated. First, the coefficients were 
calculated. The Estimate coefficient was calculated as intercept 105.0857 and slope --0.0794. 
The Standard Error coefficient was calculated as 22.7821 from the intercept, and 0.0354 from 
the slope. Following the coefficients, Residual Standard Error was calculated as 15.62. 
Multiple R-squared was calculated as 0.1196, and Adjusted R-squared was calculated as 
0.0959. Finally, the p-value was calculated as 0.031. 
 
 
Figure 5.35: Scatterplot showing the distribution and lines of regression of osteon maximum length metric means 
compared with Age 
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The above image is a scatterplot showing the distribution of both healthy and pathological 
samples with regard to the age and osteon maximum length metric means. This shows the 
red regression line (healthy) as a better fit to the line of regression than the blue regression 
line (pathological). As with the previous regressions, regression for healthy control samples 
were calculated first, and then calculated for the pathological samples. 
 
Regression for the healthy control samples was calculated. First, the coefficients were 
calculated. The Estimate coefficient was calculated as intercept 123.4884 and slope -0.2509. 
The Standard Error coefficient was calculated as from the intercept 22.4824 and from the 
slope 0.0897. Following the coefficients, Residual Standard Error was calculated as 17.24. 
Multiple R-squared was calculated as 0.1786, and Adjusted R-squared was calculated as 
0.1558. Finally, p-value was calculated as 0.0082. 
 
Next, regression for the pathological samples was calculated. First, the coefficients were 
calculated. The Estimate coefficient was calculated as intercept 110.7793 and slope -0.2379. 
The Standard Error coefficient was calculated as 20.3362 from the intercept, and 0.0851 from 
the slope. Following the coefficients, Residual Standard Error was calculated as 15.13. 
Multiple R-squared was calculated as 0.1745, and Adjusted R-squared was calculated as 





The current research project, regardless of the amount of planning put into it at the 
beginning, was faced with certain limitations. These limitations have been divided into three 
sections: Research limitations, methodological limitations, and personal limitations.  
 
6.1. Research Limitations 
 
Bone histomorphometry is a destructive technique that requires specialised equipment and 
knowledge to be applied.  In addition, it is time-consuming and observer and experience 
dependent. The development of research methodologies based on destructive techniques is 
often criticized due to ethical guidelines set out by different professional bodies and academic 
institutions. The current research was conducted in a country that has strict regulations for 
the use of human tissue in research that made the collection of samples practically impossible 
from local sources in the timeframe of the PhD project.  More specifically, due to the 
regulations laid out in the Human Tissue (Scotland) Act of 2006 it was easier to obtain samples 
from countries outside of the UK. For this reason, samples were collected from forensic 
departments and modern skeletal collections in Crete, Albania, and Cyprus. These countries 
were chosen in part for their connections to the project’s supervisor, Dr Elena Kranioti.  While 
these samples were more easily obtained and provided the quantity and type of samples 
required for this research, certain limitations accompanied these relationships. These 
included short, translated records of pathology and cause of death. As further information 
was not available, or was difficult to obtain, the records was assumed to be accurate. 
Research would have been improved by a more open relationship with the forensic 
departments, and more in-depth medical and autopsy records. 
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Originally, in the project proposal, it was intended that all pathological samples would be 
taken from individuals with liver disease associated with chronic alcohol abuse. This would 
have allowed for a more specific study of a particular system, in this case the hepatic system, 
and its relationship and effect on the skeletal system. This, however, turned out to be 
impractical due to a number of factors such as lack of detailed medical history, different 
degrees of decomposition and problems with importing samples in the course of the study. 
Consequently, the criteria for inclusion of samples in the study was expanded to include 
individuals with a history of any chronic pathology, to increase the number of samples to a 
statistically relevant number for the proposed project. Even with these expanded criteria, the 
collection of these samples took the greater part of three years.  As the samples were 
imported from three different countries, which created several problems and delays with 
regard to the selection of the samples, the collection of ante-mortem information, and 
transportation depending on each country’s legislation.  
 
As discussed in the literature review, the way that bone remodels as a tissue, is in itself a 
constraint, especially as it pertains to the observation of changes caused by disease. As 
osseous tissue has a very slow turnover rate, only a chronic disease would have the necessary 
time and ability to have a pathological effect on the tissue’s microstructure. Especially in the 
case of a disease that does not target bone directly, as in the case of an infection, the disease 
would need time to permeate and disrupt the metabolism of the entire body in order to have 
any measurable effect on the bone. Even then, the effect on the bone is fundamentally 
restricted to a single reaction with one of two effects: creating imbalance in the remodelling 
process, and either causing greater osteoclast (destructive) or osteoblast (prolific) activity. 
This in turn could result in lesions, both lytic and prolific, osteopenia and/or osteoporosis. 
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Due to the restriction in the ways bone tissue can react, it is very difficult, if not impossible to 
reverse engineer a diagnosis of a specific disease from observation of the bone 
microstructure. Once this limitation has been understood, it is possible to proceed, and try to 
understand what can be observed about pathology from the microstructure of bone. It is also 
impossible to differentiate between certain changes that occur as part of the natural aging or 
postmenopausal processes, although these changes occur at much higher rates in individuals 
with chronic disease. 
 
One of the most difficult limitations of the project was that of current software and 
technology, specifically in the case of taking the osteon specific metrics. There is currently no 
software available for the automation of quantification of osteons, osteon fragments, or 
measuring of Haversian systems. If such a software did exist, it would be possible to assess 
many more samples much more quickly with increased accuracy. At this point in time, 
however, it is not yet possible to automate these measurements, forcing researchers to 
quantify and measure features by hand. This adds a certain amount of human error to the 
process and is why inter and intra-observer error calculations and researcher experience are 
so important in these studies. In the future, it might be possible to mitigate these limitations 
by using software capable of measuring Haversian Systems. One such software is QuPath, a 
quantitative pathology and BioImage analysis software currently being developed by the 
University of Edinburgh Division of Pathology (University of Edinburgh, Division of Pathology, 
2017). If such future software is capable of delivering accurate measurements of Haversian 
Systems, this research would be improved both in practicality and accuracy. 
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Finally, the protocols themselves provide a certain amount of limitation. Certain aspects of 
this thesis project required the creation of new criteria, categories of features, and metric 
measurements. As with all excursions into the frontier, it is not possible to compare these 
variables with existing data. In the future more comparative data should be generated in 
order to verify or reject the observations of the current work. 
 




There were also some limitations that occurred in the lab during the course of this project. 
The first of these is the protocol for thin sectioning and creating the slides. The protocol 
evolved over the course of the project, and in some cases were forced to change due to 
change in facilities or the needs of fellow researchers in the laboratory. At the start of the 
project, the protocol set out by Paine (2007) was followed, which included the boiling and 
macerating of the bone, in the case of any remaining soft-tissue existing on the bone. This 
process occurred in the Edinburgh City morgue. The samples were then taken back to the 
histology lab at the University, and following Paine’s instructions, embedded in epoxy resin, 
thin sectioned, and adhered to glass slides for reading. This protocol was amended, however, 
after experiments done in the lab by Julieta Garcia-Donas discovered that after embedding 
the slides, cleaner and clearer slides were produced by cutting the embedded sample in half, 
polishing the area, adhering it to the slide with resin, and then cutting the thin-section using 
a slide-holder chuck for the IsoMetTM saw. The full details of this revised method can be read 
in Garcia-Donas and colleagues (2017).  
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Protocol was further amended after the addition of another project to the lab involving bio-
mechanical analysis of bone. Due to the scarcity and difficulty in obtaining samples, these 
autopsy samples were often shared amongst multiple projects. With the addition of the 
biomechanics project, the maceration process had to be changed, as boiling would change 
the integrity of the bone and render it unusable for biomechanical experiments. For this 
reason, going forward bones were defleshed by hand with a scalpel instead of boiled and 
macerated. This caused several changes to the thin sectioning process. Bone samples now 
had to be kept in refrigerated or freezing temperatures until embedding in resin to limit 
spread of bacteria. The remaining tissues, as well as the remaining bacteria in the trabeculae 
caused the thin sections to be less clear in some circumstances. In future, bone samples that 
are unable to be boiled could be defleshed by hand and then soaked in acetone to help 
remove additional flesh and kill any bacteria that might obscure the slide.  
 
Although a more consistent protocol would have been better for the control of the project, 
the length of time over which the samples were prepared, and the change in adjacent projects 
and facilities meant that the protocol had no choice but to be amended to fit the 
circumstances. Ultimately, the slides were legible, and the analysis of the slides was able to 
be carried out, regardless of the method used to prepare them. 
 
6.2.1 Slide analysis 
 
For the standard histological analysis, photographs were not necessary for the quantification 
of the microstructural elements. The features of complete and fragmented osteons were 
possible to quantify with a transmitted light microscope fitted with a polarised filter. 
 200 
Calculating cortical area, however, required either a stitched image created by seaming 
multiple photographs of the slide together to create a complete cross-section in software 
attached to the microscope, or for the cross-section to be photographed using a handheld 
microscope camera, like a Dino-Lite digital microscope. Preferably, if everything had gone 
according to plan, full stitched cross-sections would have been taken of each slide, but as this 
was not always possible, a compromise was devised, and a solution was implemented. In the 
case of several samples, the Leica software attached to the photographing microscope was 
unable to stitch a cross-section together. This may have been related to a glitch in the 
software, or possibly the clarity of the slide. These slides were then photographed using the 
Dino-Lite to calculate cortical area, and four individual field of view photographs were taken 
for use in the osteon specific metrics. Any slides that were unable to meet the criteria for data 
of the standard histological analysis were excluded from the study.  
 
The majority of the slides used as healthy controls were obtained from another study being 
conducted in tandem with this project. In the case of these slides, another researcher, with 
very similar results in quantification of histological features, provided the quantifications for 
standard histology, as they had already been quantified for other research. The same was 
true for the other study, with this researcher contributing data for some slides used in that 
study. While this saved time, these numbers would ideally have all been re-quantified by the 
researcher conducting this study. In the case of two slides used as healthy controls for the 
standard histological analysis, photographs were unavailable and were therefore excluded 
from the osteon specific metrics analysis. 
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In the case of the osteon specific metrics, the original protocol, as designed, called for 
measurements of every complete osteon in the cross-section. After several months of 
attempts, it was determined that measuring the entire cross-section was extremely time-
consuming and impractical for the purposes of useful research. Several of the slides were 
reassessed using one field of view from each cardinal point of the rib. These were then 
compared to the data gathered from the measurements of the complete cross-section and 
subjected to a comparative t-test. It was found that there was no statistically significant 
difference between the two sets of data, and therefore it was determined that sampling of 
the cross-section would be the protocol going forward. Although a complete cross-section 
and additional data would always be worth having for analysis, the impracticalities of 
obtaining said data forced the change to the study protocol. 
 
6.3 Problems in infrastructure 
 
 
The current project is a lab-based project requiring specific equipment and facilities to 
accommodate work on modern bone tissue as appropriate for the development of any 
forensic methodology. Although the PhD proposal was approved by the University of 
Edinburgh, and a functioning histology lab already existed within the confines of the School 
of History, Classics and Archaeology (HCA), due to governmental and University regulations it 
was not possible to work with modern samples obtained from autopsy in this lab. This was 
revealed to both the researcher and the supervisor of this project after the beginning of the 
PhD project and naturally led to negotiations on how to resolve the issue. To solve the 
problem HCA has negotiated a lab space for those students undertaking research in forensic 
anthropology using modern samples in the Anatomy building next to the HCA building. In 
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addition to this move, new equipment for creating histological bone samples was ordered for 
the new histology laboratory. By the time the use of this new lab had been finalised, and the 
necessary equipment obtained and set up, it was six months into the beginning of this project, 
adding to the delay in sample preparation. 
 
Work continued in this lab for about two years, with samples being processed and thin 
sectioned as they arrived. In September of 2016, for unknown reasons to the researcher it 
was decided by the anatomy department that it was no longer acceptable for the bone 
histology lab to remain there. In addition, for reasons unknown to the histology lab users, 
including the researcher of this project and the supervisor, HCA started an investigation 
regarding the appropriate permissions for conducting modern histology work in the lab. This 
lead to a six-month stall in the project as the laboratory was closed overnight, and without 
notice, and the samples that had been collected were confiscated and locked away pending 
an inquiry by the National Health Service (NHS). Ultimately, it was discovered that all the 
necessary paperwork had been filed, the projects being undertaken by the student at the 
bone histology lab were all in accordance with established regulations, and that a mistake 
had been made on the part of the University. By the time this was discovered, however, six 
months had passed, causing a long interruption in studies as well as large amount of anxiety 
and upset on the part of the students working in the histology laboratory. A new lab facility 
was finally found in March of 2017, when the department was offered bench space in the 
pathology lab at Western General Hospital, in Edinburgh. The final preparations and analysis 
were then undertaken at the hospital. 
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In addition to these limitations caused by accessibility to samples and facilities, there were 
personal limitations on the part of the researcher, most notably stress and anxiety caused by 
turbulent circumstances during their thesis project. The disturbance in lab facilities, as well 
as the enquiry by the NHS caused a large amount of stress and anxiety for the student 
undertaking this project. In addition to these normal stress responses, additional stress and 
loss of time were caused when the student, who was studying internationally, had to apply 
for a visa extension to finish their studies from their home country, due to the disruption in 
lab facilities. This process ultimately took longer than anticipated, resulting in the student 
being forced to stay in their home country for a month and a half while the visa extension 
was sorted out between the Home Office, and the University. Finally, in March of 2018, a 
nationwide strike by University staff limited the amount of interaction between the student 








Forensic anthropology is a discipline often faced with the challenges of analysing fragmented 
remains with the aim of creating a biological profile that will lead to forensic identification of 
the deceased. Although complete skeletons can be assessed for biological characteristics 
using a variety of techniques, these have a limited value in the case of extreme fragmentation. 
In that event, microscopic methods such as bone histomorphometry are the most plausible 
option for continued analysis. 
 
Bone histomorphometry in particular, has been used for estimating age based on the 
predicted remodelling patterns of bone tissue for many decades. Early research includes the 
pioneering work of Kerley (1965) on the femur, and later Stout and Paine’s (1992) work on 
the rib and clavicle. These methods have been expanded and improved over the years by the 
addition of validation studies such as Ahlqvist and Damsten (1969), population studies (Cho 
& al., 2002; Bednarek, et al., 2009; Lee, et al., 2014; Garcia-Donas, 2017), sexual dimorphism 
(Cho, et al., 2006), age (Goliath, et al., 2016), dietary deficiencies (Paine & Brenton, 2006), 
and paleopathology (Schultz, 2001). Different bones present different variation in the 
histomorphometric variables, but the correlation with age is present in all cases at least until 
the asymptote is reached.  
 
Several researchers have investigated the relationship between histomorphometric variables 
and sex claiming that sexual dimorphism exists (Ericksen, 1991; Cho, et al., 2006) while others 
reported the opposite (Kerley, 1965; Pfeiffer, 1998). The degree of correlation with age is 
affected by several factors such as genetics, diet and activity, although these factors are most 
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apparent in the weight-baring bones. The ribs are considered an excellent material for 
histomorphometry as they are not affected by mechanical loading, making it the most popular 
bone for integration in histomorphometric studies. It is for this reason that the rib was chosen 
as the subject for the current study. 
 
The purpose of this study was to investigate the effect of systemic metabolic disease on bone 
metabolism as reflected in the bone microstructure. To best assess the changes to the bone 
microstructure, a number of qualitative and quantitative variables were selected and tested 
on a group of subjects suffering from metabolic disease. These were then compared to a 
group of healthy controls. The results are discussed in relation to the impact of pathology in 
bone microstructure as an age indicator and as a general health indicator. 
 
The study employed two sets of variables, qualitative and quantitative, that will be analysed 
separately. 
 
7.1 Qualitative Interpretations and Explanations 
 
 
7.1.1 Category 1 Features 
The most common qualitative features encountered in this study are those features belonging 
to category 1. This category includes the subtler, abnormally shaped osteons and canals. This 
means that the Haversian system is complete and intact, but the shape and size of the osteon 
and/or its canal is outside the realm of normal. Features in this category include changes in 
the circularity of both the osteon and canal, as well as disproportionate sizing of the osteon 
and canal. These features are often accompanied by the thinning of cortical bone. This can be 
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observed, for example, in those patients with osteoporosis (Parfitt, 1984). Their bones are 
unusually porous, and this has been seen and identified by the enlarged canals visible in the 
cross-section. Category 1 pathological features are caused by an imbalance in the bone 
metabolism in favour of the osteoclasts. This causes the destruction of bone cells to outweigh 
the construction of new bone, resulting in increased porosity, and sometimes cortical bone 
thinning.  
 
A combination of abnormally sized and shaped osteons, and slight to moderate cortical 
thinning was described in all but one of the pathological cases in this study (97.5%) and in 
four of the healthy controls (10.8%). These features represent evident signs of the disruption 
of the normal remodelling process. This level of metabolic disturbance does not prevent the 
bone from forming complete Haversian systems, but it contributes to the overall increase in 
bone porosity. These features seem to increase with age especially for individuals over 30 
years old. In the younger age groups, it is not possible to confirm the trend as the number of 
cases is too small to make any statistically relevant conclusions. The healthy controls that 
present category 1 features are all over 41, suggesting that age is a factor in their appearance. 
Age-related bone loss has been associated with an increase in the number and the size of 
Haversian canals (Thompson, 1980; Brockstedt, et al., 1993; Brockstedt, et al., 1995; Bell, et 
al., 1997). Category 1 features in pathological samples seem to manifest earlier than the 
expected age-related changes.  This suggests that the underlying pathology accelerates 
remodelling disturbance and bone loss. As category 1 features appeared in the higher age 
groups of both the pathological and healthy control groups, these features could also be 
attributed to pathology, the aging process or a combination of the two, as suggested by the 
trends of the older age brackets of pathological group. At this time, from the samples 
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analysed for this study, it is not possible to differentiate between category 1 features caused 




Cortical thinning and bone loss have been described in cases of menopausal females as a 
result of oestrogen deficiency (Kaptoge, et al., 2003). It does however also occur in males at 
a slower rate (Frost, 2003). The clear majority of the pathological sample was male, and 
therefore no meaningful comparison can be made between the sex groups. It is worth noting 
that from the five females that presented category 1 features in the study four were in 
menopause and all presented cortical thinning as would have been anticipated (Kaptoge, et 
al., 2003). Yet, almost all samples with recorded pathologies, the vast majority of which were 
men, were associated with features of category 1 and showed cortical thinning. The same is 
observed for four healthy controls. Therefore, the underlying mechanism of normal 
remodelling disruption cannot be attributed solely to hormonal changes. As with the older 
age groups, however, it is not currently possible to differentiate between the category 1 
features caused by postmenopausal hormonal changes, and those caused by pathology. 
Again, further research is needed. 
 
Low bone mass in patients has been found to be a risk factor for cardiac episode or death 
compared to subjects with normal bone mass (Sprini, et al., 2014; Bagger, et al., 2007; Magnus 
& Broussard, 2005; Farhat, et al., 2006). Marcovitz and colleagues (2005) were able to use 
low BMD as a predictor of CAD, connecting osteoporosis with heart disease predominantly in 
postmenopausal women. This is in line with the results of this study, which show that 90% 
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patients in the cardiovascular group have type 1 features correlated with abnormal osteons 
and bone thinning. The results further suggest that menopause is not the only factor linking 
bone metabolism and CAD as the majority of individuals in the current study were male. This 
is, however, expected as CAD is more frequent in males than females (Fabian Sanchis-Gomar 
et al., 2016). In addition, most subjects with CAD were diagnosed with diabetes, alcoholism 
or were heavy smokers, which suggest a multifactorial effect on bone metabolism. 
 
Decreased bone density has also been connected to chronic alcoholism (Bikle, et al., 1985; 
Feitelberg, et al., 1987), with alcoholic liver disease (ALD) being named as a possible cause of 
increased incidence of osteoporosis and osteopenia in patients who abuse alcohol (Long, et 
al., 1978; Spencer, et al., 1986; Labib, et al., 1989). It is likely that conditions often associated 
with ALD, such as vitamin D deficiency and hypogonadism, are connected to the systemic 
metabolic disturbances that eventually reach the skeletal system, causing the stimulation of 
osteoclasts, and resulting in osteoporosis (George, et al., 2009). The current study showed 
that 81.25% of patients with hepatic disease presented signs of category 1 features associated 
with abnormal osteons and cortical thinning. The majority of the subjects were males (6 of 7) 
while all subjects but one had a history of alcoholism. The medical data did not include further 
information on the time of alcohol abuse, or the daily consumption of alcohol and the 
histological examination of the liver thin sections showed slight to moderate fatty 
accumulation, which indicates a similar level of alcohol abuse in all cases associated with type 
1 features. Age for these subjects ranged from 50 to 59 and showed no positive correlation 
with the degree of fatty accumulation. The most severe case of hepatic disease, which 
resulted in liver cirrhosis showed category 3 features. 
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Cancer (Greenspan & Remagen, 1998; Drake, 2013), diabetes (Bouillon, 1991), pulmonary 
disease (Jørgensen, et al., 2007; Cavaillès, et al., 2013), and renal disease (Malluche & 
Faugere, 1990; Ott, 2009; Williams, 2009) all have documented connections to osteoporosis 
and osteopenia. Yet, the sample sizes for each of these disease classes was too small to make 
any significant inferences. While meaningful conclusions cannot be drawn from these 
categories, it is worth noting that all the samples in each of these classes had category 1 
features, consistent with previous studies connecting these diseases and the abnormal 
osteons and cortical thinning associated with osteoporosis (Drake, 2013; Choi & Chung, 2016; 
Cavaillès, et al., 2013; Ott, 2009). 
 
Each of the diseases encountered during this study can manifest systemically, causing 
consequences in multiple systems (Magnus & Broussard, 2005; Pérez-Castrillón, et al., 2004; 
Spencer, et al., 1986; Kuller, et al., 2000; Jørgensen, et al., 2007; Webster, et al., 2017). It is 
therefore unsurprising that several of the individuals sampled had multiple conditions 
affecting different systems. Likewise, it is consistent with the findings of this study that all the 
samples from the multiple class group had category 1 features present. Due to the varied 
nature of this group, it is not possible to insinuate which disease contributed to the skeletal 
manifestation of pathology, and in fact the pathological features of the bone may have been 
caused by the presence of more than one systemic pathology. Another important factor to 
take under consideration is the fact that although subjects were diagnosed with these 
conditions it is not known whether there were receiving treatment at the time of death and 
for how long. This is very difficult to track due to the nature of the collected sample. One 
could speculate differences in the manifestation of metabolic disease in the skeletal system 
between untreated subjects and subjects under medication.  
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7.1.2 Category 2 Features 
 
This category of features contains the deranged Haversian systems, or Swiss Cheese Effect. 
While similar in some ways to the category 1 features, in that they display an increase in bone 
porosity, the features seen in the deranged, or incomplete, Haversian systems of category 2 
are much more evident and clearly distinguished from normal bone formation. While 
category 2 features can appear on their own, they can also appear in conjunction with 
category 1 and 3 features. Like the category 1 features, category 2 features can also appear 
either on their own, or with thinning of the cortical bone. Category 2 features can appear as 
single focci in the compact bone or can affect the entire cross-section. 
 
These features can be thought of as a possible extension of the features seen in category 1, 
and can also be associated with osteoporosis, as they are contributing to the unusual and 
extreme porosity, or even trabecularisation, of the cortical bone, both features of advanced 
osteoporosis (Parfitt, 1984). Therefore category 2 features are more advanced signs of 
imbalance in the bone metabolism favouring the destructive osteoclasts. Again, this causes 
the destruction to outpace the reconstruction of bone, but in a more dramatic fashion, 
resulting in the extreme porosity, incomplete Haversian systems, and deranged canals 
associated with category 2. 
 
Category 2 features were present in 32.5% (12/40) of the pathological cases, and in none of 
the healthy controls. In all cases category 1 features coexisted with category 2 features, which 
may further suggest that they are different stages of the same metabolic disruption. The 
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presence of category 2 features seems to increase with age, with four cases appearing under 
the age of 40, and nine appearing later. This figure however, may be skewed by the age 
distribution of the samples, as the sample size for younger individuals was very small. In 
addition, since these features do not appear in any of the healthy controls one can exclude 
the possibility of representing age-related changes. The higher frequency with which they 
appear with increasing age can simply be an association with the severity of the disease with 
progressing age and not the age itself. 
 
Although bone loss has been described in both post-menopausal females (Kaptoge, et al., 
2003) and in older individuals of both sexes (Frost, 2003; Goliath, et al., 2016), as discussed 
for category 1 features, the presence of category 2 features seemed to fall outside the range 
of normal for bone porosity. All but two of the samples with category 2 features present were 
males, and the two females with category 2 features were both under the age of 40. 
Therefore, these changes cannot be associated with hormonal changes based on the existing 
data. 
 
The higher risk of bone loss in cardiovascular disease (Sprini, et al., 2014; Bagger, et al., 2007; 
Magnus & Broussard, 2005; Farhat, et al., 2006) is consistent with the fact that 40% of the 
cardiovascular cases, namely the ones associated with generalised atherosclerosis and 
myocardial infarction presented with category 2 features. With many cardiovascular 
conditions beginning in childhood and manifest in adulthood (Theise, 2015), there is ample 
time for some cases to develop into more pronounced cases of osteoporosis.  
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Likewise, in the case of hepatic disease, chronic disease of the liver is associated with bone 
loss (Bikle, et al., 1985; Spencer, et al., 1986; Feitelberg, et al., 1987; George, et al., 2009). The 
effect of chronic liver disease, as is that case with ALD, on bone depends heavily on the 
severity and progression of the disease, inferring that some cases of bone loss associated with 
liver disease (hepatic osteodystrophy) would be more pronounced than others (George, et 
al., 2009). In the current study 18.75% one (3 of 7) of the samples from the hepatic class 
presented with category 2 features, correlated with dramatic porosity of the cortical bone.  
 
Samples from the cancer class (1 of 2), diabetes class (1 of 1), and pulmonary class (2 of 2) 
had category 2 features present, consistent with previous studies (Greenspan & Remagen, 
1998; Drake, 2013; Bouillon, 1991; Jørgensen, et al., 2007; Cavaillès, et al., 2013) connecting 
these diseases and the cortical porosity. The renal class, which consisted of only one sample, 
did not show any signs of category 2 features, however the connection between chronic 
kidney disease and renal osteodystrophy (Ott, 2009) suggests that it is possible that more 
dramatic forms of osteoporosis may exist in other CKD patients.  
 
As the diseases used in this study manifest systemically (Magnus & Broussard, 2005; Pérez-
Castrillón, et al., 2004; Spencer, et al., 1986; Kuller, et al., 2000; Jørgensen, et al., 2007; 
Webster, et al., 2017), it is expected that several of the individuals with multiple conditions 
affecting different systems would also have more pronounced bone loss. It is therefore 
consistent with the findings of this study that 25% the samples from the multiple class group 
had category 2 features present. Again, as this group is varied, with different combinations of 
diseases, it is not possible to indicate which disease caused the pathological bone response, 
or whether the response was caused by multiple conditions. 
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Diabetes in particular is reported in the medical history of four subjects, three of whom had 
multiple diagnoses involving other disease classes, without further information on whether it 
was type 1 or 2, under treatment or not. Type 2 diabetes has two characteristics a) high serum 
insulin levels and b) tissue insulin resistance (Choi & Chung, 2016) These features have been 
associated with low bone mass and “deteriorated bone strength” (Choi, et al., 2014; Choi, et 
al., 2014). It has been widely accepted that type 2 diabetes is associated with higher bone 
porosity and fracture risk in subjects over 50(Choi & Chung, 2016). Similarly, type 1 diabetes 
presents higher risk of fractures due to porosity even when scaled for factors such as age, sex, 
duration and complications of the disease and when compared to type 2 (Shah, et al., 2015). 
The difference would probably be in the earlier appearance of signs of metabolic disturbance 
in type 1, which is inherited, compared to type 2. From the four subjects suffering from 
diabetes, three had multiple pathological conditions, and one only reported diabetes (age 94 
years old). It is very likely that this individual also had asymptomatic or undiagnosed CAD, of 
which diabetes is the primary cause, that could have been the cause of death. This 
information unfortunately is not included in the Census office archives. Interestingly, this is 
the only individual that presented category 2 features of the diabetic subjects, but also the 
oldest individual in the group. Of the remaining three individuals, the youngest and only 
female was 49 years old and suffered from several conditions (Hypertension, Diabetes, Heart 
ischemia, left ventricular hypertrophy, hepatic steatosis, pyelonefritis, bronchopneumonia) 
according to her medical records. 
 
7.1.3 Category 3 Features 
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The last, and least common category of features encountered in this study was category 3 
features. Unlike the previous two categories, this category of features is characterised by 
prolific bone formation, as opposed to a loss of bone. The striated bone deposited near the 
periosteum is very different from the previous two categories and should immediately be 
evident to the observer. Category 3 features can also appear alongside category 1 and 2 
features, as well as thinning cortical bone. This is possibly due to the misdirection of bone 
building osteoblasts and destroying osteoclasts, as opposed to a complete and overall 
imbalance (Ortner, 2003). Similar to category 2 features, category 3 features are more likely 
to appear in part of the cross-section, and most likely near the periosteum, than over the 
entire cross-section. 
 
The rapid deposition of striations of bone was described in only one case in this study. As 
such, it is not possible to make any inferences from the results of this category, however it 
may be useful to treat this one sample as a case study. The case occurred in a 62-year-old 
male with liver cirrhosis, the most progressed hepatic disease in the whole group, leaving 
open the possibility of associations between age and disease with the presence of category 3 
features. 
 
This kind of rapid bone deposition has been described in several other studies referencing 
extraspinal hyperostosis related to DISH (Lill, 2013), and several cases of lesions as a response 
to chronic infection (Schultz, 2012; Schultz, 2001). While this type of pathological feature is 
clearly the work of constructive osteoblasts, the aetiology of these kinds of prolific lesions in 
hepatic disease patients is unknown. Further study, with a larger sample size, is necessary to 
understand whether the presence of this category of feature is related to hepatic disease, or 
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possibly to another unidentified underlying condition, and whether they have any connection 
to aging process. 
 
In summary, category 1 and 2 features are indicators of different degrees of cortical porosity 
due to disruption of bone metabolism with increased osteoclast activity with category 2 
features being the more severe indicators. It seems that the majority of conditions can cause 
category 1 features as early signs of disease, appearing earlier when compared with the 
similar age-related changes in healthy subjects. Category 2 features appear in cases of longer 
duration of more severe manifestation of the disease, and they are not compatible with age-
related changes as they do not appear in any of the healthy subjects. The relatively small 
number of females in the study does not allow for testing the influence of menopause on the 
degree of porosity that has been previously reported in the literature (Kaptoge, et al., 2003; 
McCarthy, 2010; Riggs, et al., 1998; Brickley & Ives, 2008). Yet it seems that more than one 
underlying mechanism exists for the metabolic disruption associated with both category 1 
and 2 features. Category 3 features appeared only in one case of liver cirrhosis but as form of 
rapid bone deposition that suggests a different mechanism compared to the other two 
categories. 
 
7.2 Quantitative Interpretations and Explanations 
 
 
As in the previous results chapter, quantitative analysis and discussion has been separated 
into two sections, one for standard bone histology and one for osteon specific metrics. Again, 
the first section involves the standard histological metrics and quantifications as developed 
by Stout and Paine (1992). These include the quantification of osteons, both complete 
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secondary and fragmented osteons, measurements, such as cortical area, and calculated 
values, in this case OPD. These are the metrics used in most age estimation methods focusing 
on rib cross-sections, as developed by Stout and Paine (1992), and Cho and colleagues (2002). 
While these particular age estimation methods were not used in this study, as they proved 
ineffective for the study population (Garcia-Donas, 2017), they could be used to develop a 
population-specific age estimation formula. Even without a formula for age estimation, 
significant connections remain between cortical area and OPD, and age. This is then 
important when comparing the correlations and regressions of cortical area and OPD versus 
age between the healthy control group and the pathological group. 
 
The second section discusses the results of the osteon specific metrics and deals with the new 
metric measurements and statistics developed for this study. The purpose of these 
measurements was to quantify changes in the bone microstructure. In the previous section 
of this chapter qualitative changes were noted from visual analysis, in this section the 
measurements provide quantifiable data to apply to the observations made in the qualitative 
analysis. In this chapter, the results given in the previous chapter will be discussed, as well as 
any implications or possible future used for these metrics, and the consequences of including 
or excluding pathological individuals from the sample. 
 
7.2.1 Standard Bone Histology 
 
 
The standard bone histology section of the results chapter dealt with, as previous described, 
the standard quantifications and measurements as set out by (Stout & Paine, 1992). Once this 
data had been collected, it was subjected to several forms of statistical analysis. These 
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analyses included inter-observer error, correlations, regressions, standard errors, and 
bootstrapping. The correlations and regressions were all applied first to the complete set of 
data, to simulate previous collections used in the creation of age estimation techniques. 
Afterwards, the data was split into two groups, healthy controls and pathological samples, 
and applied to the statistical models again, to see if there was any significant difference 
between the two groups, or indeed between the two groups and the complete sample. The 
results of these statistical analyses will now be discussed in the following sections. 
 
7.2.1.1 Inter-observer Error 
 
Inter-observer error was calculated for the standard histology variables, number of intact 
osteons, number of fragmented osteons, and total number of osteons. For this study, each 
variable was analysed using a paired t-test to compare the values of both observers. In 
addition, the other observer, Julieta G. Garcia-Donas, analysed these variables using TEM, 
relative TEM (rTEM), and associate R values for a related study done in conjunction with this 
one (Garcia-Donas, 2017). 
 
The first variable to be tested was the number of intact osteons. From the values returned by 
the paired t-test, it is possible to conclude that within a 95% confidence interval that there 
was no statistically significant difference between the two observers. These results are 
consistent with the results of the TEM and rTEM conducted on the same population by Garcia-
Donas (2017) and represent a high degree of repeatability between observers and with other 
histological studies (Keough, et al., 2009). Contrary to this, for fragmented osteons 
statistically significant differences were found between the two observers. This is consistent 
with the results from Garcia-Donas (2017), as well as other histological studies (Lynnerup, et 
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al., 1998; Crowder, 2005) and it suggests that the classification of fragmented osteons is more 
subjective. Fragmented osteons are defined as osteons where at least 10% of their Haversian 
canal has been remodelled by the next generation of osteons. This includes the remnants of 
osteons in which the entirety of their canal has been obscured (Stout & Crowder, 2012). As 
this classification relies upon the observers’ judgement as to what constitutes at least 10% of 
the canal, it follows that the number of fragmented osteons quantified by each observer 
would be inconsistent. 
 
The last variable to be tested was the total number of osteons in the cross-section. From the 
values returned by the paired t-test it is possible to conclude that within a 95% confidence 
interval that there was a statistically significant difference between the two observers. The 
difference, however, is relatively small, and likely due to the difference in the previous 
variable. When tested by Garcia-Donas using TEM and rTEM, it was concluded that less than 
3% of the variance was due to measurement error, and that the rTEM was below the 5% 
acceptance threshold (Garcia-Donas, 2017). While this variable meets the standards for 
acceptable levels of inter-observer error seen in other studies (Keough, et al., 2009; Crowder, 
2005), it would be advised to be cautious of overly inconsistent fragmented osteon 
quantifications, as this can in turn effect the repeatability of other important variables, such 
as OPD, where the number of total osteons is a factor in calculating the OPD variable 
(Crowder, 2005). 
 
From the results of these paired t-tests, and the TEM testing by Garcia-Donas (2017), the 
observations of the two observers were relatively consistent, and demonstrate a degree of 
repeatability within acceptable levels. It is advised, however, for further studies to take inter-
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observer error into account when quantifying the number of fragmented and total osteons, 




The first set of correlations was calculated using the complete data set, including information 
from both the healthy control and pathological groups. This mirrored the samples used by 
Stout and Paine to create their 1992 formula. While correlations between all variables were 
calculated, those correlations of primary interest were those most strongly correlated with 
age. As expected, the strongest correlations with age were cortical area and OPD, with cortical 
area presenting a strong negative correlation with age, and OPD presenting a strong positive 
correlation with age. While these results are consistent with the findings of Stout and Paine 
(1992), as well as subsequent studies using cortical area and OPD as variables for age 
estimation (Cho & al., 2002; Bednarek, et al., 2009; Lee, et al., 2014), it was the aim of this 
research to assess if better results could be obtained by separating out the pathological cases. 
 
The next correlations were calculated using only the pathological samples. In the case of the 
pathological samples, none of the expected correlations existed to the extent that was 
expected. While cortical area was still significantly correlated with age, this correlation was 
much weaker than the correlation between these two variables in the complete set of data. 
When comparing OPD and age the correlation was even weaker, as there was no significant 
correlation between these variables in the pathological sample. The only consistency 
between the complete data and the pathological group was the direction of the correlations, 
with cortical area and age remaining a negative correlation, and OPD and age remaining a 
positive correlation.  
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These results are inconsistent with most previous research using cortical area and OPD for 
age estimation (Stout & Paine, 1992; Stout & Paine, 1994; Cho & al., 2002; Cho, et al., 2006; 
Bednarek, et al., 2009; Lee, et al., 2014). Instead, the results of these correlations are 
consistent with research done using individuals with bone affected by malnutrition (Paine & 
Brenton, 2006). The significance, or lack thereof, of these correlations in the pathological 
group would indicate that pathological bone, like the pellagra cases, could negatively impact 
the significance of the correlations between cortical area and OPD, and age in the complete 
set of data.  
 
The final correlations were calculated using only the healthy control samples. For the healthy 
samples, age was once again strongly correlated with cortical area and OPD. While these 
findings are consistent with the correlations found and used for age estimation in previous 
studies (Stout & Paine, 1992; Cho & al., 2002), the improvement upon removing the 
pathological samples from the data set is notable. The correlation values for the healthy data 
set demonstrate that the correlations between age, and cortical area and OPD are stronger 
and more significant when the pathological samples are removed.  
 
Although it is important to note that correlation does not equal causation, the correlations 
found between the variables of cortical area and OPD, and age provide evidence that supports 
the hypothesis of this study, which suggests pathologically affected bone has the potential to 
negatively affect the results of histological age estimation. Even though the complete data 
set returned reasonably sound results, confirming the results of past studies (Stout & Paine, 
1992; Cho & al., 2002), the marked improvement of correlations for the healthy data set, and 
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the decreased correlation for the pathological data set support the expectations of this study. 
From the results of these correlations, regression models can then be created to test the 
significance of the relationships between the variables and age, which then provide a basis 
for histological age estimation formulae. 
 
7.2.1.4 Regression Analysis 
 
Following the results of correlations, these regression models were also divided into the same 
three groups and focused on the relationships between age and cortical area, and age and 
OPD. Regression analysis is particularly important in terms of bone histology, as it is 
regression models that form the basis of all histological age estimation formulae, following 
the original model set out by Kerley (1965) for his equation using the femur. These regression 
equations were then continued into further methods using other bones, like the Stout and 
Paine method (1992), which popularised the use of ribs for age estimation, and any improved 
methods created since (Cho & al., 2002; Bednarek, et al., 2009; Goliath, et al., 2016). Since 
previous studies have reported R2, both multiple and adjusted, as the most significant 
indicators of model fit, these were the statistics focused on for this study (Han, et al., 2009; 
Goliath, et al., 2016; Maat, et al., 2006). Likewise, R2 has been presented as a percentage, for 
better comparison. 
 
The first regression model was the model for the complete sample group comparing cortical 
area and age. As with the correlations, this group was analysed to simulate the sample data 
used to develop previous age estimation formulae, such as Stout and Paine (1992) and Cho 
(2002). For the complete data set, a multiple R2 of 24.77% and an adjusted R2 of 23.81% were 
reported. These represent the amount of age variance that could be attributed to cortical 
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area. While cortical area has been demonstrated as having a strong relationship with age, 
consistent with the Stout and Paine (1992) formula, cortical area alone would not be a good 
predictor of age. It could, however, as in other age estimation formulae (Stout & Paine, 1992; 
Cho & al., 2002; Lee, et al., 2014), be combined with another variable, in a multiple linear 
regression, for greater predictive abilities. 
 
After the regression analysis for the complete group, the same variables were analysed using 
only the pathological data. While there does appear to be a relationship between age and 
cortical area for the pathological group, the relationship was much weaker than the 
corresponding values from the complete data set, and the fit of the model was not as good 
as the previous model. As for the first regression, R2 was used as an indicator of fit. For the 
pathological data set, a multiple R2 of 11.07% and an adjusted R2 of 8.73% were reported. 
These results are an indicator of the poor fit of the model between cortical area and age, a 
reflection of the weak correlation between the variables seen in the previous section. Even if 
cortical area was included in a multiple linear regression formula such as the Stout and Paine 
(1992) formula, the performance of the equation would most likely be too poor for forensic 
standards (Christensen & Crowder, 2009; Scientific Working Group for Forensic Anthropology 
(SWGANTH), 2013). The next step was to compare the results of the healthy control group, 
and to see if the regression model improved once the pathological samples were removed. 
 
Finally, the healthy data set was analysed using linear regression, comparing cortical area and 
age. The results given for this regression model show an improved outcome from the first 
regression model, which included the pathological data. The healthy data set reported a 
multiple R2 of 33.33% and an adjusted R2 of 31.57%, a nearly 6% improvement from the model 
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using the complete data set. This data proves that equations which utilise cortical area as a 
variable, such as Stout and Paine (1992) or Cho and colleagues (2002) would yield more 
accurate results if pathological data were to be excluded. 
 
Once regression models had been completed for the variables cortical area and age, 
regression models were created to analyse the relationship between OPD and age. As with 
the previous models, the complete data set was analysed first. The resulting regression model 
shows a significant relationship between the variables; however, it is slightly weaker than the 
cortical area regression results. With a multiple R2 of 22.35% and an adjusted R2 of 21.35%, 
indicating the percentage of variance in age attributed to OPD, the model fits, but would be 
a poor predictor of age alone. As OPD is usually the most significant variable used in 
histological age estimation techniques (Stout & Paine, 1992; Cho & al., 2002; Garcia-Donas, 
2017), it is unusual to have a lower R2 for OPD than for cortical area. This is possibly caused 
by the inclusion of the pathological data in the model. 
 
Next, a regression model was created to analyse the relationship between OPD and age using 
only the pathological data. The regression model for this data set show no significant 
relationship between OPD and age, a reflection of the correlation results discussed above. 
With a multiple R2 of 1.26% and an adjusted R2 of 1.34%, only a very small percentage of the 
variance in age could be attributed to OPD. This is inconsistent with the findings of most 
histological age estimation studies, as typically, OPD is one of the strongest variables for age 
prediction (Stout & Paine, 1992; Cho & al., 2002; Garcia-Donas, 2017; Goliath, et al., 2016). 
Not only is OPD a poor predictor of age for the pathological group, but it is likely that the 
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underperformance of OPD as a predictor for the complete group is due to the inclusion of the 
pathological samples in the data set. 
 
Finally, to test if age prediction improves when the pathological data was excluded, a 
regression model was created using only the healthy data set. The regression model for this 
data set showed a significant relationship between OPD and age. A multiple R2 of 47.1% and 
an adjusted R2 of 45.71% were reported, increasing the strength of OPD as a predictor of age 
by over 24% when compared with the complete data set. These results are consistent with 
the Garcia-Donas study on the same population (2017), as well as other histological age 
estimation studies giving OPD as a significant predictor of age (Stout & Paine, 1992; Cho & al., 
2002; Goliath, et al., 2016). This proves that pathology has a clear effect on the strength of 
OPD as an age predictor, and that pathological data should be excluded to ensure accurate 
histological age estimation. 
 
Overall, the results of the regression models comparing cortical area and age, and OPD and 
age, were consistent with the expectations of this study. As bone microstructure is affected 
by pathology, it is unlikely that the metrics and variables typically used in histological age 
estimation techniques would continue to have the same relationships with age. This is 
particularly true of OPD as a variable, and any study incorporating a histological age 
estimation method in which OPD is a factor should exclude any pathological samples from 
the data to avoid inaccurate results. These findings are also consistent with the results of 
Paine and Brenton (Paine & Brenton, 2006) which note similar inaccuracies in a population 
with dietary deficiencies and malnutrition. 
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7.2.1.5 Standard Errors 
 
While R2 statistics are useful in evaluating the strength of a variable as a predictor as they are 
given as a percentage and are easily understood, often the standard error is a better indicator 
of the usefulness of a regression model. As the standard error of the estimates (SEE) measures 
the accuracy of prediction made with the regression model, with better accuracy yielding a 
SEE closer to zero, these numbers can easily be compared and analysed as part of the 
development of an age estimation formula. For this reason, many previous studies have 
included SEE as well as R2 statistics when describing new regression equations for age 
estimation (Stout & Paine, 1992; Crowder, 2005; Keough, et al., 2009; Goliath, et al., 2016). 
The results of the SEE calculations for the cortical area and OPD regression models can then 
be compared for accuracy with the results of previous studies. 
 
First, standard errors were calculated for the cortical area and age regression model.  Overall, 
the results were very similar, with the pathological data set performing slightly worse than 
the complete data set, and the healthy data set performing slight better than the other two 
data sets. All three data sets yielded standard errors between 15.36-15.52, meaning there 
was only a difference of 0.16 between the best performing and the worst performing 
regression models. These standard errors are slightly higher than the standard errors 
reported by Cho and colleagues (2002) and Garcia-Donas (2017) for cortical area, and much 
higher than the standard errors reported by Pfeiffer (2016).  
 
Standard errors were then calculated for the OPD and age regression model. These results 
were more variable than the standard errors for the cortical area regression model. Like the 
results from the cortical area regressions, the pathological data set performed the worst of 
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the three regression models, and the healthy data performed the best of all three models. 
For the OPD regression models there was a difference of 2.68 between the highest and lowest 
scoring models, a much larger difference than seen in the cortical area models. The standard 
error for the healthy data set is slightly higher than the standard error reported by Garcia-
Donas (2017), and generally higher than the standard errors reported in other studies (Cho & 
al., 2002; Pfeiffer, et al., 2016). As most studies use OPD as part of a multiple linear regression-
based model, the standard errors reported for these models are generally better than the 
errors returned from this study. If OPD were to be included in a multiple regression model, it 
is speculated that the standard error would improve with the fit of the model. 
 
Overall, the results of the SEE calculations were consistent, if slightly higher than the standard 
errors reported by other studies. As many of these studies incorporated multiple linear 
regressions, it is speculated that if cortical area and OPD were combined in an equation, like 
those developed by Stout and Paine (1992) or Cho and colleagues (2002), the error rates 
would improve. In both the case of the cortical area regression model and the OPD regression 
model, the pathological data set performed poorly, and appeared to have an impact on the 
accuracy of the complete data set regression models. The healthy data set performed best, 




The last statistical analysis used for the standard histology was bootstrapping. By using a 
sampling and replacement method, it was possible to simulate the results of the true 
population, by resampling from the relatively small sample size used for this study. For the 
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purposes of this study, bootstrapping was used to test the multiple R-squared statistic, 
resulting from the earlier regression analysis. The bootstrapping was used to confirm the 
results of the regressions from the previous section, focusing on the regressions comparing 
age and cortical area, and age and OPD. By using bootstrapping, this study could better 
compare its results with those of studies with larger samples sizes (Cho & al., 2002; Pfeiffer, 
et al., 2016).  
 
Beginning with the cortical area and age regression model, bootstrapping was applied first to 
the entire sample, and then separately to the pathological and healthy control groups. From 
the results of the bootstrapping the differences between the pathological group and the other 
two groups become apparent. The bootstrapping mimics a larger population, theoretically 
improving the results of the regression, as well as testing the accuracy of the linear regression 
models. The bias and the standard error both indicate a good fit for the model, with the 
healthy data set performing best, followed by the complete data set, and then the 
pathological data set last, performing poorer than the others and by a larger increment. The 
BCa 95% confidence interval indicates that the pathological data set has a much larger range 
included in the confidence interval than the other data sets. These statistics prove the validity 
of the above calculated linear regression models, as well as displaying the deviance of the 
pathological samples from the normal healthy samples. This also has implications for the 
creation and application of histological age estimation formulae for this population, as the 
healthy group exhibits a good fit relationship between the variables of age and cortical area. 
As demonstrated by the results of the study, the inclusion of pathological samples could, 
however, have a negative effect on these estimations. 
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Following the bootstrapping for cortical area and age, bootstrapping was applied to the 
regression model comparing OPD and age. Again, it is evident that the results from the 
pathological samples are different from those of the healthy and complete data sets. From 
the bias results, it is evident that the healthy and complete data sets have lower results 
relative to the pathological data set, indicating a better fit to the regression model. This 
reflects expectations and the results from the previous regression section. The standard 
errors for the groups are low, indicating a good fit for the regression models, however inverse 
to the results from the cortical area regression model, the pathological group has the lowest 
standard error of the three groups tested. As for the cortical area results, the BCa 95% 
confidence interval indicates that the pathological data set has a much larger range included 
in the confidence interval than the other data sets. This reflects the fit of the linear regression 
model, and the bootstrapping implies that while the healthy regression model is a good fit, 
the pathological data set is not a good fit for the regression model. This could have potential 
implications for histological age estimation methods and supports the concept of excluding 
pathological samples from the creation of such formulae, as well as indicating the relative 
effectiveness of implementing such a formula when attempting to estimate the age of an 
individual with a pathology. 
 
Overall, the results of the bootstrapping analysis corroborated the results of the regression 
analysis, confirming the accuracy of the R2 statistic. This supports the previous comparisons 
with other studies (Stout & Paine, 1992; Cho & al., 2002; Goliath, et al., 2016; Pfeiffer, et al., 
2016), as well as the implications of including pathological samples when using histological 
age estimation formulae. 
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7.2.2 Osteon Specific Metrics 
 
Once the effects of pathology on the standard building blocks of histological age estimation 
had been thoroughly examined, the study continued on to analyse osteon specific metrics. 
These metrics were designed for this study and do not reflect any previous research, although 
several of the metrics appear individually in other studies (Keough, et al., 2009; Goliath, et al., 
2016). These metrics were done to better quantify the observations made in the qualitative 
section, as the appearance of unusual or enlarged canals does not necessarily mean that they 
are metrically unusual upon measurement. In addition, these metrics could then be compared 
to age, to see if there are any correlations that might be useful in further histological research. 
Ten measurements were taken per Haversian system, with a total of 52,700 measurements 
taken in total. Inter and intra-observer error were calculated to test the reliability of the 
metrics. Welch’s t-tests were then done to compare the healthy and pathological groups, first 
as a complete data set, and then as 40 individual pairs. The metric variables were then 
analysed through means, for correlations with age, and linear regression analysis with age. 
 
7.2.2.1 Inter-observer Error 
 
Inter-observer error was done by this researcher and an undergraduate volunteer. As it was 
carried out early in the process, not all the variables had been finalised, and the sampling 
technique has not yet been adopted. For these reasons, only seven of the ten osteon specific 
metrics were tested, but they were tested across the entire cross-section, as opposed to the 
four fields of view sampling methods. 
 
Overall, the inter-observer error was not successful. While certain measurements, like the 
cortical area were statistically similar, most of the other variables were not as effective. There 
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were statistically similar measurements in all but one of the metrics, osteon maximum length, 
which had no statistically similar measurements. This is not necessarily uncommon, as other 
studies also reported high variability between observers (Keough, et al., 2009; Crowder, 
2005). 
 
There are several possible explanations for the marked difference between observers. The 
undergraduate volunteer was relatively new to bone histology, and therefore part of the 
dissimilarities could be due to experience level (Crowder, 2005), especially when considering 
the irregular Haversian system formations found in this study. Another possible explanation 
could be the method for measuring each osteon. Eventually, each osteon was measured by 
tracing the cement line of osteon and the canal. From this measurement, the maximum and 
minimum length, as well as perimeter and area could be taken. If, however, the observer had 
tried to measure maximum and minimum length by eye, the measurement would be less 
accurate, and less reliable. Method of tracing, for example using a mouse, or a stylus, could 
also influence the accuracy of the results.  It is recommended that further testing be done in 
conditions that control for measurement method and experience, on all ten variables, 





7.2.2.2 Intra-observer Error 
 
Intra-observer error was done by one observer, the author, to determine the consistency of 
the measurements. Metrics were conducted on thin sections from five samples, using the 
final ten metrics, and sampling method.  Each set of measurements were taken several 
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months apart, to avoid bias. As for the intra-observer error conducted on the standard 
histological variables, independent t-tests were used to evaluate the measurements. 
 
Overall, the results for the intra-observer error were successful. Three of the five samples had 
all statistically similar results, and one had only one statistically different metric. One sample, 
CC195, had only two statistically similar variables. Two variables, canal area and canal 
circularity had statically similar results across all five samples, and one metric, osteon 
circularity, had three statistically similar results. The rest of the metric variables had four of 
five statistically similar results. 
 
A possible explanation for the majority statistically different results for sample CC195, is the 
timing of the measurements. CC195 was one of the first slides measured, and as for the inter-
observer error, may have suffered from similar problems. The more accurate stylus method 
of taking measurements had not yet been developed, and length measurements may have 
been taken separately from the area and perimeter measurements, again, possibly affecting 
the accuracy of the results.  
 
While the intra-observer results suggest a reasonable amount of reliability and repeatability, 
similar to other studies incorporating intra-observer error for osteon specific metrics (Pfeiffer, 
et al., 2016; Goliath, et al., 2016), it is important to use a consistent technique to avoid varying 
results. It is recommended that a validation study be conducted in the future to confirm the 




7.2.2.3 Independent T-Tests (Full Sample) 
 
The first comparative tests run on the osteon specific metrics were a set of ten independent 
t-tests on the complete sets of data to determine whether the health status of the individual 
had an influence on the metrics of osteons and canals. These variables could be tied to the 
observations made in the qualitative analysis section about osteon and canal size and shape. 
A Welch’s independent t-test was used to analyse the samples due to the unequal variance 
between the pathological and healthy sets of variables. 
 
From the results of the t-tests, five of the metrics taken had statistically significant differences 
between the healthy and the pathological data sets. The samples estimated means for osteon 
maximum length indicate that overall, osteon maximum length is smaller in the pathological 
samples. Canal area was significantly larger in healthy control group. This is not consistent 
with expectations (Brickley & Ives, 2008; Parfitt, 1984; Cho, et al., 2006), and whether this is 
consistent throughout the various age groups will be evaluated in the next section. For canal 
maximum length, the healthy samples were statistically larger than the pathological samples. 
Likewise, for canal minimum length, the healthy samples were statistically larger than the 
pathological samples. The final significant variable was canal circularity, with the sample 
means indicating that the healthy samples had greater circularity than the pathological 
samples. 
 
From these results, several useful conclusions can be made. Overall, canals are larger in the 
healthy control set. It is possible that the larger canals observed in the qualitative section 
merely appear larger in comparison with the thinning cortical area often seen in the 
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pathological samples, meaning that canals occupy  a larger portion of the section compared 
to osteons. This observation implies that qualitative assessment of bone thin section contains 
the same level of subjectivity as any other non-metric visual method (Nakhaeizadeh, et al., 
2014; Todd, 1920; Işcan, et al., 1984; Phenice, 1969; Buikstra & Ubelaker, 1994), and 
quantification is necessary in order to draw useful and reliable conclusions. Another useful 
conclusion is the significant difference in circularity found in the canals (Ortner & Turner-
Walker, 2003). This confirms the observations made earlier, as the pathological samples 
appear to be far less circular and consistent in shape, than the healthy controls. This supports 
the hypothesis that chronic pathology can have a significant effect on the metabolism of 
bone, similar to post-menopausal or age-related osteoporosis (Parfitt, 1984; Brickley & Ives, 




7.2.2.4 Paired Independent T-Tests 
 
After tests had been run on the complete data set, the samples were divided into 40 pairs of 
one pathological and one healthy sample, matched by age, and sex if available, and tested 
against each other. This was done using a Welch’s two sample t-test to account for the 
variance between samples. These samples were then further divided into five age groups, to 
assess any age-related connections to the metric variables. 
 
While it is important to note that there were more samples in the older age groups on 
average, the older age groups also appeared to have more statistically significant differences 
between the healthy and the pathological samples. Overall, of 400 t-tests run for this section, 
approximately 42% (169 of 400) showed statistically significant differences between the 
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pathological sample and its healthy control samples. Of the five age groups, the group with 
the proportionally largest disparity between the healthy and pathological samples was age 
group 3 (41-50 years) with 57% (34 of 60) of metric variables returning statistically significant 
differences between pairs. Next was age group 4 (51-60 years) with 45% (58 of 130) and age 
group 5 with 43% (52 of 120). Age groups 2 and 1 had notably weaker results, with 34% (24 
of 70) and 5% (1 of 20) respectively. This reflects the earlier conclusion from the qualitative 
section implying that age is a contributing factor in the appearance of pathological changes 
to bone microstructure. The fact remains that the highest percentage of differences between 
pathological and healthy controls was from the middle age group. One interpretation of this 
data may be that the period between ages 40 and 50 there is enough time for chronic disease 
to develop and affect the bone, while healthy bone has usually yet to be affected by age 
(Ortner, 2003). This may account for the 12% difference between age group 3 (41-50 years) 
and the next highest percentage group. It may also be connected to the OPD asymptote, the 
point where OPD no longer reflects age (Stout & Paine, 1994; Stout & Crowder, 2012).  
 
Age Group 1: Under 30 
Age group 1 only included two pairs, the first were both 19-years-old, and the second were 
24 and 28-years-old. Of the ten variables tested, only the canal circularity metric from the 
second pair showed a statistically significant difference between the healthy and pathological 
samples. From the sample estimated means shown in the previous chapter, it is evident that 
on average the canals of the pathological sample were less circular than the healthy samples. 
This is consistent with previous findings in this study that show osteon shape irregularity in 
the pathological samples, as well as general expectations of bone metabolism related to 
osteoporosis (Ortner & Turner-Walker, 2003; Wu, et al., 2009). In the case of this age group, 
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the one statistically significant result came from the older of the two pairs, which included an 
individual with hypertension.  
 
  
Age Group 2: 31-40 
 
Age group 2 consisted of seven age-matched pairs. Of the ten osteon specific metrics tested, 
osteon perimeter had the most statistically significant differences between the pathological 
and healthy, with four of the seven pairs, followed by osteon maximum length, osteon total 
area, and canal circularity, which were present in three pairs of samples. Overall, there is a 
marked increase in statistically significant differences, jumping from 5% significant 
differences in the first age group, to 34% in the second. The trend in osteon metrics, rather 
than canal metrics is worth noting, as osteon dimensions appear to be more varied, while 
canal dimensions appear to remain similar regardless of health status. Canal circularity is also 
significant as it appeared in the previous age group as well and is consistent with expectations 
from previous studies (Ortner & Turner-Walker, 2003; Wu, et al., 2009). 
 
Of the pairs included in this age group, the pair that returned the most statistically significant 
results was pair 3, which included the pathological sample B12 from an individual with 
generalised hepatic steatosis. While four other pathological samples in this age group had 
disease in the hepatic class, all were less advanced cases of hepatic steatosis, reflected in the 
fewer statistically significant results for those pairs. Two pairs from this age group included 
individuals who presented with atherosclerosis and returned four and three statistically 
significant results respectively. 
 
Age Group 3: 41-50 
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The third age group consisted of six pairs. Of the ten osteon specific metrics, three had the 
most statistically significant differences appearing in five of the six pairs, including osteon 
maximum length, osteon minimum length, and osteon perimeter, followed by osteon area, 
which appeared in four of the six pairs. Of the six pairs, pair 13 had the most statistically 
significant differences, with differences present for all ten metric variables. Again, osteon 
dimensions seem to be the most varied, while canal dimensions appear to remain similar 
regardless of health status. Of all the age groups, age group 3 had the largest proportion of 
statistically significant differences between pathological and healthy samples, with 57% (34 
of 60) of comparative tests returning statistically significant p-values. This could be an 
indication of a ‘sweet spot’ between chronic pathology development, and age-related bone 
microstructural changes (Stout & Paine, 1994; Stout & Crowder, 2012).  
 
Of the pairs included in this age group, the pair that returned the most statistically significant 
results was pair 13, which included an individual with multi-system pathology, including 
hypertension, heart ischemia, left ventricular hypertrophy, diabetes, hepatic steatosis, 
pyelonephritis, and bronchopneumonia. This pair had statistically significant results for all ten 
variables, although due to the extent of the disease and the systemic involvement, it is not 
possible to know which condition provoked the skeletal response, or if the response was 
provoked by multiple conditions. The next most significant results came from pair 14, which 
included an individual with atherosclerosis, left ventricular hypertrophy, and hepatomegaly, 
with eight of ten variables returning significant results. The remaining pairs in this group came 
back with at least four significant results, with the exception of pair 10, which included an 
individual with hepatic steatosis. Although other pairs from this group included individuals 
with hepatic steatosis, it is possible those cases were more advanced, resulting in more 
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Age Group 4: 51-60 
 
The next group, age group 4, consisted of thirteen pairs. Of the ten variables, two variables, 
osteon minimum length and osteon area, had statistically significant differences present in 
the most pairs, appearing in eight of the thirteen pairs, followed by osteon maximum length, 
and canal circularity that had statistically significant differences in seven of the thirteen pairs. 
Again, osteon dimensions, with the exception of canal circularity appear to be the main point 
of difference between the healthy and pathological samples. Of the thirteen pairs, pair 16 had 
the most statistically significant differences, with p-values <0.05 for nine of the ten variables. 
Approximately 45% (58 of 130) of the paired tests returned statistically significant results, a 
12% decrease from the previous age group. As the groups are of unequal sample sizes, it is 
difficult to determine whether this difference is significant, however, it may be due to the 
increase in age, as relatively healthy bone can begin to show age-related osteoporosis (Parfitt, 
1984; Ortner, 2003; Cho, et al., 2006; Stout & Crowder, 2012).  
 
Of the pairs included in age group 4 (51-60 years), the pair that returned the most statistically 
significant results was pair 16, which included an individual with CAD and hypertension, as 
well as complications from heavy smoking, with nine statistically significant results. Pair 22, 
which included an individual with CAD and chronic hepatitis, had eight statistically significant 
results. There were four other pairs that returned seven statistically significant results, one 
with cancer, one with CAD and a myocardial infarction, and two with hepatic steatosis.  
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Overall, the results from the pairs in this age group were higher scoring, perhaps due to their 
age as well as the duration of their disease. Age group 4 did, however, include several lower 
scoring pairs, including two with hepatic steatosis, possibly indicating a less severe or shorter 
duration of disease in those individuals. 
 
Age Group 5: Over 60 
 
The last group, age group 5, consisted of twelve pairs. The metric with the highest number of 
significant differences was canal minimum length, with p-values <0.05 for eight of twelve 
pairs, followed by osteon area, which had statistically significant differences for seven of 
twelve pairs. This is inconsistent with the statistical differences seen in the previous age 
groups, which favoured osteon dimensions and canal circularity as the main points of 
difference between pathological and healthy samples. This may be due to the age of the 
healthy samples, as healthy individuals can show signs of age-related osteoporosis (Parfitt, 
1984; Brickley & Ives, 2008), minimising the differences between the pathologically affected 
samples and the healthy samples. The pair with the most significant differences was pair 35, 
with statistically significant differences <0.0001 for all ten variables. In contrast, pair 34 
showed no significant differences for any of the ten variables. There was only a slight 
difference between the prevalence of statistically significant differences of this age group and 
the previous age group, decreasing to 43% (52 of 120). While still significant, the decrease in 
prevalence for this age group may be due to the overlap with age-related osteoporosis and 
the OPD asymptote (Parfitt, 1984; Ortner, 2003; Cho, et al., 2006; Stout & Crowder, 2012), 
rather than a decrease in pathologically significant features. 
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Of the pairs included in the final group, pair 35, which included and individual with diabetes, 
CAD and brain ischemia, had the most statistically significant results, with all ten variables 
returning significant results. Three other pairs returned eight statistically significant results, 
including one with cancer, and two with multi-systemic diagnoses. Overall, this group had 
more lower scoring pairs than the previous two groups, but that may be due to age-related 
bone loss, as opposed to less significant disease. 
 
 
Overall, the metric variables which seemed to differ the most significantly between healthy 
and pathological groups were those related to osteon dimensions. While this seems 
incongruous with previous research (Jowsey, 1963; Ortner, 1975), stating that canal 
dimensions change with osteoporosis, they may only appear to change. Meaning, as the 
dimensions of the osteon change around the Haversian canal, the canal dimensions only 
appear to change in relation to the surrounding osteon. The one exception appears to be 
osteon circularity, which was found significantly different in most of the above age groups. 
This implies that the metabolic changes caused by the presence of systemic pathology can 
affect the shape of canals, supporting the observations made in the qualitative analysis 
section, as well as other studies involving the histopathology of bone (Ortner & Turner-
Walker, 2003; Cho, et al., 2006; Paine & Brenton, 2006). The exception to these results is the 
oldest age group, however due to the inherent changes present in aging bone, the possible 
presence of age-related osteoporosis, and the crossing of the OPD asymptote (Stout & Paine, 
1994; Stout & Crowder, 2012), it is not possible to gauge which of these histomorphometric 
changes are related or age or pathology. As the type and severity of disease was extremely 
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varied, it is recommended that this testing be verified using more consistent pathological 
samples. 
 
7.2.2.5 Metric Mean Values vs. Age 
 
 
After statistics had been run using the complete data sets, means for each metric in each 
sample were calculated. These metric means were then used for correlations and linear 
regression models. As there is no previous research using these ten variables to test against, 
unlike the standard histological analysis done earlier, samples were split into pathological and 
healthy controls only. As age is the most significant comparative factor, the five variables 
observed to have a strong correlation with age were then compared with age using linear 
regression models to evaluate their ability to predict age, and the influence pathology would 





To create a baseline for the new osteon specific metrics, correlations were run for the ten 
osteon metric means, and age. Of primary interest to this study, however, were the 
correlations with age. Potential age correlations may support the observations made in the 
qualitative section, as well as previous observations of histological bone that had not yet been 
quantified (Parfitt, 1984; Ortner & Turner-Walker, 2003). In addition, correlations were used 
as a starting point from which to begin linear regression analysis.  
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In the healthy group 50% (5 of 10) of the osteon specific metrics had statistically significant 
correlations with age. All other variables were not significantly correlated. This is consistent 
with Keough and colleagues (2009), who found no correlation between canal diameter and 
age. The variables significantly correlated with age were osteon area, osteon total area, 
osteon minimum length, osteon perimeter, and osteon maximum length. The correlation of 
osteon area with age is consistent with the findings of Goliath and colleagues (2016), however 
that study also found a relationship between osteon shape and age that was not reflected 
here for the osteon circularity variable. All five variables were negatively correlated with age.  
 
The negative correlation implies that as age increases, the value of the variable decreases. As 
all the significantly correlated variables were related to osteon dimensions, this suggests that 
as an individual ages, the overall size of the osteons shrink, however, as there is no statistically 
significant correlation with age for any of the canal metrics, it appears that the canal size 
generally stays the same. It would then appear to the observer that the canal size had 
increased, as noted in the qualitative section. This observation is consistent with the findings 
of the 40 paired t-tests.  
 
In connection with the standard histological correlations, it is evident that there is a negative 
correlation between age and cortical area. Therefore, if the average area of the cortical bone 
and the osteons decrease, but the area of the canals stay the same, this would contribute to 
the increased porosity seen in age-related osteoporosis, as observed in the qualitative 
section, and in previous studies (Parfitt, 1984; Paine & Brenton, 2006; Brickley & Ives, 2008). 
These results are consistent with expectations and provide a baseline for the correlation 
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analysis of the pathological samples, as well as linear regression to test the predictive abilities 
of the metric variables. 
 
In the case of the pathological group as with the healthy samples, relationship to age was the 
primary focus of the correlation analysis. In the pathological correlations, 30% (3 of 10) of the 
osteon specific metrics had statistically significant correlations with age, however these 
correlations were much weaker than those seen in the healthy group. All other variables were 
not significantly correlated. The lack of correlation with the canal dimensions is consistent 
with the results from the healthy group and further support the findings of Keough and 
colleagues (2009). The variables that showed statistically significant correlation with age were 
osteon maximum length, osteon area, and osteon minimum length. As with the healthy 
controls, the significance of osteon area agrees with the findings of Goliath and colleagues 
(2016), despite the weaker results from the pathological group. All three variables showed a 




As with the healthy samples, negative correlations between the variables and age imply an 
inverse relationship. It is important to note, however, the strength of these relationships 
declines considerably between the healthy and the pathological samples. Osteon maximum 
length, the strongest correlation in the pathological group, returned a p-value of 0.0263, and 
the other two variables with significant correlations, osteon area and osteon minimum length 
were closer to 0.05. In comparison with the healthy group, osteon total area and osteon 
perimeter do not have a statistically significant relationship with age in the pathological 
group, implying that pathology could influence these values. This corroborates observations 
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made earlier in this study, and from previous studies on histopathology (Schultz, 2001; Paine 
& Brenton, 2006; Schultz, 2012), that pathology can have a significant effect on the 
histomorphometrics of bone. While this was suggested by the results of the standard 
histological analysis, by measuring the dimensions of the osteons, it is now possible to 




7.2.2.5.2 Regression Analysis 
 
 
After the correlations for both the healthy and pathological groups, the results of these 
correlations were then used to inform linear regression models to test the predictive value of 
the relationships. As the five metric variables, osteon area, osteon total area, osteon 
minimum length, osteon perimeter, and osteon maximum length, were all significantly 
correlated with age for the healthy controls, these were the variables selected for regression 
analysis.  
 
The most promising of the healthy variables was osteon area, with an adjusted R2 of 0.3123, 
suggests approximately 31% of the age variance can be attributed to osteon area. Osteon 
total area was also promising with an adjusted R2 of 0.2545, or approximately 25% of the age 
variance attributable to osteon total area. This is consistent with the findings of Goliath and 
colleagues (2016), which found that osteon area combined with osteon circularity in a 
multiple linear regression equation using the femur, produced an accurate formula (within 
roughly 5.9 years) for histological age estimation. Osteon minimum length and osteon 
perimeter were less promising, with adjusted R2 of 0.203 and 0.1988 respectively, or 
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approximately 20% of the age variance attributable to the variables. This does not show a 
strong enough relationship with age to be useful in the context of histological age estimation, 
although it does provide a contrast for comparison with the results of the pathological group 
regressions. The final healthy variable, osteon maximum length, had the weakest result, with 
an adjusted R2 of 0.1558, or approximately 16% of the age variance attributable to osteon 
maximum length. While the last three variables are most likely not useful in terms of 
histological age estimation methods, they do provide a platform for comparison with the 
regression analysis from the pathological group. 
 
The pathological variables were compared with age using linear regression models in the 
same order as the healthy controls. The results of these models take almost reverse order to 
the healthy controls, the osteon total area variable being the weakest, with an adjusted R2 of 
0.0743 or approximately 7% of the age variance attributable to the variable. Osteon area was 
only slightly better, with an adjusted R2 of only 0.0924, or approximately 9% of the age 
variance attributable to osteon area. While the healthy group returned good results for 
possible histological age estimation, it is clear that these variables would only work for a 
healthy population, and any method containing these variables, such as Goliath and 
colleagues (2016),  would not be advised for use on individuals suffering from pathology. The 
variables osteon minimum length and osteon perimeter also returned low adjusted R2, 0.1031 
and 0.0959 respectively, or approximately 10% of the age variance attributable to age. These 
also show a clear difference between the healthy and pathological groups, regarding the 
variables’ relationship with age, although there is less of a difference for osteon minimum 
length and osteon perimeter than for osteon area and osteon total area. The final variable, 
osteon maximum length, returned an adjusted R2 of 0.1522, or approximately 15% of the age 
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variance attributable to the variable. This is very close to the R2 returned by this variable in 
the healthy group, inferring that there is little difference between the healthy and the 
pathological groups with relationship to age for this variable. Although these results could be 
good for potential age estimation, as the regression models for this variable show that it is 
too weak to be useful as a predictor for histological age estimation. 
 
Overall, of the regressions models created for the five most promising osteon metric means, 
the variable with the strongest correlation was the best for predictive purposes, although 
with an adjusted R-squared value of only 0.3123 it would not be recommended to use on its 
own, but rather as part of a multiple linear regression equation, possibly with the standard 
histological variables of OPD or cortical area. Although each metric variable was not valuable 
on its own for their predictive abilities with relation to age, the comparison of the healthy and 
pathological metric means was valuable, illustrating how the changes to the pathological 
microstructure negatively influence the correlations between the histomorphometrics and 
age. This clarifies the observations made from the standard histological regressions, and 
confirms the results of other studies that tested pathological or osteoporotic samples (Paine 
& Brenton, 2006; Cho, et al., 2006; Goliath, et al., 2016).  
 
From these results, a better indication is given of the changes that might be influencing the 
bone remodelling process in pathological individuals, as osteon area and osteon total area, 
which were the most effective models for age prediction in the healthy group, were the 
weakest models for prediction in the pathological group. As for the standard histology 
variable regression models, these results indicate a change in the osteon area caused by the 
pathological imbalance in the bone metabolism. These fundamental changes to the bone 
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microstructure therefore must be taken into account when developing, or using, histological 
age estimation methods, such as Stout and Paine (1992) or Cho and colleagues (2002).  
 
The variables tested between healthy and pathological samples clearly illustrate that changes 
in the microstructure of pathological bone reduce the correlation with age and negatively 
influence age estimation formulae. This is an important outcome as several studies, some of 
which have very limited sample sizes (e.g. Goliath et al., 2016), include pathological cases in 
the sample that is used to produce age estimation formulae without any control for the effect 
that this may have in the reliability of such formulae. Paine and Brenton (2006) have proven 
the relationship between pathology and bone microstructure in the case of pellagra and 
showed its negative influence in age prediction equations. The current study corroborates 
this evidence but larger samples for each pathology are needed in order to better describe in 
detail the associated changes in bone microstructure. As to the purposes of the current 
research it is evident that the inclusion pf pathological samples cannot be recommended 








Modern disease is a challenge for the biological anthropologist and pathologist. For years, as 
archaeological and forensic based biological anthropology are inextricably linked, focus has 
been drawn by diseases of the past. Infections and vitamin deficiencies that, for the most 
part, are gone from the modern world. In their place, new monsters, of our own making, are 
rising from the shadows. Metabolic and lifestyle diseases have existed well before the 
twentieth century, but as infections and deficiencies have receded to the background, non-
communicable diseases have been allowed to come to the fore. In today’s world, it is non-
communicable lifestyle diseases that kill humans by the millions. If biological anthropologists 
wish to apply their knowledge of the human skeleton to these problems, they must adapt to 
these new diseases, and learn to see the marks they leave on the bone.  
 
Bone histology can, and should, be a part of this adaptation. As many of these diseases affect 
bone on a metabolic level, macro assessment of the bones can only tell us so much. By 
examining the bone histologically, we are better able to see and understand the changes to 
the bone on a micro level, to see the imbalance of the bone metabolism as it wreaks havoc 
on the microstructure of the skeleton. Once these changes to the microstructure are 
identified and classified, they can be applied to modern material, as well as historical. As 
histological age estimation methods have been developed and improved over the past 50 
years, acknowledging these changes becomes even more important, especially when it comes 
to the application of forensics. 
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While accuracy is important in the application of methods to archaeological material, it is 
even more vital in the context of forensic applications. An accurate age estimation allows 
forensic anthropologists to help in the identification of deceased individuals, something that 
is becoming ever more significant in light of current world events. With the prevalence of 
these non-communicable diseases in the developing as well as the developed world, it is 
important to consider them when attempting to estimate the age of an individual.  
 
With these considerations in mind, the following are the conclusions drawn from this 
research. 
 
With regards to the qualitative analysis, three categories of micro-morphological features of 
pathological bone were defined. These correspond to three different responses of bone 
metabolism to pathological stimuli.  By categorising these pathological features, it will be 
easier for other pathologists to recognise and replicate the results of this study. It also makes 
it easier to compare the pathological features of different conditions. 
 
The sample sizes of the disease classes make it difficult to assess the connection between any 
particular class and any category of pathological feature. That being said category 1 features 
were overwhelmingly present in most pathological cases. Category 2 features were the 
second most common. Category 3 features, unlike the first two categories, represent a rapid 
deposit of bone and were only present in one case, being the least common of the 
pathological features. While it is unlikely that these categories could be used for diagnostic 
purposes due to the broad definitions and the commonality between disease classes, further 
study into the applications of this categorisation with larger sample sizes could yield more 
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informative results. Expanding into other populations and doing more disease specific studies 
could also enhance our understanding of pathological changes to bone microstructure.  
 
It was also observed that age group had an effect on the appearance of pathological features, 
although this only included category 1 features, and only in the oldest three age groups. This 
skew towards the older age groups does not appear to be as present in the pathological data, 
but as the study included more samples in the older age groups, it would be beneficial for 
further studies to compare across a more even distribution of sample ages, to better 
understand the connection between age and the appearance of pathological features in the 
bone microstructure. 
 
Quantitative analysis served a dual purpose. The first involved the analysis of the data using 
the standard histological variables used for histological age estimation formulae using the rib. 
For the complete set of data, a significant relationship was proven to exist, using correlation 
and regression statistics, between cortical area and age, and OPD and age. These are the same 
statistics Stout and Paine (1992) originally used to create the histological age estimation 
formulae. There was, however, a significant improvement in the relationship between cortical 
area and age, and OPD and age, in the healthy control group. The pathological group had very 
weak relationships, and poor fitting regression regarding the two variables and age. This 
suggests that pathology does have a significant effect on the accuracy of histological age 
estimation techniques. Bootstrapping confirms the fit of the models, alleviating some of the 
pitfalls associated with relatively small sample size. The strength of the relationships between 
the healthy samples and age, and the weakness of the relationships between the pathological 
samples and age, should not only be considered when creating new formulae for new 
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populations, but also for the application of these techniques on potentially pathological 
individuals. Further study involving other populations to investigate whether these 
differences in accuracy exist in them as well should be done to confirm this research. 
 
The second part of the quantitative analysis involved the osteon specific metrics. Welch’s two 
sample t-tests, both for the complete set of data as well as the 40 test pairs proved that there 
was a significant difference between the metrics of the pathological group and the healthy 
control group. While not every metric was significant, the canal dimensions proved to be 
significantly different between the groups. For the paired data, divided into age groups, age 
was proved to be a factor in the number of significantly different metrics, with differences 
peaking in the 41-50 age group at 57%. This is likely due to the fact that by this age, chronic 
conditions have had the time to dramatically affect the bone, but normal changes due to 
aging have not yet begun. These changes should be considered when attempting to estimate 
age for any individuals in these age groups who potentially have pathologically affected bone, 
as the aging affects could obscure the results. These results should also be considered when 
selecting metrics for use in age estimation regression equations. 
 
The metric means of the osteon specific metrics were analysed to assess the potential 
relationships that might exist between any metric and age. Correlation statistics found 
negative relationships between the osteon metric means and age in the healthy control 
group, suggesting osteon dimensions shrink with age, while canal dimensions, which showed 
no correlation with age, would stay the same. These relationships weakened noticeably in the 
pathological group, suggesting pathology has a significant effect on the normal dimensions of 
osteons. While the regressions of these significant relationships were not particularly strong, 
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on their own, they could be useful if incorporated with another variable, such as OPD or 
cortical area, in a multiple linear regression equation. They also proved valuable when 
comparing the relationships of the healthy control groups with the pathological groups, giving 
further evidence of the microstructural differences between pathological and healthy bone. 
As these measurements are new to being used for histological assessment, it is recommended 
that further validation studies, especially on other populations, be undertaken to test the 
accuracy of these assessments. It is also recommended that further inter-observer studies be 
undertaken, to test the repeatability of the method and measurements. 
 
Overall this study succeeded in proving the connection between chronic pathologies with the 
ability to affect the metabolism, and bone microstructure. If there are suspected pathological 
features present when samples are histologically examined, it is suggested that this be 
considered when attempting to estimate age, as this study has proven pathology to affect the 
microstructure of bone. Further studies into specific pathologies, different populations, as 
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A. 1: Spearman’s R and Converted p-values for Standard Histology 
 
















A.2 Regression Outputs for Standard Histology 
 
A.2.1 Complete Sample Regression Model Output: Cortical Area and Age 
 
Residuals: 
  Min      1Q  Median      3Q     Max  
-32.336 -10.564   0.799   9.118  40.673  
 
Coefficients: 
  Estimate Std. Error t value Pr(>|t|)     
(Intercept)  82.1126     5.1013  16.097  < 2e-16 *** 
  CortArea     -1.2744     0.2514  -5.068 2.63e-06 *** 
  --- 
  Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 15.46 on 78 degrees of freedom 
Multiple R-squared:  0.2477, Adjusted R-squared:  0.2381  
F-statistic: 25.69 on 1 and 78 DF,  p-value: 2.633e-06 
 
A.2.2 Pathological Sample Regression Model Output: Cortical Area and Age 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-31.502 -11.520   0.516   8.016  38.504  
 
Coefficients: 
            Estimate Std. Error t value Pr(>|t|)     
(Intercept)  72.0406     8.5843   8.392 3.51e-10 *** 
CortArea     -0.8615     0.3961  -2.175   0.0359 *   
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 15.52 on 38 degrees of freedom 
Multiple R-squared:  0.1107, Adjusted R-squared:  0.0873  
F-statistic:  4.73 on 1 and 38 DF,  p-value: 0.03593 
 
A.2.3 Healthy Sample Regression Model Output: Cortical Area and Age 
 
Residuals: 
   Min     1Q Median     3Q    Max  
-32.39 -11.81   2.39  11.42  23.60  
 
Coefficients: 
            Estimate Std. Error t value Pr(>|t|)     
(Intercept)  87.3396     6.4228  13.598 3.54e-16 *** 
CortArea     -1.4886     0.3416  -4.358 9.63e-05 *** 
--- 
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Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 15.36 on 38 degrees of freedom 
Multiple R-squared:  0.3333, Adjusted R-squared:  0.3157  
F-statistic: 18.99 on 1 and 38 DF,  p-value: 9.625e-05 
 
A.2.4 Complete Sample Regression Model Output: OPD and Age 
 
Residuals: 
  Min      1Q  Median      3Q     Max  
-29.418  -9.674  -1.630   7.496  44.304  
 
Coefficients: 
  Estimate Std. Error t value Pr(>|t|)     
(Intercept)  28.0238     6.5226   4.296 4.96e-05 *** 
  OPD           2.1234     0.4481   4.738 9.51e-06 *** 
  --- 
  Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 15.71 on 78 degrees of freedom 
Multiple R-squared:  0.2235, Adjusted R-squared:  0.2135  




A.2.5 Pathological Sample Regression Model Output: OPD and Age 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-32.332 -11.202   0.203   6.752  41.454  
 
Coefficients: 
            Estimate Std. Error t value Pr(>|t|)     
(Intercept)  47.1246    10.4336   4.517 5.93e-05 *** 
OPD           0.5312     0.7643   0.695    0.491     
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 16.36 on 38 degrees of freedom 
Multiple R-squared:  0.01255, Adjusted R-squared:  -0.01343  
F-statistic: 0.4831 on 1 and 38 DF,  p-value: 0.4913 
 
A.2.6 Healthy Sample Regression Model Output: OPD and Age 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
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-29.869  -8.658  -2.011   6.647  35.464  
 
Coefficients: 
            Estimate Std. Error t value Pr(>|t|)     
(Intercept)  17.5412     7.8482   2.235   0.0314 *   
OPD           2.9633     0.5095   5.817 1.02e-06 *** 
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 13.68 on 38 degrees of freedom 
Multiple R-squared:  0.471, Adjusted R-squared:  0.4571  







A.3 Osteon Specific Metrics Correlations 
 













  Age OMaxLMean OMinLMean OPeriMean OTAreaMean CAreaMean OAreaMean OCircMean CMaxLMean CMinLMean CCircMean 
Age 1 -0.47 -0.48 -0.47 -0.56 -0.1 -0.64 -0.15 -0.16 0.05 0.32 
OMaxLMean -0.47 1 0.85 0.93 0.89 0.61 0.89 -0.02 0.67 0.5 -0.45 
OMinLMean -0.48 0.85 1 0.87 0.9 0.63 0.89 0.2 0.66 0.63 -0.29 
OPeriMean -0.47 0.93 0.87 1 0.94 0.64 0.93 -0.07 0.75 0.53 -0.49 
OTAreaMean -0.56 0.89 0.9 0.94 1 0.72 0.95 0.07 0.76 0.59 -0.38 
CAreaMean -0.1 0.61 0.63 0.64 0.72 1 0.52 -0.06 0.93 0.84 -0.14 
OAreaMean -0.64 0.89 0.89 0.93 0.95 0.52 1 0.05 0.6 0.43 -0.46 
OCircMean -0.15 -0.02 0.2 -0.07 0.07 -0.06 0.05 1 -0.18 0.02 0.39 
CMaxLMean -0.16 0.67 0.66 0.75 0.76 0.93 0.6 -0.18 1 0.81 -0.37 
CMinLMean 0.05 0.5 0.63 0.53 0.59 0.84 0.43 0.02 0.81 1 -0.06 
CCircMean 0.32 -0.45 -0.29 -0.49 -0.38 -0.14 -0.46 0.39 -0.37 -0.06 1 
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A.3.2 Converted p-value Healthy Osteon Specific Metrics Correlations 
 
  Age OMaxLMean OMinLMean OPeriMean OTAreaMean CAreaMean OAreaMean OCircMean CMaxLMean CMinLMean CCircMean 
Age   0.0036 0.0028 0.003 0.0003 0.5466 0 0.3618 0.3463 0.775 0.0523 
OMaxLMean 0.0036   0 0 0 0 0 0.8958 0 0.0014 0.0054 
OMinLMean 0.0028 0   0 0 0 0 0.2356 0 0 0.0802 
OPeriMean 0.003 0 0   0 0 0 0.6737 0 0.0007 0.0019 
OTAreaMean 0.0003 0 0 0   0 0 0.687 0 0.0001 0.0215 
CAreaMean 0.5466 0 0 0 0   0.0009 0.7264 0 0 0.417 
OAreaMean 0 0 0 0 0 0.0009   0.7539 0 0.008 0.0043 
OCircMean 0.3618 0.8958 0.2356 0.6737 0.687 0.7264 0.7539   0.2763 0.8947 0.0162 
CMaxLMean 0.3463 0 0 0 0 0 0 0.2763   0 0.0226 
CMinLMean 0.775 0.0014 0 0.0007 0.0001 0 0.008 0.8947 0   0.7025 
CCircMean 0.0523 0.0054 0.0802 0.0019 0.0215 0.417 0.0043 0.0162 0.0226 0.7025   
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A.3.3 Spearman’s R Pathological Osteon Specific Metrics Correlations 
 
  Age OMaxLMean OMinLMean OPeriMean OTAreaMean CAreaMean OAreaMean OCircMean CMaxLMean CMinLMean CCircMean 
Age 1 -0.36 -0.32 -0.31 -0.3 -0.1 -0.33 -0.03 -0.18 -0.08 0.14 
OMaxLMean -0.36 1 0.93 0.97 0.95 0.61 0.94 -0.09 0.68 0.57 -0.07 
OMinLMean -0.32 0.93 1 0.95 0.97 0.61 0.97 0.14 0.66 0.62 0.09 
OPeriMean -0.31 0.97 0.95 1 0.97 0.61 0.96 -0.04 0.69 0.58 -0.07 
OTAreaMean -0.3 0.95 0.97 0.97 1 0.63 0.97 0.05 0.71 0.62 0.02 
CAreaMean -0.1 0.61 0.61 0.61 0.63 1 0.5 0.16 0.91 0.96 0.26 
OAreaMean -0.33 0.94 0.97 0.96 0.97 0.5 1 0.03 0.59 0.5 0 
OCircMean -0.03 -0.09 0.14 -0.04 0.05 0.16 0.03 1 0.02 0.21 0.56 
CMaxLMean -0.18 0.68 0.66 0.69 0.71 0.91 0.59 0.02 1 0.9 0.01 
CMinLMean -0.08 0.57 0.62 0.58 0.62 0.96 0.5 0.21 0.9 1 0.35 




A.3.4 Converted p-values Pathological Osteon Specific Metrics Correlations 
 
  Age OMaxLMean OMinLMean OPeriMean OTAreaMean CAreaMean OAreaMean OCircMean CMaxLMean CMinLMean CCircMean 
Age   0.0263 0.0493 0.0524 0.0629 0.5286 0.0375 0.8683 0.2721 0.6397 0.4045 
OMaxLMean 0.0263   0 0 0 0 0 0.5737 0 0.0001 0.6916 
OMinLMean 0.0493 0   0 0 0 0 0.3985 0 0 0.5872 
OPeriMean 0.0524 0 0   0 0 0 0.8105 0 0.0001 0.6898 
OTAreaMean 0.0629 0 0 0   0 0 0.7485 0 0 0.9085 
CAreaMean 0.5286 0 0 0 0   0.0012 0.3234 0 0 0.1135 
OAreaMean 0.0375 0 0 0 0 0.0012   0.8439 0 0.0011 0.9824 
OCircMean 0.8683 0.5737 0.3985 0.8105 0.7485 0.3234 0.8439   0.8804 0.1905 0.0002 
CMaxLMean 0.2721 0 0 0 0 0 0 0.8804   0 0.9522 
CMinLMean 0.6397 0.0001 0 0.0001 0 0 0.0011 0.1905 0   0.0309 
CCircMean 0.4045 0.6916 0.5872 0.6898 0.9085 0.1135 0.9824 0.0002 0.9522 0.0309   
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A.4 Osteon Specific Metrics Regression Outputs 
 
A.4.1 Healthy Regression Model Osteon Area 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-43.436  -8.011  -0.546  11.557  31.753  
 
Coefficients: 
              Estimate Std. Error t value Pr(>|t|)     
(Intercept)  1.044e+02  1.063e+01   9.823 1.35e-11 *** 
OAreaMean   -1.446e-03  3.473e-04  -4.165 0.000193 *** 
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 15.65 on 35 degrees of freedom 
Multiple R-squared:  0.3314, Adjusted R-squared:  0.3123  
F-statistic: 17.35 on 1 and 35 DF,  p-value: 0.0001931 
 
A.4.2 Pathological Regression Model Osteon Area 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-32.578 -12.481   2.482   9.615  40.501  
 
Coefficients: 
              Estimate Std. Error t value Pr(>|t|)     
(Intercept) 78.3634634 11.1873066   7.005 2.79e-08 *** 
OAreaMean   -0.0008640  0.0003916  -2.206   0.0336 *   
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 15.65 on 37 degrees of freedom 
Multiple R-squared:  0.1163, Adjusted R-squared:  0.09239  
F-statistic: 4.868 on 1 and 37 DF,  p-value: 0.03365 
 
A.4.3 Healthy Regression Model Osteon Total Area 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-44.210  -9.214  -0.199   9.741  31.316  
 
Coefficients: 
              Estimate Std. Error t value Pr(>|t|)     
(Intercept)  1.011e+02  1.119e+01   9.033 1.13e-10 *** 
OTAreaMean  -1.156e-03  3.172e-04  -3.645 0.000859 *** 
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--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 16.29 on 35 degrees of freedom 
Multiple R-squared:  0.2752, Adjusted R-squared:  0.2545  
F-statistic: 13.29 on 1 and 35 DF,  p-value: 0.0008589 
 
A.4.4 Pathological Regression Model Osteon Total Area 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-32.928 -11.947   2.153   9.383  40.977  
 
Coefficients: 
              Estimate Std. Error t value Pr(>|t|)     
(Intercept) 77.2264158 11.6661447   6.620 9.15e-08 *** 
OTAreaMean  -0.0007242  0.0003598  -2.012   0.0515 .   
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 15.81 on 37 degrees of freedom 
Multiple R-squared:  0.09866, Adjusted R-squared:  0.0743  
F-statistic:  4.05 on 1 and 37 DF,  p-value: 0.05149 
 
A.4.5 Healthy Regression Model Osteon Minimum Length 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-41.739  -5.218   0.181  12.106  27.632  
 
Coefficients: 
            Estimate Std. Error t value Pr(>|t|)     
(Intercept) 137.3212    23.9512   5.733 1.73e-06 *** 
OMinLMean    -0.4465     0.1400  -3.189  0.00301 **  
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 16.85 on 35 degrees of freedom 
Multiple R-squared:  0.2251, Adjusted R-squared:  0.203  
F-statistic: 10.17 on 1 and 35 DF,  p-value: 0.003008 
 
A.4.6 Pathological Regression Model Osteon Minimum Length 
 
Residuals: 
    Min      1Q  Median      3Q     Max  




            Estimate Std. Error t value Pr(>|t|)     
(Intercept) 103.0467    21.1816   4.865 2.14e-05 *** 
OMinLMean    -0.3010     0.1299  -2.317   0.0261 *   
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 15.56 on 37 degrees of freedom 
Multiple R-squared:  0.1267, Adjusted R-squared:  0.1031  
F-statistic: 5.369 on 1 and 37 DF,  p-value: 0.02614 
 
A.4.7 Healthy Regression Model Osteon Perimeter 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-44.663  -5.758  -0.841   9.904  33.400  
 
Coefficients: 
             Estimate Std. Error t value Pr(>|t|)     
(Intercept) 132.73148   22.78609   5.825 1.31e-06 *** 
OPeriMean    -0.10737    0.03407  -3.151  0.00332 **  
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 16.89 on 35 degrees of freedom 
Multiple R-squared:  0.221, Adjusted R-squared:  0.1988  
F-statistic: 9.931 on 1 and 35 DF,  p-value: 0.003323 
 
A.4.8 Pathological Regression Model Osteon Perimeter 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-32.797 -11.619   0.973   9.210  39.766  
 
Coefficients: 
             Estimate Std. Error t value Pr(>|t|)     
(Intercept) 105.08567   22.78209   4.613 4.64e-05 *** 
OPeriMean    -0.07941    0.03541  -2.242    0.031 *   
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 15.62 on 37 degrees of freedom 
Multiple R-squared:  0.1196, Adjusted R-squared:  0.09585  




A.4.9 Healthy Regression Model Osteon Maximum Length 
 
Residuals: 
    Min      1Q  Median      3Q     Max  
-44.719  -7.764  -0.088  10.177  34.950  
 
Coefficients: 
             Estimate Std. Error t value Pr(>|t|)     
(Intercept) 123.48840   22.48244   5.493 3.31e-06 *** 
OMaxLMean    -0.25091    0.08969  -2.798  0.00821 **  
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 17.24 on 36 degrees of freedom 
Multiple R-squared:  0.1786, Adjusted R-squared:  0.1558  
F-statistic: 7.827 on 1 and 36 DF,  p-value: 0.008214 
 
A.4.10 Pathological Regression Model Osteon Maximum Length 
 
Residuals: 
   Min     1Q Median     3Q    Max  
-33.51 -11.98   1.44  10.15  41.48  
 
Coefficients: 
             Estimate Std. Error t value Pr(>|t|)     
(Intercept) 110.77934   20.33621   5.447 3.52e-06 *** 
OMaxLMean    -0.23791    0.08506  -2.797  0.00814 **  
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 15.13 on 37 degrees of freedom 
Multiple R-squared:  0.1745, Adjusted R-squared:  0.1522  
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